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8Chapter 1
General Introduction
Serotonin (5-hydroxytryptamine or 5-HT) is implicated in many physiological and behavioral 
processes, including thermoregulation, sleep, feeding and sexual behavior. Moreover, 
disturbances in the 5-HT system are known to be involved in neuropsychiatric disorders 
including anxiety, aggression, impulsivity and mood disturbances (Delgado et al., 1990; Griebel, 
1995; Barnes & Sharp, 1999; Stain-Malmgren et al., 2001; Neumeister et al., 2002; Moreno et al., 
2002; Holmes et al., 2003c); however, the exact role of 5-HT in the etiology and cause of these 
neuropsychiatric disorders is not known. The pharmacotherapy of patients with these diseases 
that encompasses agents that modulate serotonergic neurotransmission, is beset by problems 
of poor efficacy and is marked by many unwanted sideeffects. Therefore, it would be useful 
to use a model in which these disorders can be studied. The laboratory rat is one of the most 
extensively studied model organisms for various aspects of human medical research, including 
neural regeneration, psychiatric disorders, behavioral intervention, and addiction, as well as 
drug development (Jacob & Kwitek, 2002; Gibbs et al., 2004). The wealth of literature on the rat 
helps to interpret novel findings. Many behavioral tests have been developed and validated 
for rats, and rat behavioral repertoires and related neural correlates have been welldescribed. 
Furthermore, most rat models have phenotypic characteristics that are relevant to a particular 
human condition. Initially these phenotypes were induced surgically or pharmacologically, but 
eventually these models were developed by phenotypic selection for certain traits. Rat models 
have made inestimable contributions to biomedical research in general, and although they 
do not always recapitulate the clinical outcome of human diseases, animal models are crucial, 
especially when little is known about the basis of a complex human disease. Thus, animal models 
can provide important insights into clinically relevant pathways, besides being a means to 
investigate candidate disease genes. 
As the mouse can easily be manipulated genetically, many mouse models are in use nowadays  for 
biomedical research. Among these mouse models  are  models for human serotonergic disorders, 
like the 5-HT1A knockout mouse (Ramboz et al., 1998), the 5-HT1B knockout mouse (Saudou et 
al., 1994), and the serotonin transporter knockout mouse (Bengel et al., 1998). However, mice 
and rats do differ, for example in their physiological responses to 5-HT1A receptor agonists and 
antagonists (Goodwin et al., 1985b; Bill et al., 1991; Moser, 1991; Martin et al., 1992; Meller et al., 
1992; Millan et al., 1993; De Vry, 1995). Therefore, it is important to generate knockout rats to 
study human disorders. In this thesis we propose the serotonin transporter knockout (SERT-/-) 
rat as a model for human serotonergic disorders, especially neuropsychiatric disorders such as 
anxiety and depression. While research on SERT-/- mice has already revealed several novel 5-HT-
mediated phenotypes and processes, the SERT-/- rat allows complementary in-depth research 
through its greater potential of behavioral and neurochemical techniques. 
As elaborated in paragraph 2 of this chapter, the serotonin transporter (SERT) has been 
implicated in several 5-HT disorders and is an important target site for a number of drugs that 
are given to subjects suffering from neuropsychiatric diseases. In the first five paragraphs of 
this chapter attention is therefore focussed on (1) the synthesis and metabolism of serotonin as 
well as its receptors, (2) the SERT, (3) tryptophan depletion as a tool to analyse the vulnerability 
of individuals (humans and animals) for central serotonergic disorders, (4) the involvement of 
serotonin in neuropsychiatric disorders such as anxiety and depression, and (5) the involvement 
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of serotonin in the regulation of hypothermia and stress-induced hyperthermia, i.e. characteristic 
dysfunction of the autonomic nervous system. In paragraph six the SERT-/-   rat is introduced. In 
the final paragraph of this chapter the aim and outline of this thesis are described.   
1.  Synthesis and metabolism of serotonin and the involvement of  its 
receptors
5-HT has long been the subject of study in many areas of biomedical sciences. In the body, 95% 
of total 5-HT is found in the periphery. Therefore, it is no coincidence that initial research was 
focussed on this area.  After it was found in the mammalian brain, 5-HT was recognized as a 
neurotransmitter, bringing it into the field of neuroscience. These findings were followed by the 
discovery that 5-HT plays an important role in many physiological and behavioral processes. 
5-HT is synthesized in a two-step enzymatic pathway. The hydroxylation of the aromatic amino 
acid tryptophan forming 5-hydroxytryptophan (5-HTP) by the rate-limiting enzyme tryptophan 
hydroxylase is the first step in the synthesis of 5-HT. 5-HTP is then converted into 5-HT by 
the enzyme L-amino acid decarboxylase. As shown in Figure 1, metabolism of 5-HT primarily 
occurs by deamination via mitochondrial monoamine oxidase (MAO) to form 5-hydroxy-indole 
acetaldehyde, which in turn is oxidized by aldehyde dehydrogenase to produce 5-hydroxyindole 
acetic acid (5-HIAA). MAOs are degradative enzymes of monoamines, such as norepinephrine, 
5-HT, and dopamine. There are two subtypes of MAO, MAO-A and MAO-B, based on their selectivity 
to substrate and inhibitors. Whereas MAO-A preferentially metabolizes norepinephrine and 5-HT, 
MAO-B acts on dopamine. Any cell that can take up 5-HT and possesses MAO has the potential 
to metabolize 5-HT.
Serotonergic cell bodies are mainly located in the mid- and hindbrain (Tork, 1990). Serotonergic 
neurons originate from the raphe nuclei and project to many brain areas, including the 
prefrontal cortex, the amygdala, the hippocampus, the medial preoptic area, the hypothalamus 
and the ventral striatum. They also project to caudal areas like the cerebellum, medulla and 
spinal cord (Jacobs & Azmitia, 1992). The effects of 5-HT are mediated by at least 14 different 
5-HT receptors: 5-HT1A, 5-HT1B , 5-HT1D, 5-HT1E, 5-HT1F, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT3, 5-HT4, 5-HT-
5A, 5-HT5B, 5-HT6, and 5-HT7. These receptors are anatomically localized at different sites in 
the CNS (Palacios et al., 1990). Besides all these receptors the SERT plays an important role in 
the modulation of 5-HT. The SERT is localized both at the terminal portion of the axon and at 
the cell body of the 5-HT neuron (D’Amato et al., 1987; Hrdina et al., 1990; Chen et al., 1992). 
Figure 1
Synthesis and metabolism of 5-HT.
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The activity of a serotonergic neuron is presumably regulated via two different presynaptic 
receptors (5-HT1A and 5-HT1B) and the SERT (Pineyro & Blier, 1999). When the serotonergic neuron 
fires, 5-HT is released from the terminal and activates all available 5-HT receptors at that time. 
Several mechanisms are  at work in order to regulate the firing and the release of 5-HT. First the 
SERT in the synaptic terminal and at the cell bodies and the dendrites of the 5-HT neurons return 
5-HT back into the neuron via an uptake mechanism, where it is degraded or retained for future 
release (Murphy et al., 2004). This 5-HT uptake is very important in order to end the 5-HT signalling, 
thereby avoiding overstimulation of receptors, restoring the resting condition of a cell, and be 
able to fire again. Besides activation of the SERT, activation of the somatodendritic 5-HT1A (at the 
level of the cell body and dendrites) and 5-HT1B (at the level of the synaptic terminals) presynaptic 
receptors also contribute to the inhibition of firing and release of 5-HT. The interaction between 
these three processes leads to a very fine-tuned system of serotonergic activity.
2. Serotonin transporter
The SERT is important for two reasons. First, genetically determined changes of the SERT gene are 
associated with certain neuropsychiatric diseases. Second, the SERT is the target site for a number 
of pharmacotherapeutic agents that are prescribed for patients with various neuropsychiatric 
disorders. These aspects are elaborated below.
The SERT gene (SLC6A4) is located on chromosome 17 and consists of 14 exons. The protein 
contains 630 amino acids with 12 transmembrane domains. The SERT is associated with several 
human neuropsychiatric disorders (Murphy et al., 1999; Gingrich & Hen, 2001; Holmes et al., 
2003c). Like  non-human primates, humans exhibit a polymorphism in the SERT gene, termed 
the 5-HTTLPR. The 5-HTTLPR is a 44-base pair deletion/insertion of a repetitive sequence in the 
promoter region upstream of the transcription initiation site of the SERT gene. Studies in reporter 
gene constructs and in human lymphoblastic cell lines have found that the short variant (S) of 
the polymorphism reduces the transcriptional efficiency of the SERT gene as compared to the 
long (L) variant (Lesch et al., 1996; Heils et al., 1996; Heils et al., 1997). Moreover, the L variant 
shows a more rapid initial platelet 5-HT uptake (Greenberg et al., 1999). Originally, this did not 
hold true for SERT mRNA levels (Parsey et al., 2006) and SERT binding (Naylor et al., 1998; Mann 
et al., 2000; Willeit et al., 2001; Shioe et al., 2003; Lim et al., 2006) in the brain. Van Dyck et al. 
(2004) have even found that the SERT availability in young S-S homozygotes is greater than  in 
young L-S heterozygotes. This apparent discrepancy between the periphery and the brain can 
be understood by considering the findings of Nakamura et al. (2000). They describe several 
novel variants of S and L,  including a functional single nucleotide variant within the L allele, 
designated L(A) and L(G). Interestingly, only L(A) is associated with high levels of in vitro SERT 
mRNA transcription, whereas L(G) is low expressing and more similar to S (Hu et al., 2006). This 
also holds for  the brain, where the L(A)/L(A) is associated with higher SERT binding potential 
in the putamen (Praschak-Rieder et al., 2007). Hence, the original failure to observe 5-HTTLPR-
related changes in central SERT binding in previous studies may be explained by the pooling 
of L(A) and L(G) allelic variants. Anyhow, there is hard evidence that a reduced SERT expression 
resulting in a reduced SERT function, as seen in the subjects with the S variant, is associated 
with anxiety- and depression-related personality traits;  it exhibits more depressive symptoms, 
diagnosable depression, and suicidal tendencies in  case of stressful events (Mann et al., 2000; 
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Caspi et al., 2003; Schmitz et al., 2007; Dick et al., 2007; Canli and Lesch, 2007).  Not every study 
has reached the same conclusion in this respect though (e.g. Lang et al., 2004). Overall, HTTLPR 
association studies lead to the hypothesis that the HTTLPR, together with other regulatory and 
structural variations, seems to play a role in neuropsychiatric conditions such as bipolar disorder, 
depression, anxiety disorders (in particular obsessive-compulsive disorder), suicidal tendencies, 
eating disorders, substance-abuse disorders, autism, attention-deficit/hyperactivity disorder and 
neurodegenerative disorders (Greenberg et al., 2000; Murphy et al., 2004; Hu et al., 2006).  Hu et al. 
(2006) found that the L(A)/L(A) genotype was about twice as common in patients with obsessive-
compulsive disorder compared to healthy people; Lesch et al. (1996) found a negative association 
between the S variant and agreeableness. However, most studies reveal an association between 
the S variant and an increased risk  of neuropsychiatric conditions.
Apart from the involvement of SERT in neuropsychiatric diseases, the SERT is the actual target 
site for a whole subclass of antidepressants, namely the Selective Serotonin-Reuptake Inhibitors 
(SSRI’s). SSRIs like paroxetine, citalopram, fluoxetine, fluvoxamine, and sertraline are widely used 
in the treatment of depression, anxiety, and impulse control disorders, as well as substance abuse 
including alcoholism. SSRIs elevate the extracellular 5-HT levels in the CNS through blockade of 
the SERT (Nutt et al., 1999; Vaswani et al., 2003). The SERT promoter polymorphism also seems to 
be associated with therapeutic responses and side-effects following treatment with citalopram 
(Hu et al., 2007). Together, these data imply an important role for the SERT in the CNS. 
3.  Tryptophan depletion to analyze the vulnerability of individuals for 
central serotonergic disorders
As mentioned before, 5-HT is synthesized from its amino acid precursor tryptophan (TRP), which 
is taken up from the blood. While most of the TRP is protein-bound, approximately 5% of the TRP 
circulates free in the bloodplasma and is available for transport to the brain. Although 5-HT itself 
is not able to pass the blood-brain barrier, (free) TRP can be actively transported to the central 
nervous system. However, this transport system also transports five other large neutral amino acids 
(LNAAs) namely tyrosine, phenylalanine, leucine, isoleucine and valine. These LNAAs also enter 
the circulation when food is consumed, implying that TRP has to compete with them.  Therefore, 
the access of TRP to the brain depends not only on serum TRP levels itself, but also on the serum 
concentrations of the other large neutral amino acids that compete with TRP for uptake (Guroff 
& Udenfriend, 1962; Fernstrom & Wurtman, 1972). Once in the brain, TRP is converted into 5-HT 
(see figure 2). The availability of free plasma TRP is thus a limiting factor in the synthesis of 5-HT. 
Therefore, acute tryptophan depletion (ATD) is used as a tool to challenge the 5-HT system by 
reducing systemic TRP levels and, consequently, central 5-HT concentrations (Biggio et al., 1974; 
Gessa et al., 1974; Fernstrom, 1981; Moja et al., 1989). To investigate the role of 5-HT in behavioral 
functions (e.g. anxiety, sleep, aggression, memory, impulsivity) ATD is a validated model that 
can be used in humans as well as in animals (Young, 1996; Moore et al., 2000; Bell et al., 2001). 
Administration of an amino acid mixture that lacks TRP has been shown to reduce plasma TRP 
levels and 5-HT tissue levels in the brain of the rat (Biggio et al., 1974; Gessa et al., 1974; Moja 
et al., 1989; Brown et al., 1998). Moreover, TRP depletion has been shown to lower extracellular 
5-HT levels in the hippocampus (Stancampiano et al., 1997). Previous studies using a gelatin-
based-carbohydrate mixture showed a robust reduction in plasma TRP (about 70%) and central 
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tissue 5-HT (about 40–45%) concentrations in Wistar 
rats (Lieben et al., 2004a; Jans et al., 2007a). Moreover, 
this ATD method has been reported to impair object 
memory, but not affective behavior in rats (Lieben et 
al., 2004b). This memory impairment has also been 
shown in healthy human volunteers, whereas other 
effects of ATD, such as effects on mood, are only found 
in vulnerable subjects (Riedel et al., 1999; Schmitt et al., 
2000; Riedel et al., 2002). 
 Some controversy has been found in TRP depletion 
studies. The inconsistency may be related to the degree 
of TRP depletion used in these studies. It seems like a 
certain threshold level needs to be exceeded before 
certain effects will appear that are due to the depletion. 
An overview of several TRP depletion studies given 
by Van Der Does (2001) suggests that the threshold 
for possible mood effects to occur lies somewhere 
around a 60% reduction of free plasma TRP. High and 
low TRP depletion turned out to give different results in 
depressed patients. An impaired processing of positive 
information was found in all patients after a high dose 
of TRP depletion, whereas no impairment was found at 
all after a low dose of TRP depletion (Booij et al., 2005). 
These results together confirm the idea of a threshold 
that needs to be exceeded before symptoms occur after 
TRP depletion.
4.  Involvement of serotonin in neuro-
psychiatric disorders such as anxiety and 
depression
Mood and anxiety disorders are generally classified 
as separate types of syndromes; however, depression 
and anxiety share many overlapping symptoms, 
including impaired concentration, fatigue, irritability, sleep disturbance, nervousness, worry, 
and restlessness (Ninan, 1999).  It is widely accepted that diminished serotonergic functioning is 
involved in the onset of depression. Indirect measures of precursor availability and metabolite 
concentrations provided initial evidence for abnormalities in the system. In depressed patients, 
alterations such as decreased plasma tryptophan levels (Coppen et al., 1973; Cowen et al., 1989) 
have been found. In addition, decreased 5-HIAA levels in cerebrospinal fluid (CSF) (Asberg et 
al., 1976a), suggesting decreased 5-HT metabolism in the CNS, have been found in depression. 
Moreover, imaging studies have shown that the binding of both pre- and postsynaptical 5-HT1A 
receptors in the brain is reduced and fails to normalize after remission for depression (Drevets et 
al., 1999; Sargent et al., 2000). In patients with major depression a decreased availability of SERT 
has been found in the midbrain and brainstem regions (Malison et al., 1998). Another indication 
Figure 2
The ratio of total tryptophan to the diet-
induced changes in brain serotonin con-
centration in the rat. Combined levels of 
tyrosine, phenylalanine, Ieucine, isoleu-
cine, and valine in serum determines the 
tryptophan level in brain.
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that 5-HT is involved in the onset of depression is that consequent lowering of brain 5-HT, by 
means of tryptophan depletion, can cause transient depressive symptoms in individuals that are 
vulnerable for depression, based on their personal or family history of depression (Ellenbogen et al., 
1999; Klaassen et al., 1999; Moreno et al., 2002; Neumeister et al., 2004). Some 5-HT abnormalities 
have also been found in subjects with a family history of depression or in remitted depressed 
patients, indicating that either some dysfunction in 5-HT systems or an increased sensitivity of 
the 5-HT system is a trait abnormality in depression. Further evidence for abnormalities in 5-HT 
transmission are the findings of reduced SERT binding in the post-mortem cortex of depressed 
patients (Leake et al., 1991; Mann et al., 2000); however, this was not consistently found (Lawrence 
et al., 1993). In brain imaging studies fewer SERT have been reported in depressed patients as 
well (Malison et al., 1998). In addition, reduced 5-HT uptake and reduced SERT binding have 
been found in platelets (Owens & Nemeroff, 1994). Reduced SERT binding has also been found 
in anxiety disorders (Iny et al., 1994). Overall, the data is quite consistent indicating that the 5-HT 
system exhibits decreased activity. Alterations in the 5-HT system likely mediate many of the 
signs and symptoms of depression and anxiety. Apparently either underactivity or overactivity 
of the 5-HT system can cause anxiety and mood disorders. Therefore, it is essential that the 5-HT 
system functions properly during development and adulthood to prevent the development of 
anxiety and mood disorders.
5.  Involvement of serotonin in the regulation of hypothermia and stress-
induced hyperthermia
Hypothermia
Autonomic responses to selective 5-HT1A receptor agonists are frequently used to measure the 
5-HT1A receptor function (Hjorth, 1985; Millan et al., 1993; De Vry, 1995; Cryan et al., 1999; Ootsuka 
and Blessing, 2003; Nalivaiko et al., 2005; Ootsuka and Blessing, 2006). Selective 5-HT1A receptor 
agonists are known to cause hypothermia in both animals (Hjorth, 1985; Millan et al., 1993; De 
Vry, 1995; Cryan et al., 1999; Bouwknecht et al., 2000) and humans (Pitchot et al., 2002; Pitchot 
et al., 2004). The hypothermic response to 5-HT1A receptor agonists in rats and humans appear 
to be mediated by postsynaptic 5-HT1A receptors (Bill et al., 1991; Millan et al., 1993; Blier et al., 
2002), although some researchers have suggested that these effects are mediated by presynaptic 
receptors in rats (Goodwin et al., 1987; Higgins et al., 1988; Hillegaart, 1991) and mice (Goodwin et 
al., 1985b; Bill et al., 1991; Martin et al., 1992). In addition to 5-HT1A receptor agonists, 5-HT7 receptor 
agonists are also able to induce hypothermia (Vinkers et al., in press). Besides the induction of 
hypothermia, 5-HT receptors are also involved in hyperthermia. 5-HT2 receptor agonists increase 
the basal temperature, whereas 5-HT2 receptor antagonists prevent this hyperthermia and even 
reduce the temperature (Zethof et al., 1995; Nisijima et al., 2001; Yamada et al., 2001). Overall 
these data show that multiple 5-HT receptors play a role in the regulation of body temperature.
Stress-induced hyperthermia
Body temperature is not only affected by pharmacological agents, but also increases when an 
organism is confronted with a stressor. This relatively short-lasting increase in body temperature 
is generally referred to as stress-induced hyperthermia (SIH) (Friedman & Thayer, 1998; Nijsen et 
al., 1998a; Olivier et al., 1998; Bouwknecht et al., 2000). SIH is an integral part of an individual’s 
response to situations perceived as threatening or distressing (Reeves et al., 1985). Several 
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psychological and physical stressors may induce SIH, for example taking an exam (Marazziti 
et al., 1992) or attending a sports contest (Renbourn, 1960). In animals, a mild disturbance 
(Bouwknecht et al., 2001), injection (Olivier et al., 2003), clean cage (Spooren et al., 2002; Groenink 
et al., 2003), predator smell (Rorick-Kehn et al., 2005), or restraint stress (Terlouw et al., 1996) 
induces hyperthermia. The SIH has a high face validity, since a stress-induced temperature rise is 
a universal phenomenon that occurs in many species (for a review, see Bouwknecht et al., 2007), 
including rats (Briese and De Quijada, 1970; Briese and Cabanac, 1991), rabbits (Yokoi, 1966) and 
humans (Marazziti et al., 1992). 
Administration of drugs with anxiolytic properties, like GABAA and 5-HT receptor agonists, results 
in a reduction or even ablation of the SIH response; however, as described before, anxiolytic 
drugs may also induce hypothermia. In this way, especially after high doses of the drug, the SIH 
is reduced or ablated because of the hypothermia and not because of the anxiolytic mode of 
action of the drugs (Olivier et al., 2003). Extensive pharmacological testing has shown that the SIH 
model is suitable for predicting anxiolytic drug properties. Benzodiazepines and 5-HT1A receptor 
agonists, drugs that have been proven to be effective in the clinic, attenuate the SIH response 
(Olivier et al., 2003). SSRIs do not seem to have an effect on the SIH acutely (Olivier et al., 2003) 
or chronically (Roche et al., 2007); however, Conley and Hutson (2007) showed a reduction of the 
SIH after treatment with fluoxetine. Together these data suggest that the SIH model is sensitive 
to anxiolytic drugs and the 5-HT system seems to be involved. 
6. Serotonin transporter knockout rat
The laboratory rat is one of the most extensively studied model organisms in various areas of 
human health and disease. The wealth of literature on the rat helps interpreting novel findings. 
Further, many behavioral tests have been developed and validated for rats, and rat behavioral 
repertoires and related neural correlates have been well-described. Rats are also preferred 
because of their relatively large size, which allows for the effective use of a wide variety of tools to 
study the brain, such as imaging, micromanipulation and in vivo sampling. In 2004, the rat joined 
the mouse and human as the third vertebrate species for which the complete genome sequence 
(more than 90% coverage) has been determined (Gibbs et al., 2004). For these reasons, knockout 
rats would be valuable models in, among others, neuroscience research, and could complement 
knockout mice studies to dissect gene-behavior associations.
As a genetic model, the rat is clearly lagging behind the mouse, primarily because gene knockout 
technology using pluripotent embryonic stem (ES) cells is still lacking due to the lack of suitable 
ES cell lines. An alternative approach to the embryonic stem cell technique for generating 
genetic knockouts is target-selected mutagenesis or TILLING (Targeting Induced Local Lesions 
in Genomes). Recently, N-ethyl-N-nitrosourea (ENU)-driven target selected mutagenesis was 
successfully established for the rat (Zan et al., 2003; Smits et al., 2004; Smits et al., 2006). The 
approach starts with inducing mutagenesis of the male germline by intraperitoneal injection 
of ENU. ENU induces random point mutations, primarily in spermatogonial stem cells. These 
mutations become fixed in the sperm cells during spermatogenesis, which lasts approximately 
12 weeks in rats. Mutagenized males are mated with untreated females to generate a large 
population of F1 animals that harbour many random heterozygous point mutations in their 
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genome. Next, DNA samples are extracted 
from each F1 individual. These samples are 
subsequently screened for induced mutations in 
exons of interest (see Figure 3). 
The most deleterious type of mutation is the 
nonsense mutation or premature stopcodon, 
which interrupts the translation process. 
Mutations can also involve missense mutations, 
amino acid changes that could lead to structural 
and/or functional changes of the protein, e.g. 
when the amino acid change is located in a 
conserved region of the protein. Splice-site 
mutations affect alternative splicing processes and are of interest as well. Silent mutations are 
not expected to have any phenotypic effects (Smits & Cuppen, 2006). The dideoxy resequencing 
allows the detection of all types of mutations. The dideoxy resequencing method, applied 
to approximately 400 amplicons (~200 genes) in 1500 rats (mainly Wistars), resulted in the 
identification of more than 120 ENU-induced mutations. These included  fifty-six missense and 
six nonsense mutations, among which a premature stopcodon in the SERT gene. To be precise, 
the ENU-induced mutagenesis caused a C to A transversion at position 3924 in the third exon 
encoding the second extracellular loop of the SERT (ENSRNOG0000003476) in a female F1 rat 
with a Wistar/Crl background, resulting in a premature stopcodon (TGC > TGA). As described 
above, the SERT is very important in the CNS, making this rat an interesting model to study 
dysfunctions in the serotonergic system.
7. Aim and outline of the thesis
The SERT is a major regulator of synaptic 5-HT availability, and is very important in processes 
in which 5-HT is involved. The aim of the present thesis was to phenotypically characterize a 
rat that lacks the SERT. Several behavioral paradigms were assessed in the SERT-/- rat, and 
pharmacological and physiological parameters were measured. Following the introductory 
chapter, the experimental outcome of our studies is  presented in the next five chapters. The final 
chapter is devoted to a discussion of the results described in chapters 2-6. 
Disturbances in the 5-HT system are known to be involved in many neuropsychiatric disorders, 
although the exact role of 5-HT in these disorders is not known. Chapter 1 gives an overview 
of the synthesis and metabolism of 5-HT and 5-HT receptors. Moreover, chapter 1 describes 
Figure 3
Schematic representation of ENU-driven target selec-
ted mutagenesis. Male rats are injected with ENU and 
crossed with untreated females. A cohort of animals 
(F1) with at random point mutations is generated, and 
their DNA is isolated for high-throughput screening re-
sequencing of genes of interest.
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the involvement of the SERT in neuropsychiatric disorders, as well as the 5-HT vulnerability to 
develop these disorders. To confirm that a premature stopcodon in the SERT gene results into 
a SERT-/- rat, and to establish whether rats and mice similarly adapt to the absence of the SERT, 
some experiments that were already performed in the SERT-/- mouse have been replicated in the 
SERT-/- rat. However, some interesting new insights were obtained by the experiments performed 
and described in this thesis.
Animal models are very useful in studying both the behavioral and the biochemical consequences 
of disturbed 5-HT homeostasis. They may reveal the contribution of compensatory adaptations, 
that in turn might reveal novel targets for medication. To allow for cross-species comparison 
with (knockout) mouse  data and extrapolation to the human situation, a SERT knockout model 
would complement existing tools and help in understanding the complexity of the serotonergic 
modulation of major human disease states. We generated such a model by ENU-driven target-
selected mutagenesis and the primary biochemical characterization of the SERT-/- rat. The 
functional consequences for the serotonergic as well as the non-serotonergic systems are 
described in chapter 2.
Genetic alterations in the SERT are associated with multiple neuropsychiatric disorders like anxiety 
and depression. Moreover, women experience depression about twice as often as men, and are 
more vulnerable to develop anxiety disorders. We hypothesized that rats lacking the SERT show 
increased vulnerability to anxiety- and depression-related behaviors, and that females are more 
vulnerable to develop anxiety- and depression-related behaviors after the SERT deletion than 
males. Several anxiety- and depression-related tasks were assessed in male and female SERT-/- 
rats and are described in chapter 3.
As individual differences exist in central 5-HT neurotransmission, the impact of a challenge on 
this system, like ATD, may vary accordingly. ATD results in lower peripheral and central levels 
of tryptophan and 5-HT and several studies have shown an impaired object recognition after 
ATD. In chapter 4 we tested the hypothesis that male SERT-/- rats are more vulnerable to the 
effects of a normal or low-dose of ATD in an object recognition task than male SERT+/+ and SERT+/- 
rats. Moreover, plasma amino acid concentrations and concentrations of 5-HT and 5-HIAA in the 
frontal cortex and hippocampus were measured to investigate the effect of ATD in these rats.
In chapter 5 we focus on the extent to which life-long disturbed 5-HT neurotransmission in 
SERT-/- rats may result in adaptive changes in the serotonergic system. Chronic administration 
of SSRIs desensitizes 5-HT1A receptors in rats and humans. As such adaptive changes are known 
to occur after chronic manipulations of the serotonergic system, we investigated the 5-HT1A 
receptor pathways in the SERT-/- rat. Autonomic responses to selective 5-HT1A receptor agonists 
are frequently used to measure 5-HT1A receptor function. Therefore we investigated to what 
extent the thermoregulatory effects of 5-HT1A receptor agonists and antagonists were altered in 
the SERT-/- rat, and whether these alterations differed for stress-induced hypothermia (SIH) and 
core body temperature (TC). The effects of both the 5-HT1A receptor agonist flesinoxan and the 
5-HT1A receptor antagonist WAY100635 were analyzed, as well as the receptor specificity of these 
effects on Tc, heart rate and SIH, to investigate the role of 5-HT1A receptors in the modulation of 
these autonomic responses.
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Besides studying the adaptive changes in the serotonergic system, we also investigated possible 
adaptations in other neurotransmitter systems in the SERT-/- rat. The 5-HT system interacts with the 
GABAergic, the dopaminergic and the noradrenergic system. Alterations in the serotonergic system 
may affect the sensitivity of these systems. To investigate to what extent life-long disturbed 5-HT 
neurotransmission may result in adaptive changes of these systems, we challenged the SERT-/- rat 
with a GABAA receptor agonist, a dopamine transporter blocker, and a noradrenaline transporter 
blocker. We studied the resulting changes in body temperature and SIH in chapter 6. In chapter 7, 
the outcomes of all preceding chapters are shortly summarized and discussed.
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Chapter 2
Abstract
Serotonergic signaling is involved in many neurobiological processes and disturbed 5-HT 
homeostasis is implicated in a variety of psychiatric and addictive disorders. Here, we describe 
the functional characterization of the serotonin transporter (SERT) knockout rat model, that 
is generated by N-ethyl-N-nitrosurea (ENU)-driven target-selected mutagenesis. Biochemical 
characterization revealed that SERT mRNA and functional protein are completely absent in 
homozygous knockout (SERT−/−) rats, and that there is a gene dose-dependent reduction in the 
expression and function of the SERT in heterozygous knockout rats. As a result, 5-HT homeostasis 
was found to be severely affected in SERT−/− rats: 5-HT tissue levels and depolarization-induced 
5-HT release were significantly reduced, and basal extracellular 5-HT levels in the hippocampus 
were ninefold increased. Interestingly, we found no compensatory changes in in vitro activity of 
tryptophan hydroxylase and monoamine oxidase, the primary enzymes involved in 5-HT synthesis 
and degradation, respectively. Similarly, no major adaptations in non-serotonergic systems 
were found, as determined by dopamine and noradrenaline transporter binding, monoamine 
tissue levels, and depolarization-induced release of dopamine, noradrenaline, glutamate and 
GABA. In conclusion, neurochemical changes in the SERT knockout rat are primarily limited to 
the serotonergic system, making this novel rat model potentially very useful for studying the 
behavioral and neurobiological consequences of disturbed 5-HT homeostasis. 
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Introduction
5-HT, the most ancient neurotransmitter, plays an important modulatory role in emotion, 
motivation and cognition, and has a function in gut and neuroendocrine systems. Hence, 
disturbed 5-HT homeostasis contributes to many disorders, including affective disorders, 
drug addiction, schizophrenia, eating disorders, impulse control disorders and irritable bowel 
syndrome (Murphy et al., 2004). Because of the complexity of the serotonergic system, which 
consists of at least 14 different receptor subtypes, it is still not yet completely understood how 
5-HT contributes to these disorders, which hampers the development of effective medication.
Extracellular 5-HT levels are increased upon activation of serotonergic neurons that originate 
from the raphe nuclei (RN) and project to almost all parts of the brain. 5-HT homeostasis is 
primarily regulated by the Na+/Cl−-dependent serotonin transporter (SERT), which reuptakes 
5-HT from the extracellular space into the presynaptic serotonergic nerve terminal to recycle 
5-HT for future release (Murphy et al., 1998). The SERT is of interest in many research areas as it 
is the target for selective serotonin reuptake inhibitors (SSRIs), which have therapeutic efficacy 
in several neuropsychiatric disorders, including depression (Murphy et al., 1998). Furthermore, 
psychostimulants such as cocaine, amphetamine and related drugs act on it (Ritz and Kuhar 
1989; Ritz et al., 1990). Interestingly, humans carry a polymorphism in the promoter region of the 
SERT gene (5-HTTLPR), which involves a common 44-base pair insertion/deletion of a repetitive 
sequence (Lesch et al., 1996). The dominant short (s) allelic variant reduces transcriptional 
efficiency of the SERT as compared with the long (l) allelic variant (Lesch et al., 1996), and is 
associated with reduced brain SERT mRNA levels (Little et al., 1998), reduced SERT binding 
sites (Heils et al., 1996), and a 40% decrease in 5-HT re-uptake in blood platelets (Greenberg et 
al., 1999). In line with the wide range of processes mediated by 5-HT and the effects of drugs 
targeting the SERT, this common polymorphism has been linked to various, mostly psychiatric, 
disease states, from affective disorders to alcoholism, obsessive compulsive disorder and drug 
dependence (Bengel et al., 1999, Caspi et al., 2003 and Gerra et al 2004).
Animal models are highly informative to study both the biochemical as well as the behavioral 
consequences of disturbed 5-HT homeostasis and may reveal the contribution of compensatory 
adaptations that could serve as novel targets for medication. The SERT knockout mouse has 
revealed that ablation of the SERT increases extracellular 5-HT levels (Fabre et al., 2000; Mathews 
et al., 2004) and induces several behavioral phenotypes, which include anxiety, and depression-
like symptoms (Holmes et al., 2002a; Holmes et al., 2003b; Lira et al., 2003; Adamec et al., 2006), 
reduced aggression (Holmes et al., 2002b), and altered responses to drugs of abuse (Bengel et 
al., 1998; Sora et al., 1998). In some research areas the rat is traditionally one of the preferred 
animal models. Especially in the area of complex cognitive tasks, addiction, and pharmacology, a 
lot of data in the rat model have been acquired over the last decades. To allow for cross-species 
comparison with mouse (knockout) data and extrapolation to the human situation, a SERT 
knockout model in the rat would complement existing tools and help in understanding the 
complexity of the serotonergic modulation of major human disease states.
Recently, we generated such a model by N-ethyl-N-nitrosurea (ENU)-driven target-selected 
mutagenesis (Smits et al., 2006) and here we describe the primary biochemical characterization 
of this novel model and the functional consequences for the serotonergic as well as the major 
non-serotonergic neurotransmitter systems. We show that, in line with the central role of SERT in 
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regulating extracellular 5-HT levels, 5-HT homeostasis is dramatically disturbed in homozygous 
SERT knockout (SERT−/−) rats. Interestingly, no adaptations were observed in the presynaptic 
functioning of non-serotonergic systems, indicating that the primary consequences of the 
absence of SERT are restricted to the serotonergic system.
Experimental procedures
Animals 
All experiments were approved by the Animal Care Committee of the Royal Dutch Academy of 
Science, the Free University of Amsterdam, the Radboud University Nijmegen, and the University 
of Groningen according to the Dutch legal ethical guidelines. Experiments were designed to 
minimize the number of required animals and their suffering.
The SERT knockout rat (Slc6a41Hubr) was generated by target-selected ENU-induced mutagenesis 
(for detailed description, see Smits et al., 2006). Briefly, high-throughput resequencing of genomic 
target sequences in progeny from mutagenized rats revealed an ENU-induced premature stop 
codon in exon 3 of the SERT gene in a female rat (Wistar/Crl background). The heterozygous 
mutant animal was outcrossed for at least six generations to a Wistar background to eliminate 
confounding effects from other mutations that may have been induced by the ENU mutagenesis. 
Under the used mutagenesis conditions the mean mutation frequency was roughly 1 in 1.2 million 
base pairs (about 1 cM). Although the chance for the occurrence of a strongly linked mutation 
with a phenotypic effect is very small, this possibility should be taken into account in the design 
and interpretation of experiments. To control for this possibility as much as possible, we always 
generated experimental animals by incrosses between outcrossed heterozygous SERT knockout 
(SERT+/−) rats. Furthermore, we compared as much as possible wild type (SERT+/+) and mutant 
littermates. Finally, we have repeated several measurements in multiple backcross generations 
and could perfectly replicate previous findings. At the age of 3 weeks ear cuts were taken and used 
for genotyping. Genotypes were reconfirmed after experimental procedures were completed. 
Animals were housed under standard conditions in groups of two to four per cage per gender 
under controlled experimental conditions (12-h light/dark cycle, 21±1 °C, 60% relative humidity, 
food and water ad libitum). Only male rats at the age of 11–15 weeks were used for experiments.
Genotyping
DNA isolation and genotyping were performed as described previously (Smits et al., 2006). 
In brief, a 670 bp fragment of the SERT gene, containing the ENU-induced mutation was 
amplified using gene-specific primers (forward, TCACAAAGCACTGAGACCAG; reverse, 
AACCTGCCAAGAGAGAGTTG) and a touchdown PCR cycling program (92°C for 60 s; 12 cycles 
of 92°C for 20 s, 65°C for 20 s with a decrement of 0.6°C per cycle, 72°C for 30 s, followed by 20 
cycles of 92°C for 20 s, 58°C for 20 s and 72°C for 30 s; 72°C for 180 s; GeneAmp9700, Applied 
Biosystems, Foster City, CA, USA). The PCR reactions were diluted with 25 μl water, and 1 μl 
was used as template for the dideoxy sequencing reactions, which were preformed according 
to the manufacturer instructions (Applied Biosystems). Sequencing products were purified 
using Sephadex G50 (superfine, coarse, Sigma, Zwijndrecht, The Netherlands) mini-columns 
and analyzed on a 96-capillary 3730XL DNA analyzer (Applied Biosystems). Sequences were 
analyzed for polymorphisms using polyphred (Nickerson et al., 1997) and manual inspection of 
the mutated position.
Proefschrift.indb   22 09-10-2008   23:00:12
Characterization of the serotonin transporter knockout rat
23
Northern blot analysis
The dorsal and medial RN, which contain large amounts of SERT mRNA, were dissected quickly 
from male SERT+/+, SERT+/− and SERT−/− rats with sterilized instruments on an ice plate. Poly A+ RNA 
was isolated using a MicroPoly(A) Purist Isolation Kit (Ambion Inc., Austin, TX, USA) according to 
the manufacturer’s instructions. Poly A+ RNA (0.75 μg) was fractionated by electrophoresis on 
an agarose gel (1%), containing 0.6 M formaldehyde, and transferred by capillary elution during 
16–24 h to nylon hybridization membranes (Hybond-N, GE Healthcare, Chalfont St. Giles, UK). The 
RNA was UV-crosslinked to the membrane by a UV-stratalinker 1800 (Stratagene, Amsterdam, 
The Netherlands) (2×1200 μJ×100). Following pre-hybridization of the membrane for 1 h at 65°C 
in pre-hybridization buffer (0.36 M Na2HPO4.2H2O, 0.14 M NaH2PO4.2H2O, 0.5 M EDTA, 20% SDS), 
a radiolabeled PCR-generated SERT probe (forward primer, GCCTAGCCAAATATCCAATG; reverse 
primer, GCCAGTTGGGTTTCAAGTAG), generated using Megaprime DNA labeling system (GE 
Healthcare) in the presence of [α-32P]dCTP (3000 Ci/mmol), was heat denaturated together with 
50 μg/ml salmon sperm DNA at 98°C for 10 min. The samples were added to the hybridization 
buffer for overnight hybridization (65°C). Membranes were exposed to a phosphor screen and 
results were visualized using a 9200 Typhoon scanner (GE Healthcare). Densitometric analysis 
of autoradiograms was performed using ImageQuant 5.2 software. After stripping the same 
membrane was re-used for a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe 
hybridization that served as internal standard.
Quantitative autoradiography
Rats were killed by decapitation and brains were rapidly removed. The brains were frozen in 
aluminum cups, which were held for 30 s just above liquid nitrogen and were then plunged into 
the liquid nitrogen. The brains were stored at −80°C. Coronal sections (16 μm) were cut on cryostat 
microtome at −20°C, thaw-mounted onto gelatin-coated slides and stored at −20°C until use. The 
tissue sections (four slides per animal, two animals per genotype) were pre-incubated for 20 min 
at room temperature in 50 mM Tris–HCl buffer at pH 7.4, containing 120 mM NaCl and 5 mM KCl 
([3H]citalopram), in 50 mM Tris–HCl buffer containing 300 mM NaCl, 0.2% bovine serum albumin, 
1 μM cis-flupenthixol (Sigma) ([3H]GBR12935), or in 50 mM Tris–HCl buffer containing 300 mM 
NaCl and 5 mM KCl ([3H]nisoxetine). Subsequently, the sections were incubated in fresh buffer 
containing 1 nM of [3H]-citalopram (85.0 Ci/mmol, GE Healthcare) for 2 h at room temperature, 
buffer containing 2 nM [3H]GBR12935 (45.0 Ci/mmol, Perkin Elmer, Boston, MA, USA) for 20 h at 
4°C, or in buffer containing 3 nM [3H]nisoxetine (85.0 Ci/mmol, Perkin Elmer) for 4 h at 4°C. The 
slides were washed in ice cold buffer (4×5 min), rapidly dipped in cold distilled water and dried 
under a cold stream of air. [3H]citalopram sections together with [3H]Microscales™ standards (GE 
Healthcare) were exposed to a tritium sensitive screen (GE Healthcare) and scanned after 1 week 
using a 9200 typhoon scanner (GE Healthcare). [3H]GBR12935 and [3H]nisoxetine sections were 
exposed to [3H]hyperfilm (GE Healthcare) and developed after 1 week ([3H]GBR12935) or 8 weeks 
([3H]nisoxetine). Optical densities were converted into fmol/mg of tissue equivalent using the 
standard curve. Non-specific binding for [3H]-citalopram binding was determined by binding in 
SERT−/− rats, and non-specific binding for [3H]GBR12935, and [3H]nisoxetine was determined using 
50 μM mazindol and 10 μM desmethylimipramine (desipramine, DMI), respectively.
Body temperature telemetry
Under isoflurane anesthesia rats were surgically equipped with a temperature-sensitive radio-
transmitter (TA10TA-F40, Data Sciences Inc., St. Paul, MN, USA) in the peritoneal cavity. Following 
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surgery the rats were individually housed in test cages that were placed on receivers (Data 
Sciences Inc.) and allowed to recover for at least 1 week before drug challenge tests. Output signals 
from each of the implanted transmitters were monitored by the receivers and channeled into a 
consolidation matrix (BCM 100) connected to a PC-based data acquisition and analysis system 
(Dataquest Labpro, Data Sciences). This system demodulated the signals and converted the raw 
telemetry data into degrees Celsius using the factory calibration values, and was configured to 
sample temperature every 10 min for 10 s on a 24 h basis. Drug challenge tests were performed 
at 4 h after lights on. Animals received saline (1 ml/kg, s.c.) or d-fenfluramine (10 mg/kg, s.c.) in a 
randomized order.
Synaptosomal [3H]5-HT uptake
Rats were decapitated and brains were rapidly removed. To obtain brain synaptosomes, 
hippocampi were rapidly dissected from the brains, transferred into 20 volumes of ice-chilled 0.32 
M sucrose, buffered by 5 mM Hepes (pH 7.4), and homogenized a motor-driven Teflon pestle. The 
synaptosomes were obtained by centrifugation at 1000×g (10 min, 4°C) and centrifugation of 
the supernatant at 12,000×g (30 min, 4°C). The resulting pellets were resuspended (50 volumes 
of original weight) in oxygenated (5%:95% CO2:O2) incubation buffer containing 120 mM NaCl, 5 
mM KCl, 1.2 mM MgSO4, 25 mM NaHCO3, 1 mM KH2PO4, 10 mM glucose, 100 μM pargyline, 0.05 
mM EDTA, 1.3 mM CaCl2, 0.1 mM ascorbic acid, pH 7.4 (adjusted with 1 M Tris). Tubes containing 
10–300 nM [3H]5-HT (25 Ci/mmol, GE Healthcare) were pre-incubated in 450 μl incubation buffer 
for 5 min at 37°C. Subsequently, 50 μl of the synaptosomal suspensions were added and uptake 
was allowed to occur for 10 min at 37°C under weak agitation. The process was terminated by 
adding 2 ml of ice-chilled incubation buffer followed by rapid filtration under vacuum through 
Whatman GF/B filters. The filters were washed with Krebs buffer and the radioactivity trapped 
on the filters was counted by liquid scintillation. Specific [3H]5-HT uptake was calculated as the 
difference between total uptake and uptake in the presence of 10−4 M fluoxetine and expressed as 
pmol/mg protein/min [3H]5-HT uptake. Protein concentrations were determined using Bradford 
protein assay (Biorad, Hercules, CA, USA).
Tryptophan hydroxylase (TPH) activity
Male rats were decapitated, the caudate putamen (CP) and RN (dorsal and medial) were 
dissected on an ice plate and stored at −80°C until use. TPH activity was determined according 
to Vrana et al. (1993). In short, brain tissue was sonicated in 20 mM NaH2PO4+0.2% Triton X-100 
(pH 7.0). Tissue homogenate (25 μl) was added to 25 μl of reaction mixture containing 1 μCi 
lyophilized [3H]tryptophan (31.0 Ci/mmol, GE Healthcare), 50 mM Hepes (pH 7.0), 5 mM DTT, 
0.01 mM Fe(NH4)2(SO4)2, 0.5 mM 6-MPH4 and 0.1 mg/ml catalase (Sigma), and the reaction mix 
was incubated for 15 min at 37 °C. Unreacted [3H]tryptophan and 5-hydroxytryptophan (5-HTP) 
were absorbed with 500 μl of 7.5% charcoal (in 1 M HCL; Crescent Chemical Company Inc., 
Islandia, NY, USA). The samples were thoroughly vortexed and centrifuged at 14,000×g for 2 min 
at RT. Supernatant (350 μl) was removed and centrifuged at 14,000×g for 2 min at RT, and 200 
μl supernatant was counted by liquid scintillation. The counts per minute (cpm) were converted 
to fmol 5-HTP per hour per mg protein by dividing the cpm in the total reaction (corrected for 
a blank measure in the absence of brain homogenate) through the amount of added cpm that 
reacted during 15 min per mg protein. The sensitivity of the assay is 1 fmol 5-HTP/mg protein/h. 
Protein concentrations were determined using Bradford reagent.
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Monoamine oxidase (MAO) activity
MAO-A activity was measured using the Amplex™ Red MAO Assay Kit (Invitrogen, UK). This assay 
is based on the production of H2O2 and its detection by an HRP-coupled reaction using 10-acetyl-
3,7-dihydroxyphenoxazine (Amplex Red reagent) to yield the fluorescent product resofurin. Male 
rats were decapitated, and the hippocampus, CP and RN (dorsal and medial) were dissected on 
an ice plate. As described previously (Mathews et al., 2004), tissue homogenates were obtained 
by homogenization in 0.1 vol. 0.32 M ice-cold sucrose using a glass pestle, and subsequent 
centrifugation at 12,000×g for 10 min at 4°C. The resulting pellets were resuspended in the 
same volume of cold 0.32 M sucrose and centrifuged at 21,000×g for 20 min at 4°C. Pellets were 
suspended in 0.2 volumes (of original tissue weight) 0.1 M phosphate-buffered saline (PBS) (pH 
7.4), centrifuged at 12,000×g for 10 min at 4°C and pellets were stored at −80°C. MAO-A activity 
was measured using 10−4M p-tyramine as substrate and 1 μM pargyline to inhibit MAO-B. After 
30 min of incubation resofurin fluorescence was determined at 530/590 nm. Product amounts 
were derived from resofurin standard curves (0–10 μM). Protein was determined by the method 
of Bradford.
Immunohistochemistry
Brain tissues were cut into 15-μm-thick cryosections, collected in antifreeze (5.8 μM NaH2PO4, 19.3 
μM Na2HPO4, 30% ethylene glycol, 20% glycerol) and stored at −20°C. Endogenous peroxidase 
activity was blocked by incubating the sections in 0.3% H2O2 in PBS for 30 min at room temperature, 
after which normal donkey serum (3% in PBS) was applied for 30 min at room temperature. 
Subsequently, sections were incubated overnight with primary antibody 1:500 for mouse anti-
TPH (Chemicon, Hampshire, UK; AB1541) at 4°C. Next, sections were rinsed three times in wash 
buffer (0.1% Tween-20 in PBS), followed by incubation with the secondary biotinylated donkey 
anti-guinea-pig antibody (1:500; Jackson, Cambridgshire, UK) for 120 min. The sections were 
then stained using the ABC method (Vecta stain, Vector Laboratories, Peterborough, UK) with 
diaminobenzidine tetrahydrochloride (DAB) as a substrate. As a negative control, the sections 
were processed without incubation with primary antibody. Stained neurons were counted using 
AnalySIS, Soft Imaging System (Olympus, Hamburg, Germany).
Neurotransmitter release
Rats were decapitated, the CP, cortex and hippocampus were rapidly dissected from the 
brain, slices (0.3×0.3×2 mm) were prepared using a McIlwain tissue chopper and incubated 
and superfused essentially as described before (Schoffelmeer et al., 1988). Slices were washed 
twice with Krebs–Ringer bicarbonate medium containing 121 mM NaCl, 1.87 mM KCL, 1.17 mM 
KH2PO4, 1.17 mM MgSO4, 25 mM NaHCO3, 1.22 mM CaCl2 and 10 mM d-(+)-glucose, followed by 
preincubation for 15 min in this medium in a constant atmosphere of 95% O2–5% CO2 at 37°C. 
After preincubation, the slices were rapidly washed with the Krebs–Ringer and incubated for 
15 min in 2.5 ml of this medium containing 5μCi [3H]5-HT (15.9 Ci/mmol, GE Healthcare), 5μCi 
[3H]dopamine (DA) (41 Ci/mmol, GE Healthcare), 5μCi [3H]noradrenaline (NE, GE Healthcare) (35 
Ci/mmol, GE Healthcare), 2μCi [14C]choline (56 Ci/mmol, GE Healthcare), [3H]GABA (87 μCi, Ci/
mmol, GE Healthcare) or 47 μCi [3H]glutamate (40 Ci/mmol, GE Healthcare) under an atmosphere 
of 95% O2–5% CO2 at 37°C. To prevent accumulation of neurotransmitters into dopaminergic 
or noradrenergic nerve terminals, 1 μM GBR12935 (Sigma) ([3H]5-HT, [3H]NA, [14C]acetylcholine 
(Ach)), or 3 μM DMI ([3H]DA), respectively, was added to the medium. For GABA release, the 
GABA transaminase inhibitor amino-oxyacetic acid (10 μM) (Sigma) was present throughout the 
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experiment to inhibit [3H]GABA degradation. After labeling, the slices were rapidly washed and 
transferred to each of 24 chambers of a superfusion apparatus (approximately 4 mg tissue in 0.2 
ml volume) and superfused (0.2 ml/min) with medium gassed with 95% O2–5% CO2 at 37°C. In 
each observation, calcium-dependent neurotransmitter release was studied simultaneously in 
24 parallel superfusion chambers. After 40 min of superfusion (t=40 min), the superfusate was 
collected as 10-min samples. Neurotransmitter release was induced by exposing the slices to 
electrical biphasic block pulses (1 Hz, 4 ms at 30 mA) ([3H]5-HT, [3H]DA, [3H]NA, [14C]Ach) for 10 
min at t=50. Depolarization-induced calcium-dependent release of [3H]GABA and [3H]glutamate 
was induced by exposing the slices for 10 min to 10−4 M 4-aminopyridine (4-AP) (Sigma) since 
electrical field stimulation of brain slices is not effective in this respect (A.N.M.S., unpublished 
observations). The radioactivity remaining at the end of the experiment was extracted from the 
tissue with 0.1 N HCl. The radioactivity in superfusion fractions and tissue extracts was determined 
by liquid scintillation counting. The efflux of radioactivity during each collection was expressed 
as percentage of the amount of radioactivity in the slices at the beginning of the respective 
collection period. The depolarization-induced release of neurotransmitter was calculated by 
subtracting the spontaneous efflux of radioactivity from the total overflow of radioactivity 
during stimulation and the next 10 min. A linear decline from the 10-min interval before to that 
20–30 min after the start of stimulation was assumed for calculation of the spontaneous efflux of 
radioactivity. The release was expressed as percentage of the content of radioactivity of the slices 
at the start of the stimulation period.
Microdialysis
Homemade I-shaped probes (dialyzable surface 4 mm) were inserted into the ventral hippocampus 
according to the following coordinates: bregma −5.3 mm, lateral to midline +4.8 mm and ventral 
to dura −8.0 mm (for detailed description see Cremers et al., 2004). Experiments were performed 
24–48 h after surgery. On the day of the experiment, animals were connected with flexible PEEK 
tubing to a microperfusion pump (Harvard Apparatus, South Natick, MA, USA) and perfused with 
an artificial cerebrospinal fluid, comprising 147 mM NaCl, 3.0 mM KCl, 1.2 mM CaCl2, and 1.2 mM 
MgCl2 at a flow rate of 1.5 μl/min. Fifteen minute microdialysis samples were collected in HPLC 
vials containing 7.5 μl of 0.02 M acetic acid and kept at −80°C until analyzed. Citalopram (Sigma) 
was administered at a dose of 3 mg/kg (s.c.).
Brain tissue monoamine levels
Rats were decapitated and the brains were rapidly removed. The cortex, CP, hippocampus, 
amygdala and RN (dorsal and medial) were dissected on an ice-plate and immediately frozen on 
dry-ice and subsequently stored at −80°C until use. Brain tissue was sonicated in 0.5 M perchloric 
acid and 0.5 mM EDTA. The homogenate was centrifuged at 14,000×g for 15 min at 4°C and 20 μl 
supernatant was used for HPLC analysis.
HPLC
Samples (20 μl) were injected via an autoinjector (Agilent 1100) onto a 150×4.6 mm LC18DB 
Supelcosil 3 μm diameter column (kept at 20°C) and eluted with a 50 mM isocratic ammonium 
phosphate buffer (pH 2.5) containing 0.1 mM EDTA, 1.5 sodium octylsulfate, 100 mM sodium 
perchlorate and 1.5% n-propanol. The HPLC outlet was connected to an electrochemical 
detection chamber (model 400 of Decade, Antec Leiden) using a glassy carbon fiber set to 410 
mV as compared with the reference Ag/AgCl Vt-3 electrode. Oxidation potentials were recorded 
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and analyzed with a computer. Peaks were quantified using N-methyl-serotonin that was added 
to each sample as external reference.
Statistics
Data were checked for normality and homogeneity and subjected to a log transformation when 
necessary to achieve these criteria. Analysis was performed using Students’ t-test, one-way 
ANOVA, or two-way ANOVA for repeated measures. ANOVA’s were followed by Newman-Keuls 
post hoc tests when significant (P<0.05) genotype/treatment or significant interactions were 
obtained. Non-significant=n.s.
Results
SERT knockout rat characteristics
High-throughput resequencing of target genes in a library of ENU-mutagenized rats (Smits 
et al., 2006) revealed a C to A transversion at position 3924 (relative to the start codon in 
ENSRNOG0000003476) in the SERT gene, resulting in a premature stop codon (TGC>TGA) in the 
third exon encoding the second extracellular loop (Figure. 1A), and thereby most likely resulting 
in a non-functional protein product. Northern blot analysis (Figure. 1B and C) revealed that the 
Figure 1
(A) Schematic representation of the SERT gene and the induced knockout mutation (Slc6a41Hubr) obtained by 
target-selected mutagenesis. The arrow indicates the location of the ENU-induced C to A transversion that results 
in the change of amino acid 209 from a cysteine to a stopcodon. (B) Northern blot analysis and (C) densitometric 
quantification of the SERT transcript in the raphe nucleus of a SERT+/+, SERT+/- and SERT-/- rat (n=1). GAPDH mRNA 
levels were used as internal standards and the optical density of SERT bands was corrected for the amount of 
RNA using the density of GAPDH bands. The SERT transcript in SERT-/- rats was almost completely absent.
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premature stop codon results in nonsense-mediated decay of the mutant SERT transcript. In 
addition, absence of [3H]citalopram (SSRI) binding to brain slices of homozygous SERT−/− rats 
indicates that SERT protein is completely absent (Figure 2 and Table 1), whereas in heterozygous 
SERT knockout (SERT+/−) rats, citalopram binding was reduced by approximately 40% across the 
measured brain regions (Table 1). At the functional level, d-fenfluramine-induced hypothermia 
was completely absent in SERT−/− rats, and reduced in SERT+/− rats [Figure 3; F(2,497) (genotype, 4 h 
post d-fenfluramine)=14.58, p<0.0005, F(48,497) (time×genotype)=7.57, p=0, post hoc: p<0.05 for 
all time points between SERT−/− and SERT+/+/SERT+/−]. From these data it can be concluded that 
the premature stop codon in the SERT gene results in a full knockout of the SERT, and that SERT 
expression and function is reduced in SERT+/− rats. 
Despite the important role of 5-HT in behavior and the development of the nervous system 
(Lauder, 1990), homozygous (SERT−/−) and heterozygous (SERT+/−) knockout rats appear normal, 
score similar to wild type (SERT+/+) littermates on measures of health, and breed normally (litter 
size 10). Litters consist of wild type, heterozygous and homozygous animals with a Mendelian 
distribution, indicating that the mutant allele is not associated with embryonic lethality. The 
weight of female SERT−/− rats is reduced by 10% at the age of 3 weeks and remains reduced, while 
the weight of male SERT−/− is not different from SERT+/+ rats (data not shown).
Figure 2
Representative [3H]citalopram 
autoradiograms of coronal sections 
from male SERT+/+, SERT+/- and SERT-/- 
rats (n=3) show that SERT protein is 
completely absent in homozygous 
knockout animals and is reduced in 
heterozygous animals. Images for 
all three genotypes were taken from 
the same experiment. See table 1 for 
SERT quantification in the different 
brain regions. AMY = amygdala, 
BNST = bed nucleus stria terminalis, 
CP = caudate putamen, dRN = dorsal 
raphe nucleus, Hipp = hippocampus, 
Hthal = hypothalamus, mRN = 
medial raphe nucleus, NACC 
= nucleus accumbens, PFC = 
prefrontal cortex, SN = substantia 
nigra, SCX = somatosensory cortex, 
Thal = thalamus.
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Serotonin homeostasis
The SERT reuptakes 5-HT into the presynaptic nerve terminal, and this process is likely to be 
reduced in SERT mutant rats, although there may be alternative routes by which 5-HT can be 
taken up. To investigate this, we measured 5-HT uptake in hippocampal synaptosomes (Figure. 
4). The hippocampus was chosen to ‘model’ the presynaptic adaptations in response to the 
absence of the SERT because this brain structure is of interest in many types of behavior and 
is strongly innervated by serotonergic neurons. The maximum rate (Vmax) of 5-HT uptake in 
the synaptosomes was reduced by 13.4% in SERT+/− rats, and by 72.2% in SERT−/− rats [Figure. 
4A; F(2,111) (genotype)=54.08, P=0]. Application of the noradrenaline transporter (NET) blocker 
DMI [Figure. 4C; t(1,8) (SERT+/+)=0.380, n.s.; t(1,8) (SERT+/−)=0.896, n.s.; t(1,8) (SERT−/−) 5.97, P=0], but 
not the dopamine transporter (DAT) blocker GBR12935 [Figure. 4B; t(1,8) (SERT+/+)=0.4645; t(1,8) 
(SERT+/−)=0.267, n.s.; t(1,8) (SERT−/−)=0.1, n.s.], abolished residual [3H]5-HT uptake, suggesting that 
5-HT uptake is partially maintained by noradrenergic neurons in the hippocampus. 
Although noradrenergic neurons seem to be capable of taking up 5-HT in vitro, the 5-HT Km for the 
NET is much lower than for SERT (Daws et al., 1998), raising the question if this activity is sufficient 
for efficient 5-HT re-uptake in vivo. Therefore, we determined the extracellular 5-HT levels in the 
ventral hippocampus by microdialysis. Basal extracellular 5-HT levels were found to be 9-fold 
increased in the hippocampus of SERT−/− rats (Figure. 5). Systemic citalopram administration had 
no effect in SERT−/− rats, while 5-HT levels in SERT+/+ rats were increased to basal 5-HT levels found 
Figure 3
D-fenfluramine-induced hypothermia in male SERT+/+, SERT+/- and SERT-/- rats (n = 3-9) as measured by 
telemetry. The hypothermic response is completely absent in SERT-/- rats and significantly reduced in SERT+/-. 
A very short-lasting increase of body temperature is observed in knockout animals at the time of injection, 
most likely resulting from a serotonin-independent stress-response. Data are expressed as mean (± S.E.M.) 
%  from baseline temperature (100 %). * P < 0.005. 
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Figure 4
(A) [3H]5-HT uptake into hippocampal synaptosomes of male SERT+/+, SERT+/- and SERT-/- rats in the absence 
of additional monoamine transporter inhibitors (n =3) (B) in the presence of 1 µM GBR12935 (n = 3-4), and 
(C) in the presence of 1 µM GBR12935 + 1 µM DMI (n = 3-4). 5-HT was gene-dose dependently reduced in 
SERT-/- and SERT+/- rats, but not completely absent in SERT-/- rats. Inhibition of the NET (DMI), but not DAT 
(GBR12935) attenuated residual 5-HT uptake. Data are expressed as mean (± S.E.M.) [3H]5-HT (pmol/mg 
protein/10 min) uptake. 
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in SERT−/− rats [F(1,146) (genotype)=3.06, p<0.05; F(2,146) (genotype×treatment)=2.62, p<0.005, post 
hoc: p<0.05 over baseline, t=0 and t=15].
To study whether the reduced 5-HT uptake and increased extracellular 5-HT levels affect 5-HT 
synthesis and degradation, we measured the activity and immunoreactivity  of TPH, the rate-
limiting enzyme involved in 5-HT synthesis, and the activity of MAO. TPH activity was not 
different between genotypes in the RN [F(2,12)=1.62, n.s.] and CP [F(2,10)=0.18, n.s.] (Figure 6A). Also 
TPH immunoreactivity in the dorsal RN, which most likely reflects THP2 levels as THP1 is not 
expressed in the RN (Patel et al., 2004), did not differ between genotypes [Figure 6B; F(2,5)=4.64, 
n.s]. Two MAO isoforms exist, MAO-A and MAO-B. Because 5-HT is mainly oxidized by MAO-A 
(Shih et al., 1999), we measured MAO-A activity. In neither the cortex [Figure 6C; F(2,11)=1.25, n.s.], 
nor the CP [F(2,12)=0.34, n.s.] were differences found in MAO-A activity.
As reduced 5-HT uptake may affect intracellular 5-HT and 5-hydroxyindoleacetic acid (5-HIAA, 
5-HT’s primary metabolite) levels, we measured 5-HT and 5-HIAA tissue levels, assuming 
that neurotransmitter tissue levels primarily represent intracellular concentrations. In the 
hippocampus, CP, cortex and amygdala of SERT−/− rats, but not SERT+/− rats, 5-HT and 5-HIAA 
levels were reduced by 75–50% and 45–55%, respectively (Table 2). The 5-HIAA/5-HT ratio, was 
significantly higher in the cortex and CP, but not in the amygdala.
Finally, to study whether the functioning of the presynaptic 5-HT neuron is affected by increased 
extracellular 5-HT levels we measured [3H]5-HT uptake and depolarization-induced release in 
superfused brain slices of the hippocampus and cortex. [3H]5-HT uptake was reduced by 90% 
in SERT−/− rats, and electrically-evoked [3H]5-HT release was reduced by 40% in the CP, by 90% 
in the hippocampus and by 97% in the hypothalamus and cortex of SERT−/− rats (Table 3). No 
Figure 5
Extracellular 5-HT levels in the ventral hippocampus of male SERT+/+ and SERT-/- rats as measured by in vivo 
microdialysis (n = 5). Basal dialysate 5-HT levels are six-fold increased in SERT-/- rats. 3 mg/kg citalopram 
increased 5-HT levels in SERT+/+ rats to that of SERT-/- rats, while citalopram had no effect in SERT-/- rats. Data 
represent mean (± S.E.M.) extracellular 5-HT (fmol/sample).  *P <0.05.
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Figure 6
(A) TPH activity in the dorsal and medial RN and CP. Data represent mean (± S.E.M.) 5-HTP produced per hour 
per mg protein (n=4). (B) TPH staining in the dorsal RN and (C) quantification of neurons positive for TPH 
binding per representative section (n=2-3). (D) MAO-A activity in the CP and cortex. Data represent mean 
(± S.E.M.) resofurin. For both TPH and MAO-A activity no differences were found between genotypes (n=4).
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differences in [3H]5-HT uptake were observed in SERT+/− animals, despite the observed reduced 
synaptosomal [3H]5-HT uptake in these animals. This apparent discrepancy may be explained by 
differences in sensitivity between the two assays (Montañez et al., 2003). Finally, depolarization-
induced [3H]5-HT release was not affected in SERT+/− rats.
No changes in presynaptic functioning of non-serotonergic systems
Because 5-HT strongly interacts with other neurotransmitter systems, in particular the dopaminergic 
and noradrenergic systems, the disturbed 5-HT homeostasis may have consequences for the 
functioning of these systems. First, we measured the density of the DAT and NET, which may 
partially take over the function of the SERT. Despite the finding that the NET is responsible for 
residual 5-HT uptake in the hippocampus of SERT−/− rats in vitro (Figure. 4C), NET concentrations, as 
well as DAT concentrations, were not different between genotypes throughout the brain (Table 1). 
We further determined the presynaptic functioning of dopaminergic and noradrenergic neurons 
by [3H]NE and [3H]DA uptake and their depolarization-induced release in superfused brain slices. 
Again no genotype differences were found (Table 3). In line with these observations, DA, NE, DOPAC 
and HVA tissue levels were similar in rats of all genotypes (Table 2), except for NE levels in the 
amygdala, which were increased in SERT−/− rats. Beyond the monoaminergic systems, the uptake 
and depolarization-induced release of [14C]Ach, [3H]GABA and [3H]glutamate in the hippocampus 
and cortex was also not different between genotypes (Table 3).
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Discussion
Using the recently established gene knockout technology (Zan et al., 2003, Smits et al., 2004 and 
Smits et al., 2006) we obtained a rat knockout for the SERT gene, and here we present the first 
comprehensive characterization of this novel model. We show that the ENU-induced premature 
stop codon results into a complete lack of SERT, and interestingly, that SERT+/− rats show a gene-
dosage effect with respect to SERT expression and function. The SERT+/− rat may therefore be 
a novel model system for studying the human 5-HTTLPR polymorphism (Lesch et al., 1996), 
although a more detailed (behavioral) analysis will be needed to support this. We show that 
extracellular 5-HT levels are increased in SERT−/− rats and in vitro data suggest that this may be 
counterbalanced by false 5-HT uptake by the NET in the hippocampus and reduced depolarization-
induced release of 5-HT. Most importantly, no changes were found in the presynaptic functioning 
of dopaminergic, noradrenergic, cholinergic, glutamatergic and GABAergic neurons, indicating 
that compensatory adaptations for the lifelong absence of the SERT are primarily limited to the 
serotonergic system.
The nature of non-transgenic ENU-induced gene knockouts is fundamentally different from 
the more common mouse knockouts generated by homologous recombination. In the latter 
models, genomic fragments encoding important protein domains or the complete protein are 
replaced by a selection cassette, whereas the model presented here results from a single point 
mutation that introduces a premature stop codon. Theoretically, it is still possible that an almost 
intact protein is made, for example resulting from an alternatively spliced transcript. However, 
we show that the SERT mRNA in SERT−/− rats is completely absent, suggesting that the mutated 
transcript is subjected to nonsense-mediated decay (Baker and Parker, 2004). At the protein level 
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the binding of the highly selective SSRI citalopram was completely absent, indicating that there 
is no properly folded and functionally active SERT protein in the brain of the SERT−/− rats. This 
is confirmed by the absence of an effect in knockout animals of d-fenfluramine, which in wild 
type animals induces reverse 5-HT transport via the SERT and a reduction in body temperature. 
Although the exact mechanism of this process is not clear, the absence of a response in SERT−/− 
rats is most likely due to inability of d-fenfluramine to induce 5-HT release via the SERT, as the 
response in wild type animals can be blocked by citalopram (not shown). SERT function was also 
directly measured in hippocampal synaptosomes. 5-HT uptake was strongly reduced in SERT−/− 
rats, but was not completely absent, suggesting that residual 5-HT uptake takes place via other 
transporters, such as the DAT and NET, or the cation-transporter (Schmitt et al., 2003). We show 
that the remaining 5-HT uptake activity in vitro can efficiently be inhibited by the NET-blocker 
DMI, but the observed ninefold increased extracellular levels of 5-HT suggest that this activity is 
not sufficient to maintain low homeostatic extracellular 5-HT levels in vivo. In DA rich regions, such 
as the striatum, the DAT may partially compensate for reduced 5-HT uptake in the rat (Zhou et al., 
2002). These and previous observations (Pan et al., 2001; Moron et al., 2002; Vizi et al., 2004) indicate 
that monoamine transporters are not neurotransmitter selective, insights that are important to 
understand the neurochemical and behavioral effects of drugs that inhibit (e.g. cocaine) or reverse 
(e.g. amphetamine) monoamine transporter function.
Interestingly, the SERT+/− rat shows intermediate phenotypes with respect to SERT mRNA levels, 
SERT protein density and SERT function. Despite these observations, SERT+/− rats did not differ 
from wild type animals in 5-HT tissue levels and the reactivity of serotonergic neurons. Similarly, 
in the SERT+/− mouse no changes have been reported for intracellular 5-HT levels (Kim et al., 2005), 
suggesting that there is at least a redundancy of 40–50% in SERT availability that is not needed 
for normal presynaptic functioning of serotonergic neurons. Dialysate 5-HT levels, however, are 
gene-dose dependently increased in the SERT+/− mouse (Mathews et al., 2004), suggesting that 
extracellular 5-HT levels and SERT function are directly related. This observation is of particular 
importance in relation to the human 5-HTTLPR, which influences SERT expression and function, 
and thereby may affect extraneural 5-HT levels. SERT+/− models may therefore be a valuable model 
to address the biological and behavioral consequences of the 5-HTTLPR, although detection of 
5-HTTLPR-linked symptoms of disorders or traits in SERT+/− mice are dependent on the genetic 
background and not always observed (Holmes et al., 2002a; Holmes et al., 2003b; Adamec et al., 
2006). To extend the human relevance of SERT+/− models to the rat we are currently determining 
extracellular 5-HT levels in SERT+/− rats and testing these animals in advanced human-derived 
cognitive tasks.
Our results indicate that the adaptations in the presynaptic serotonergic system are a direct 
or indirect consequence of the reduced 5-HT reuptake and high extracellular 5-HT levels. 
Thus, reduced 5-HT and 5-HIAA tissue levels are likely to result from reduced 5-HT uptake, 
as no differences were found in the activity of TPH, the rate-limiting enzyme mediating 5-HT 
synthesis, and the activity of MAO-A, the enzyme that converts 5-HT into 5-HIAA. However, in 
the SERT−/− mouse in vivo TPH activity is increased, while in vitro TPH activity is unchanged (Kim 
et al., 2005). This raises the possibility that in vivo TPH activity is increased in SERT−/− rats as well, 
despite unchanged TPH density. 5-HT synthesis is negatively controlled by presynaptic 5-HT1B 
autoreceptors in terminal regions (Moret and Briley, 1990), as well as somatodendritic 5-HT1A 
autoreceptors that influence the firing rate of serotonergic neurons in the RN (Hamon et al., 
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1991). Both types of receptors are desensitized in SERT−/− mice (Fabre et al., 2000; Li et al 2000), 
and their firing rate of raphe neurons is decreased as well (Gobbi et al., 2001). These adaptations 
would reduce 5-HT release and relieve tonic autoreceptor-mediated inhibition of synthesis. If TPH 
activity would be increased, this increase is seemingly not sufficient to compensate the reduced 
5-HT uptake. Strikingly, despite unaltered activities of TPH and MAO-A, the 5-HIAA/5-HT ratio 
was increased in the cortex and CP, but not the amygdala, of SERT−/− rats. An increase in tissue 
5-HIAA/5-HT ratios has been observed in the SERT−/− mouse (Kim et al., 2005), but an explanation 
is lacking. 5-HT is catabolized into 5-HIAA by the intracellular located MAO and 5-HIAA is freely 
diffusible across the cell membrane. As extraneural 5-HIAA levels are decreased in SERT−/− mice 
(Mathews et al., 2004), it might be that there is less diffusion of 5-HIAA to the extracellular space. 
Nevertheless, the increased 5-HIAA/5-HT ratio indicates that 5-HT turnover is increased in SERT−/− 
rats and that less 5-HT may be available for neurotransmission. Another mechanism to compensate 
for reduced 5-HT uptake is a reduction in Ca2+-dependent 5-HT release. Indeed, we found that 
[3H]5-HT release in superfused brain slices was reduced by 40% in the CP, and even more so 
in the hippocampus, hypothalamus and cortex. In comparison, in vitro depolarization-induced 
[3H]NE release is significantly reduced in cortical slices of the NET knockout mouse (Vizi et al., 
2004). The reduced release of 5-HT in SERT−/− rats in these experiments is not due to the observed 
decreased 5-HT uptake in the same assay, because the release as the fraction of radioactivity 
present at time of release was increased in the CP. The reduced 5-HT release may be explained 
by reduced availability of intracellular 5-HT, but may also reflect an adaptation to counteract the 
high extracellular 5-HT levels. 5-HT1B autoreceptors negatively control the release of 5-HT (Moret 
and Briley, 1999), and in SERT−/− mice the expression and function of these receptors are reduced 
(Fabre et al., 2000). Because 5-HT release was measured in vitro, without direct tonic regulation 
by raphe neurons, a reduced reactivity of serotonergic neurons may reflect a local adaptation. 
Clearly, understanding the mechanism underlying reduced Ca2+-dependent release requires 
further research. Combining strongly reduced 5-HT uptake and release, and reduced 5-HT tissue 
levels, 5-HT recycling appears to be attenuated in SERT−/− rats, indicating that the serotonergic 
system may have lost its dynamics and flexibility. Thus 5-HT homeostasis has changed in such a 
way that the animal is able to function normally under basal conditions, but when exposed to 
challenges or stimuli, this system may not be able to adapt appropriately, resulting in aberrant 
behavioral responses (Bengel et al., 1998; Sora et al., 1998; Holmes et al., 2002a; Holmes et al., 
2003b; Lira et al., 2003; Adamec et al., 2006).
Because the serotonergic system interacts strongly with other neurotransmitter systems, in 
particular the catecholaminergic systems, we extended our analysis on adaptive consequences 
of the SERT knockout to non-serotonergic systems. As reported previously for the SERT knockout 
mouse (Shen et al., 2004), no changes were found in DA and NE tissue levels. In addition, we did 
not find differences between genotypes in tissue levels of DOPAC and HVA (DA metabolites), as 
well as tissue levels of NE, except for NE levels in the amygdala, which were decreased in SERT−/− 
rats. Although highly speculative, this observation may relate to the observed hyperreactivity 
of the amygdala to fearful stimuli in s/s carriers of the 5-HTTLPR (Hariri et al., 2002). Also, no 
differences between SERT+/+ and SERT−/− rats were found for DAT and NET densities and for in 
vitro depolarization-induced release of DA, NE, Ach, GABA and glutamate, suggesting that the 
consequences of the absence of SERT are limited to the serotonergic system and do not result 
in compensations of non-serotonergic presynaptic neurons. Although in vivo microdialysis 
studies still need to be performed, the lack of adaptations in the presynaptic function of non-
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serotonergic systems may imply that extraneural levels of DA, NE, Ach and glutamate are 
unchanged in SERT−/− rats, as has previously been reported for extracellular DA levels in the 
striatum, cortex (Mathews et al., 2004) and substantia nigra (Fabre et al., 2000) of SERT−/− mice. 
In comparison with the DAT and NET knockout mice, it seems unique for the SERT knockout 
models that compensatory adaptations are limited to the system that is affected, as DAT and 
NET knockout mice display compensatory adaptations in the serotonergic (Rocha et al., 1998) 
and dopaminergic (Xu et al., 2000) systems, respectively. Also, DAT knockout mice exhibit severe 
reductions in tyrosine hydroxylase protein (Jaber et al., 1999) and striatal DA tissue levels, and 
increased DA synthesis (Gainetdinov et al., 1998), implying that homeostasis is differentially 
regulated in the dopaminergic and serotonergic systems.
Because one cannot simply assume that SERT knockout rats adapt in a similar fashion to the 
absence of the SERT as the respective mouse model, we replicated many measurements as done 
in the SERT−/− mouse, but also performed measurements that have not yet been addressed in 
the knockout mouse. In general, the compensatory mechanisms associated with the absence 
of the SERT are comparable to those found in SERT−/− mice (e.g. Bengel et al., 1998; Mathews et 
al., 2004; Kim et al .,2005). Extracellular 5-HT levels are increased in the hippocampus of SERT−/− 
rats similar as described for the mouse substantia nigra (Fabre et al., 2000), striatum and frontal 
cortex (Mathews et al., 2004). Furthermore, SERT knockout rats did not differ in in vitro MAO-A 
and TPH activity as did SERT−/− mice (Mathews et al., 2004; Kim et al., 2005), 5-HT and 5-HIAA 
tissue levels were decreased in hippocampus, cortex, CP and amygdala of the rat and mouse 
(Kim et al., 2005), NET density as assessed by autoradiography was unchanged in both SERT−/− 
rats and mice (Montañez et al., 2003), and DA tissue levels were unchanged in both species 
(Shen et al., 2004). Differences between SERT−/− mice and rats were also found. For example, in 
contrast to SERT−/− rats, there was no compensatory 5-HT uptake in hippocampal synaptosomes 
of SERT−/− mice (Bengel et al., 1998). Also, synaptosomal 5-HT uptake in SERT+/− mice did not 
differ from SERT+/+ mice (Bengel et al., 1998), while SERT+/− rats displayed a 13% reduction in 
5-HT uptake. Although the 5-HT concentrations used in the Bengel et al. (1998) study may have 
been below a threshold concentration of extracellular 5-HT required to maximally recruit SERT 
to the plasma membrane, intermediate levels of 5-HT uptake in SERT+/− mice have been reported 
using high-speed chronoamperometry (Montañez et al., 2003). Furthermore, we found that 1 
μM of the highly selective NE uptake inhibitor DMI, displaying an EC50 of about 0.3 μM for NET 
under our experimental conditions (A.N.M.S., unpublished observations), completely abolished 
residual 5-HT uptake, suggesting that hippocampal synaptosomes partially accumulate 5-HT in 
NE nerve terminals. In the study of Montañez (2003), however, NET inhibition had no effect on 
5-HT clearance in SERT−/− mice. Although the techniques used differ and compensatory effects 
may depend on the genetic background of the mouse inbred strain used, they may also reflect 
species-specific differences. These similarities and differences between SERT−/− rats and mice are 
highly informative for cross-species translation of results obtained in different rodent models 
and/or the extrapolation to the human situation.
Taken together, we show that genetic inactivation of the SERT gene in the rat results in a 
selective change of central serotonergic functioning. This makes this animal model very useful 
to dissect the role of 5-HT in various peripheral and neural processes that are related to 5-HT. The 
constitutive increased basal dialysate 5-HT levels most likely affect the expression and function 
of 5-HT receptors, which is currently under investigation. We argue that such adaptations are 
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not only informative because they play an important role in the regulation of 5-HT homeostasis 
and may underlie behavioral phenotypes in SERT−/− models, but also because they may serve as 
targets for medication. Interestingly, chronic SSRI treatment results in a profound reduction in 
SERT expression and function (Benmansour et al., 1999), and increased extracellular 5-HT levels, 
which is strikingly similar to the situation in the knockout model described here. This suggests 
that the SERT−/− rat may be a useful tool to get insight into the long-term effects of chronic SSRI 
treatment, although it should be mentioned that a genetic knockout model is expected to result 
in a more complete inactivation than pharmacological intervention, which could be associated 
with spatial and or temporal heterogeneity in knockout/knockdown levels. In conclusion, the 
novel rat model described here may help in unraveling the complex role of 5-HT in a wide variety 
of neurobiological phenotypes. 
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Abstract
Human studies have shown that a reduction of SERT increases the vulnerability for anxiety and 
depression. Moreover, women are more vulnerable to develop depression and anxiety disorders 
than men. For that reason we hypothesized that SERT-/- models, especially female, are valuable and 
reliable animal models for humans with an increased vulnerability for anxiety- and depression-
related disorders. As rats are extensively used in neuroscience research, we used the unique 
serotonin transporter knockout rat, that was recently generated using ENU-driven mutagenesis, 
to test this hypothesis. Behavioral testing revealed that male and female SERT-/- rats spent less 
time in the center of the open field and spent less time on the open arm of the elevated plus 
maze compared to SERT+/+ rats. In the novelty suppressed feeding test, only male SERT-/- rats 
showed a higher latency before starting to eat in a bright novel arena compared to SERT+/+ 
controls. Both male and female SERT-/- rats showed a higher escape latency from their home 
cage than SERT+/+ littermates. Moreover, SERT-/- rats were less mobile in the forced swim test, and 
sucrose consumption was reduced in SERT-/- rats relative to SERT+/+ rats. Both effects were sex-
independent. Neurochemically, basal extracellular 5-HT levels were elevated to a similar extent 
in male and female SERT-/- rats , which was not influenced by the selective serotonin reuptake 
inhibitor citalopram. 5-HT immunostaining revealed no difference between SERT+/+ and SERT-/- 
rats in the dorsal raphe nuclei, in both males and females. These findings demonstrate that SERT-/- 
rats show anxiety and depression-related behavior, independent on sex. Genetic inactivation of 
the SERT has apparently such a great impact on behavior, that hardly any differences are found 
between male and female rats. This knockout rat model may provide a valuable model to study 
anxiety- and depression-related disorders in male and female rats.
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Introduction
Serotonin (5-hydroxytryptamine, 5-HT) is a key modulatory neurotransmitter and has been 
implicated in the pathophysiology and treatment of anxiety and mood disorders (Neumeister 
et al., 2002). It is widely accepted that disturbances in the 5-HT system are involved in the onset 
of depression (reviewed in Jans et al., 2007b). Several alterations in the 5-HT system have been 
reported in depression, including decreased plasma tryptophan levels (Coppen et al., 1973;Cowen 
et al., 1989) and decreased levels of 5-hydroxyindoleacetic acid (5-HIAA; metabolite of 5-HT) in 
cerebrospinal fluid (CSF) (Asberg et al., 1976a;Asberg et al., 1976b;Owens and Nemeroff, 1998), 
suggesting decreased 5-HT metabolism in the central nervous system. Moreover, brain imaging 
studies have reported a reduction in 5-HT1A receptor binding, which failed to normalize after 
treatment for depression (Drevets et al., 1999;Sargent et al., 2000). The extracellular level of 5-HT 
is primarily regulated by the serotonin transporter (Slc6a4; SERT), which reuptakes 5-HT from the 
extracellular space into the presynaptic neuron where it can be degraded or retained for future 
release (Blakely et al., 1991;Murphy et al., 1998). Due to this important role, it is not surprising 
that genetic alterations in the SERT are associated with multiple neuropsychiatric disorders 
(Murphy et al., 1999;Gingrich and Hen, 2001;Holmes et al., 2003c). For example, the human SERT 
gene transcription is modulated by a common polymorphism in its upstream regulatory region. 
Studies in reporter gene constructs and in human lymphoblastic cell lines found that the short 
variant of the polymorphism (HTTLPRs) reduces the transcriptional efficiency of the SERT gene 
(Lesch et al., 1996;Heils et al., 1996;Heils et al., 1997). Moreover, the long variant was associated 
with more rapid initial platelet 5-HT uptake (Greenberg et al., 1999). However, the HTTLPR 
genotype was not related to the level of SERT binding by autoradiography in the prefrontal 
cortex (Mann et al., 2000).  It was even showed by van Dyck et al. (2004) that the SERT availability 
in the short-short homozygotes was greater compared to long-short heterozygotes, in young 
aged subjects. Several 5-HTTLPR genetic studies have shown a linkage between the short variant 
and psychiatric conditions. For example carriers of the short version display significantly higher 
scores in neurotism, an anxiety-related personality trait,  and exhibit more depressive symptoms, 
diagnosable depression, and suicidality in relation to stressful events compared to individuals 
with the long version (Mann et al., 2000;Caspi et al., 2003;Schmitz et al., 2007;Dick et al., 2007;Canli 
and Lesch, 2007), although not every study has reached the same conclusions in this respect (e.g. 
Lang et al. (2004)).
Women experience depression about twice as often as men (Gorman, 2006), and several possible 
explanations for this phenomenon have been proposed, some of which are directly or indirectly 
related to 5-HT neurotransmission. In human, women have significantly higher concentrations of 
both 5HIAA (5-hydroxyindoleacetic acid) and HVA (homovanillic acid) in their CSF (cerebrospinal 
fluid) than men (Agren et al., 1986), however this provides no direct measure of 5-HT synthesis in 
the brain.  In vivo measurements of 5-HT synthesis in the brain by positron emission tomography 
showed that whole brain rates of 5-HT synthesis is lower in women than in men (Nishizawa et 
al., 1997). Women also have lower SERT binding in the prefrontal cortex than men (Mann et al., 
2000). Moreover, depressed women show a substantial decrease of SERT availability, while hardly 
any decrease in depressed men was reported (Staley et al., 2006).  In view of these data, we 
hypothesized that rats lacking the SERT show increased vulnerability for anxiety and depression-
related behaviors, and that females are more vulnerable to develop anxiety- and depression-
related behaviors after the SERT deletion than males. 
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Because numerous pharmacological and physiological studies on anxiety and depression have 
been done in rats, we recently generated a SERT knockout rat (SERT-/-) by N-ethyl-N-nitrosurea 
(ENU)-driven target-selected mutagenesis (Smits et al., 2004;Smits et al., 2006). This rat has a 
pre-mature stop-codon (TGC>TGA) introduced at position 3924 in the third exon encoding the 
second extracellular loop of the transporter protein. Northern blot analyses have revealed that the 
transversion from a C to an A results in a nonsense-mediated decay of the mutant SERT transcript. 
At a functional level, d-fenfluramine, a 5-HT releaser, and flesinoxan, a full 5-HT1A agonist, are 
unable to elicit hypothermia in SERT-/- rats (Homberg et al., 2007a;Olivier et al., 2008a). Moreover, 
[3H]citalopram (SSRI) binding to brain slices is completely absent in SERT-/- rats (Homberg et al., 
2007a). 
Using this novel model, we here examined anxiety-related behaviors in several tests, including 
the open field test (Prut and Belzung, 2003), elevated plus maze test (Hogg, 1996), novelty 
suppressed feeding test (Bodnoff et al., 1988) and the home cage emergence task (Prickaerts et 
al., 1996). In addition, the knockout rats were tested in two depression-related tests, namely the 
sucrose consumption test (anhedonia) (Orsetti et al., 2007), and the forced swim test (Porsolt et 
al., 1977). Male and female SERT-/- and SERT+/+ rats were tested to investigate genotype and sex 
differences  in performance in these tasks. Moreover, we assessed the structure of the dorsal 
raphe nuclei (DRN) in male and female SERT-/- and SERT+/+ rats. Mood and emotion are modulated 
by the serotonergic midbrain raphe system, which seems to be involved in the pathogenesis of 
psychiatric disorders like those of the affective spectrum (Gurwitz, 2000). Serotonergic neurons 
within the DRN give rise to serotonergic projections to forebrain systems involved in anxiety-
related behavioral responses, such as the amygdala (Steinbusch H.W.M., 1984;Maier et al., 
1993;Graeff et al., 1996). Given these distributions and the knowledge that dysfunction of 5-HT 
neurons has been implicated in a wide variety of diseases, it is interesting to study whether SERT-/- 
and SERT+/+ rats show differences in the number serotonergic neurons in this brain structure. 
Finally, we examined extracellular 5-HT levels in the hippocampus to explore how the genetic 
inactivation of the SERT affects extracellular 5-HT levels in male and female SERT-/- rats, and 
studied the effect of the SSRI, citalopram on these levels. 
Experimental procedures 
Subjects
Serotonin transporter knockout rats (Slc6a41Hubr) were generated by ENU-induced mutagenesis 
(Smits et al., 2004;Smits et al., 2006). All subjects were generated, bred and reared in the Central 
Animal Laboratory of the Radboud University of Nijmegen. Experimental animals were derived 
from crossing SERT+/- rats that were outcrossed for 4 or 5 generations. In all experiments, male 
and female SERT+/+ and SERT-/- littermates were compared. After weaning at the age of 21 days, 
ear cuts were taken for genotyping. All animals were housed two or three per cage in standard 
Macrolon® type 3 cages (42 x 26 x 20 cm) in temperature-controlled rooms (21 ºC ± 1 ºC) with 
standard 12/12-h day/night-cycle (lights on at 7.00 am) and food (Sniff, long cut pellet, Bio 
Services, Uden, The Netherlands) and water available ad libitum. Seven groups of animals were 
used; the order of experiments was as follows. Group 1: Sucrose consumption + Open field  (3-4 
months old, open field was performed 2 days after the sucrose consumption experiments ended); 
Group 2: Elevated plus maze (3-5 months old); group 3: Novelty supressed feeding (4-6 months 
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old); group 4: Microdialysis (2-2.5 months old); group 5: 5-HT immunohistochemistry (males 8-10 
months old, females 3-4 months old); group 6: Home cage emergence task (3-4 months old) and 
group 7: Forced swim test (3-4 months old). The experiments were performed between 9.00 A.M. 
and 17.00 P.M.. All experiments were carried out in accordance with institutional, national and 
international guidelines for animal care and the Dutch law concerning welfare. 
Anxiety-related tests
Open field.  24 Male (n=12 SERT+/+ and 12 SERT-/-) and 24 female rats (n=12 SERT+/+ and 12 SERT-/-) 
were isolated 24 hours before testing. The open field test was conducted as reported in (Jans et al., 
2007a). In short, the open field is a square arena (100 x 100 x 40 cm), with an open top, dark walls 
(wood) and a dark floor (polyvinylchloride). The arena was subdivided in ‘corner’ (four squares 
each 16 x 16 cm), ‘wall’ (four rectangles each 16 x 64 cm) and ‘center’ (one square 64 x 64 cm) 
zones. Testing was carried out in dimmed white light. A camera was installed above the center of 
the field. Immediately after a rat was placed in the corner of the open field, the movements and 
position of the animals were recorded and registered automatically by a computerized system 
(EthoVision, Noldus Equipment, The Netherlands). Reported are the time (s) spent in the center 
of the open field and the total distance moved (cm). Testing was carried out on a 5-minute trial. 
The floor of the open field was cleaned with 70% alcohol solution between trials to prevent 
transmission of olfactory cues. 
Elevated Plus maze.  24 Male (n=12 SERT+/+ and 12 SERT-/-) and 20 female rats (n=10 SERT+/+ and 10 
SERT-/-) were isolated 24 hours before testing. The test was performed as described by (de Jong et 
al., 2006). The apparatus was made of polyvinylchloride. It was elevated to a height of 50 cm with 
two open (50×10) and two enclosed arms (50×10×40) arranged such that the arms of the same 
type were opposite to each other. The illumination intensity measured in the open arms was 2.5 
lux, and in the closed arm 0.2 lux. Rats were placed in the center of the maze, facing one of the 
open arms, for a free exploration period of 5 min. The movements and position of the animals 
were recorded and registered automatically by a computerized system (Plus Maze©, Nijmegen, 
The Netherlands). Results were expressed as the mean of time spent (s) in open arms, the mean 
time spent in closed arms, and the distance moved (cm) in both open and closed arms. 
Novelty suppressed feeding. The novelty suppressed feeding test was performed as described by 
Lira et al. (2003). 22 Male (n=11 SERT+/+ and 11 SERT-/-) and 20 female rats (n=10 SERT+/+ and 10 
SERT-/-) were isolated and food deprived. After 24 hours of food deprivation (water available ad 
libitum), rats were placed in a brightly lit (60W incandescent bulb 1.2 m above the arena) open 
arena (50X50) containing clean wood chip bedding. A round white filter paper, with a radius 
of 6.25 cm, was placed in the center of the arena, and one home cage food pellet weighing 
approximately 2 g was placed on the paper. Rats were removed from their home cage, and 
then placed in one corner of the arena. The latency (s) to begin a feeding episode was recorded 
(maximum time was 600 s).  Bodyweight (g) of the rats was measured before the 24 hours of food 
deprivation.
Home cage emergence task.  24 Male (n=12 SERT+/+ and 12 SERT-/-) and 24 female rats (n=12 
SERT+/+ and 12 SERT-/-) were housed socially (two per cage). The test was performed as described 
by Prickaerts et al. (1996). In short, the home cage was placed in an arena and the lid of the 
home cage was removed. During testing, the cage mate was placed in another cage for the 
Proefschrift.indb   45 09-10-2008   23:00:18
46
Chapter 3
duration of the trial. A grid was placed over the edge of the cage to make it easier for the 
rats to leave the home cage. Testing was carried out during the night period with red light. A 
stopwatch was used to measure the latency (s) to leave the cage. The latency of the rat to climb 
out of its cage into the arena was measured. The trial ended when all four paws of the rat were 
over the edge of the cage. If the rat did not emerge from its home cage within 600 s, the trial 
was ended, the home cage was closed again and the rat was given a score of 600 s.
Depression-related tests
Sucrose consumption.  The procedure was performed as described by van der Kam et al. (van der 
Kam, 2006). 24 Male (n=12 SERT+/+ and 12 SERT-/-) and 24 female rats (n=12 SERT+/+ and 12 SERT-/-) 
were housed individually and habituated to the two-bottle paradigm by offering them water in 
two plastic drinking cylinders on top of the cage, one on each side, for a total of 5 days. Immediately 
after this 5 day period, the two bottles, free-choice, 24 hour sucrose vs. water paradigm started. 
In short, animals were presented either with water in both bottles or, on alternating days, with 
water and increasing sucrose percentages (2% to 10%). Bottles were switched on sucrose days 
to prevent spatial bias. Fluid consumption (g) and bodyweight (g) were measured daily and used 
to calculate two measurements, namely the preference of sucrose above water (sucrose intake 
in ml divided by total intake x 100%) and the intake in grams of a 100% sucrose solution per kg 
bodyweight (intake in ml corrected for the voluminal weight of sucrose and recalculated towards 
a 100% solution divided by bodyweight in kg).
Forced swim test. 40 Male (n=20 SERT+/+ and 20 SERT-/-) and 36 female rats (n=17 SERT+/+ and 19 
SERT-/-) were isolated 24 hours before testing. The forced swim test was conducted as reported 
in Porsolt et al. (1977). (Porsolt et al., 1977). In short, a cylindrical glass tanks (50 cm tall x 18 cm 
diameter), filled to a depth of 30 cm with 22°C+/-1 water, were used in the forced swimming test. 
Testing consisted of two phases, the induction phase and the test phase. During the induction 
phase animals were placed in the water for 15 minutes. After 24 hours the rats are placed in the 
same tanks for 5 minutes. The movements of the rats were videotaped for off-line measurement of 
the duration of immobility (s). The behavioral variable ‘immobility’ was defined as follows: making 
no movements for at least 2 seconds or making only those movements that were necessary to 
keep the nose above the water. The rats were allowed to slightly move their forepaws or support 
themselves by pressing their paws against the wall of the cylinder. Active climbing, diving and 
swimming along the wall were scored as mobility (s). 
Microdialysis
For the microdialyses studies 10 male (n=5 SERT+/+ and 5 SERT-/-) and 12 female rats (n=6 SERT+/+ 
and 6 SERT-/-) were used. Microdialysis was performed as described by Homberg et al. (2007a).
Surgery and microdialysis. Rats were anaesthetised using isoflurane (2.5%, 400 ml/min N2O, 
600 ml/min O2). Lidocain (10% m/v) was used for local anaesthesia. The animals were fixed in a 
stereotaxic frame (Kopf Instruments, USA) and I-shaped probes (dialysable surface 4 mm, hospital 
AN 69, Brainlink, the Netherlands) were inserted into the ventral hippocampus according to the 
following coordinates: bregma –5.3 mm, lateral to midline + 4.8 mm and ventral to dura –8.0 mm 
(for detailed description see (Cremers et al., 2004)) and then secured with dental cement and 
screws. Experiments were performed 24-48 hours after surgery. On the day of the experiment, 
animals were connected with a flexible PEEK tubing to a microperfusion pump (CMA 102, 
microdialysis AB, Sweden) and perfused with an artificial CSF, comprising 147 mM NaCl, 3.0 mM 
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KCl, 1.2 mM CaCl2, and 1.2 mM MgCl2 at a flow rate of 1.5 µl/min. 15 Minutes microdialysis samples 
were collected in HPLC vials containing 7.5 µl of 0.02 M formic acid and kept at -80ºC until analyzed. 
Baseline samples were taken after a habituation of 150 minutes, for 75 minutes (6 samples).
Drug administration. Citalopram HBr was dissolved in saline. Drugs were separately injected 
subcutaneously (s.c.) with a volume of 1 ml/kg. Citalopram was injected at a dose of 3 mg/kg 
directly after baseline measurements.
5-HT analysis. Samples of 20 µl microdialysate were injected via an autoinjector (Gilson 231, France) 
onto a 100 x 2.0 mm C18 Hypersil 3 µm diameter column (Bester, Amstelveen, The Netherlands) 
and separated using a mobile phase consisting of 4.2 g/L sodium acetate, 500 mg/L EDTA, 50 
mg/L heptane sulfonic acid, 4% methanol v/v, and 30 µl/L of triethylamine, pH was set at 4.75 
at a flowrate of 0.4 ml/min (Shimadzu LC-10 AD). 5-HT was detected amperometrically using a 
glassy carbon electrode at 500 mV vs Ag/AgCl reference electrode (Antec Leyden, Leiden, The 
Netherlands). The detection limit was 0.5 fmol 5-HT per 20 µl sample (signal to noise ratio of 3).
5-HT immunohistochemistry
Immunohistochemistry was performed as described by de Jong et al. (2005a). 12 Male (n=6 
SERT+/+ and 6 SERT-/-) and 12 female rats (n=6 SERT+/+ and 6 SERT-/-) were deeply anesthetized with 
a mixture of N2O/O2 (1:2) and isoflurane (2.5%; Rhodia Organique Fine limited, Bristol, United 
Kingdom). Then, they were perfused transcardially with 0.1 M PBS, pH 7.3, followed by 400 ml 4% 
paraformaldehyde dissolved in 0.1 M PB, pH 7.2. Subsequently, the brains were removed from the 
skull and post fixed overnight in 4% paraformaldehyde at 4°C. Before sectioning, the brains were 
cryoprotected with 30% sucrose in 0.1 M PB. Brain sections were cut on a freezing microtome, 
thickness 40 µm, and collected in 6 parallel series (6 vials per rat brain with each 1/6 part of the 
DRN) in 0.1 M PBS containing 0.1% azide. One vial of each rat was used for the staining. The free-
floating sections were washed three times in PBS and preincubated with 1% perhydrol (30% 
H2O2, Merck) for thirty minutes. After washing three times in PBS the sections were presoaked 
for thirty minutes in an incubation medium consisting out: PBS with 0.1% bovine serum albumin 
and 0.5% Triton X- 100. Then the sections were incubated overnight at room temperature, on 
a shaker with a polyclonal anti-5-HT antiserum raised in rabbit (batch 3-9, gift from prof. Dr. H. 
Steinbusch) diluted 1:10,000 in the incubation medium. The sections were incubated for 90 
minutes at room temperature in donkey anti-rabbit (1:1,500 in incubation medium, Jackson 
ImmunoResearch Laboratories, West Grove, PA) and for 90 minutes at room temperature in 
ABC-elite (Vector elite 1:800 in PBS). In between incubations, sections were rinsed three times 
with PBS. The 5-HT-antibody peroxidase complex was visualized by 3,3’-diaminobenzidine 
tetrahydrochloride (DAB) staining. Sections were incubated for 10 minutes in a chromogen 
solution consisting of 0.02% DAB and 0.03% Ni-ammonium sulfate in 0.05 M Tris-buffer (pH 7.6), 
and subsequently for 10 minutes in chromogen solution containing 0.006% hydrogen peroxide. 
This resulted in a blue-black staining. Following the immunohistochemical staining procedures, 
the sections were rinsed three times in PBS and mounted on gelatin chrome alum-coated glass 
slides, dried overnight in a stove at 37°C, dehydrated in an increased serie of ethanol, cleared in 
xylene, embedded with Entellan (Merck), and coverslipped. 
Quantification. Numbers of 5-HT-immunopositive cells were quantified using the software 
program Neurolucida (MicroBrightfield Inc, Williston, VT, USA). The number of 5-HT-positive cells 
was counted in the same level of the dorsal raphe nucleus in homologous square fields (using a 
grid overlay with a size of 100x100 µm) that displayed a representative density of stained cells.
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Data analysis
Behavioral data and immunohistochemistry data were analyzed with two-way ANOVA. Genotype 
and sex were assessed as independent variables. Where appropriate, post hoc comparisons were 
conducted using one-way ANOVA. For the sucrose consumption test, effects were evaluated 
using three-way ANOVA with genotype, sex and concentration as repeated measures. If an 
interaction was found, effect were further determined with a two-way ANOVA, followed by an 
one-way ANOVA where appropriate. For microdialysis studies, effects were evaluated using 
three-way ANOVA with genotype, sex and time as repeated measures. Differences between 
citalopram treatment were analyzed using two way ANOVA for repeated measurements followed 
by independent sample T-test analysis where appropriate. Level of significance was set at p<0.05. 
All statistical analyses were performed using the Statistical Package for the Social Sciences version 
12.0.1 for windows (SPSS Inc., Chicago, IL, USA).
Results
Anxiety-related tests
Open field. To determine whether SERT-/- rats 
have an increased level of anxiety, they were 
subjected to the open field test. This test 
is based on an exploration-conflict and an 
increase in time spent in the central part of the 
open field is considered to be an indication 
of anxiolytic behavior (Walsh and Cummins, 
1976;Prut and Belzung, 2003). A genotype 
effect was found in the open field (Figure. 
1A), with SERT-/- rats spending significantly 
less time in the center compared to SERT+/+ 
rats (F(1,43)=13.362; p<0.001). There was no 
genotype effect found in the total distance 
moved (Figure. 1B; F(1,43)=1.187; p=0.282). 
However, there was a significant sex effect 
(Figure. 1C; F(1,43)=10.503; p<0.002), with female 
rats moving a greater distance than male rats. 
However there was no significant genotype x 
sex interactions. 
Elevated Plus maze. To determine anxiety in 
a different assay, SERT-/- rats were subjected 
to the elevated plus maze. Elevated open 
Figure 1. 
Open field test. Behavior was recorded for 5 min in SERT+/+ and SERT-/- male and female rats. (A) Mean ± SEM 
time (s) spent in the center of the open field. (B) Mean ± SEM distance moved (cm). (C) Mean ± SEM distance 
moved (cm) in male and female rats.  (males: n=12 SERT+/+ and n=12 SERT-/- rats; females: n=12 SERT+/+ and 
n=12 SERT-/- rats. * p< 0.05)
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alleys arouse greater avoidance responses than elevated closed alleys. Voluntary passage onto 
the open arms of an elevated, plus-shaped maze is associated with neurobiological changes 
indicative of a decreased anxiety (Handley and Mithani, 1984;Hogg, 1996). As shown in Figure. 
2, a significant genotype effect was found in the elevated plus maze with SERT-/- rats spending 
less time in the open arms (Figure 2A+C; F(1,40)=5.194; p<0.028) and moving a greater distance 
in the closed arms compared to SERT+/+ rats (Figure 2B+D; F(1,40)=8.407; p<0.006). In addition, 
we found a significant sex effect on the total distance moved (Figure 2E; F(1,40)=7.337; p<0.010), 
with females moving a greater distance compared to males. Moreover, females moved a greater 
distance in the open arms than males (F(1,40)=9.706; p<0.003). Again, as with the open field test, 
no significant genotype x sex interactions were found on any of the parameters in the elevated 
plus maze.  
Figure 2.
Elevated plus maze test. Behavior was recorded for 5 min in SERT+/+ and SERT-/- male and female rats. (A) 
Mean ± SEM time (s) spent in the open or closed arm in males. (B) Mean ± SEM distance moved (cm) in the 
open or closed arm of the maze in males. (C) Mean ± SEM time (s) spent in the open or closed arm in females. 
(D) Mean ± SEM distance moved (cm) in the open or closed arm of the maze in females. (E) Mean ± SEM total 
distance moved (cm)  in males and females. (males: n=12 SERT+/+ and n=12 SERT-/- rats; females: n=12 SERT+/+ 
and n=12 SERT-/- rats. * p< .05) Note: SERT-/- rats spend significant less time in the open arm [F(1,40)=5.194; 
p<0.028] and moved a greater distance in the closed arms [F(1,40)=8.407; p<0.006] compared to SERT+/+ rats.
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Novelty suppressed feeding. We subjected our SERT-/- rats to a third anxiety test, being the novelty 
suppressed feeding assay. The latency to approach the bright lit center and start eating is 
considered to be an indication of anxiety (Shephard and Broadhurst, 1982). A significant genotype 
effect was found for the latency to start eating in a novel environment (F(1,41)=17.344; p<0.001).  As 
shown in Figure 3, SERT-/- rats exhibited a longer latency to start eating compared to SERT+/+ rats. 
This was completely due to the male SERT-/- rats, although there was no sex effect, a genotype 
x sex interaction was found (F(1,41)=11.858; p<0.001). Male SERT-/- rats exhibited a longer latency 
to start eating (Figure. 3) in a novel environment than male SERT+/+ rats (F(1,19)=27.684; p<0.001), 
whereas this was not significantly different between female SERT-/- rats and SERT+/+ rats (Figure 3; 
F(1,22)=0.274; p=0.606). The bodyweight of all rats was measured before the 24 hours deprivation. 
There was a significant effect in sex; males weighed more compared to females (F(1,41)=166.109; 
p<0.001). There was no genotype or genotype x sex effect found in weight. 
Home cage emergence task. The home cage emergence test was used as a last assay to assess the 
level of anxiety in the SERT-/- rats. An increase in anxiety results in an increased escape latency 
to leave the home cage (Prickaerts et al., 1996). As shown in Figure 4, a significant genotype 
effect was found in the home cage emergence task, with SERT-/- rats having a longer latency 
leaving their home cage than SERT+/+ rats (F(1,44)=18.025; p<0.001). In addition, a significant sex 
effect (F(1,44)=14.912; p<0.001) was found with females emerging faster from their home cage 
than males. However, as with the previous tests, we did not find a significant genotype x sex 
interactions. 
Depression-related tests
Sucrose consumption. Loss of interest or pleasure in events that are usually enjoyed (anhedonia) is 
a core symptom of depression. In animal studies a decreased consumption of palatable solutions 
is used to measure anhedonia. This decreased consumption can be prevented by antidepressants 
(Willner et al., 1987;Muscat et al., 1992). Moreover, chronic exposure to mild unpredictable 
Figure 3
Novelty suppressed feeding test. Behavior was 
recorded for 10 minutes for male (left) and female 
(right) SERT+/+ and SERT-/- rats. Data are expressed 
as mean ± SEM latency (s) to start eating. (males: 
n=11 SERT+/+ and n=11 SERT-/- rats; females: n=10 
SERT+/+ and n=10 SERT-/- rats. * p<0 .05)
Figure 4
Home cage emergence task. Behavior was 
recorded for 10 minutes for male (left) and female 
(right) SERT+/+ and SERT-/- rats. Latency (s) leaving 
the home cage is shown as mean ± SEM. (male: 
n=12 SERT+/+ and n=12 SERT-/- rats; female: n=12 
SERT+/+ and n=12 SERT-/- rats. * p<0 .05)
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stress has been found to depress the consumption of palatable sweet solutions (Willner et al., 
1987;Orsetti et al., 2007). The preference of sucrose above water and the intake in grams of a 
100% sucrose solution per kg bodyweight were measured in the sucrose consumption test as 
described separately below. 
Sucrose preference. A significant genotype effect was observed for the sucrose preference (Figure 5; 
F(1,33)=4.625; p<0.039), with SERT-/- rats drinking less sucrose solution compared to SERT+/+ rats. This 
effect was independent of the concentration, since no genotype x concentration interaction was 
found. Although there was no significant sex effect, a significant sex x concentration interaction 
was found (F(10,330)=2.411; p<0.009). Females showed a higher preference to sucrose at lower 
concentration of sucrose (Figure 5) compared to males. At higher concentration, the preference 
is similar in males and females. We did not find any significant genotype x sex interactions .
Sucrose intake. As for sucrose preference, there was also a significant genotype effect for sucrose 
intake (F(1,39)=19.779; p<0.001), the sucrose intake being significant lower in SERT-/- rats compared 
to SERT+/+ rats (Figure 5). Moreover a genotype x concentration interaction for sucrose intake 
was found (F(10,390)=6.703; p<0.001). The sucrose intake was lower in SERT-/- rats compared to 
SERT+/+ rats especially at higher concentration of sucrose (Figure 5). In addition a significant sex 
effect (F(1,39)=21.845; p<0.001) as well as a significant sex x concentration interaction was found 
(F(10,390)=6.719; p<0.001) with male rats taking less sucrose compared to female rats, especially at 
higher concentration of sucrose. However we again did not observe any significant genotype 
x sex interactions. These data reveal that SERT-/- rats have a decreased consumption of sucrose 
compared to SERT+/+ rats, indicating a more depressive-like phenotype.
Figure 5
Sucrose consumption test.  In a free- choice two bottle paradigm male and female SERT+/+ and SERT-/- rats 
were allowed to consume increasing sucrose solutions (2-10%) on alternating days. Data are expressed as 
mean ± SEM sucrose preference (sucrose intake/total fluid intake x 100%)  in female (A) and male (B) rats, 
and as  mean ± SEM total sucrose intake (g) in female (C) and male (D) rats (male: n=12 SERT+/+ and n=12 
SERT-/- rats; female: n=12 SERT+/+ and n=11 SERT-/- rats. * p<0 .05)
Proefschrift.indb   51 09-10-2008   23:00:20
52
Chapter 3
Forced swim test. When rats are forced to swim in an inescapable situation, they typically display 
an immobile posture, which is considered to reflect a state of behavioral despair. Antidepressant 
treatments are known to reduce immobility time in the forced swim test (Porsolt et al., 
1977;Connor et al., 2000), while chronic mild stress and maternal separation increase immobility 
in the rat (Molina et al., 1994;Huang and Lin, 2006). Therefore  increased immobility is considered 
as ‘depression’-like behavior. A significant genotype effect was found in the forced swim test 
(Figure 6A+B; F(1,72)=22.521; p<0.001), with SERT-/- rats spending significantly less time in a mobile 
state compared to SERT+/+ rats. Moreover SERT-/- rats spent a longer time in the immobile phase 
than SERT+/+ rats ( F(1,72)=22.461; p<0.001). No significant sex or genotype x sex interactions 
were found. The results of the forced swim test are therefore in line with the data on sucrose 
consumption and indicate that SERT-/- rats have an enhanced level of depressive-like behavior 
compared to SERT+/+ rats, independent of the sex.
Microdialysis
We previously reported that the lack of SERT led to a nine-fold higher level of extracellular 5-HT 
in male SERT-/- rats (Homberg et al., 2007a). To determine whether this is sex dependent we here 
investigated the 5-HT levels in male and female SERT-/- rats. As shown in Figure 7, 5-HT levels 
were seven-fold elevated in the SERT-/- rats compared to SERT+/+ rats (F(1,18) =50.227; p< 0.001). 
These differences were found for male (Figure 7A) and female (Figure 7B) rats. The percentage 
rise in 5-HT after citalopram treatment was significantly different between SERT+/+ and SERT-/- 
rats (F(1,17) =19.593; p<0.001), because the high basal levels of 5-HT in the SERT-/- rats did not 
increase, whereas 5-HT levels in the SERT+/+ rats were significantly increased after citalopram 
administration. The difference in rise of 5-HT after citalopram administration was independent 
of the sex of the rat.  
5-HT immunohistochemistry
5-HT neurons within the DRN project to forebrain systems involved in anxiety-related behavioral 
responses (Steinbusch H.W.M., 1984;Maier et al., 1993;Graeff et al., 1996). We investigated the 
Figure 6
Forced swim test. Behavior was scored for 5 
minutes in male (A) and female (B) SERT+/+ and 
SERT-/- rats on the 2nd day of the test, and expressed 
as mean ± SEM time spent (s) on mobility and 
immobility. (male: n=20 SERT+/+ and n=20 SERT-/- 
rats; female: n=17 SERT+/+ and n=19 SERT-/- rats. 
Note: SERT-/- rats were significant less mobile 
[F(1,72)=22.461; p<0.001] and more immobile 
[F(1,72)=22.521; p<0.001] in the forced swim test 
compared to SERT+/+ rats.
Proefschrift.indb   52 09-10-2008   23:00:20
Anxiety and depression related behavior
53
DRN of SERT-/- and SERT+/+ rats to reveal possible neural differences. Serotonergic cell numbers in 
the DRN were quantified as shown in Figure 8. The number of 5-HT immunopositive cells was not 
significantly different between SERT+/+ and SERT-/- rats. Moreover there was not any significant sex 
or genotype x sex effect. 
Discussion 
In the present study, we analyzed anxiety- and depression-like behaviors in the SERT knockout rat 
model, with additional focus on possible sex-specific effects. The results showed that SERT-/- rats 
consistently displayed increased levels of anxiety- and depression-like behaviors, independent 
of sex and independent of the specific test used. 
Compared to SERT+/+ rats, SERT-/- rats spent less time in the center part of the open field as well as 
on the open arm of the plus maze, suggestive of an enhanced level of anxiety in the SERT-/- rats. 
In this respect, it is important to realize that the total distance moved in the open field did not 
differ between SERT+/+ and SERT-/- rats, indicating that the observed differences are unlikely to be 
due to differences in exploratory drive per se. The novelty suppressed feeding paradigm, similar 
to the open field and elevated plus maze, can also be considered as a conflict paradigm, such 
that hunger becomes the primary drive above exploration (Bodnoff et al., 1988). In this paradigm 
an increased latency to start eating was found in the SERT-/- rats. This effect was only found in 
male rats. A latency difference was found between male SERT+/+ and female SERT+/+ rats (data not 
Figure 7
Microdialysis. 5-HT levels were measured in the hippocampus under basal condition and after administration 
of citalopram  in male (A) and female (B) SERT+/+ and SERT-/-  rats. Data are expressed as mean ± SEM fmol 
5-HT per sample. (male: n=5 SERT+/+ and n=5 SERT-/- rats; female: n=6 SERT+/+ and n=6 SERT-/- rats. Note: 
SERT-/- have significant higher basal 5-HT levels  [F(1,18)=50.227; p<0.001] compared to SERT+/+ rats.
Figure 8
5-HT Immunoreactivity in the dorsal raphe nuclei 
(DRN) of male and female SERT+/+ and SERT-/- rats. 
Data represent mean ± SEM number of 5-HT 
immunoreactive neurons (male n=6 SERT+/+ and 
n=6 SERT-/- rats; female n=6 SERT+/+ and n=6 
SERT-/- rats. 
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shown). This difference might have arisen by the difference in start body weight of the animals. 
Moreover the loss of body weight after 24 hours was higher in SERT+/+ and in SERT-/- females 
compared to SERT+/+ and in SERT-/- males (data not shown). This may also have influenced the 
feeding behavior. Nevertheless the increased latency in male SERT-/- rats indicates a higher level 
of anxiety compared to male SERT+/+ rats. Finally, the home cage emergence test was performed 
to measure anxiety-like behavior in the SERT-/- rats. Again SERT-/- rats showed higher levels of 
anxiety-like behavior since the latency for escaping from their home cage was higher compared 
to SERT+/+ rats. Taken together these results show that loss of SERT induces anxiety-like behavior 
in all tests conducted here.
Previous research showed that higher anxiety-like behaviours were  also found in several SERT-/- 
mouse models. Both male and female SERT-/- mice with a 129S6/SvEv background did show 
an increased anxiety like effect in the novelty suppressed feeding test, but did not display an 
increased anxiety-like behavior in the open field and elevated plus maze (Lira et al., 2003). On 
the other hand, male and female SERT-/- mice on a Swiss albino CD-1 strain showed reduced 
locomotor activity in a novel environment (Alexandre et al., 2006). Moreover, male and female 
SERT-/- mice with a C57BL/6J background strain exhibited increased anxiety-like behavior in the 
open field, elevated plus maze, activity patterns and emergence test (Holmes A, 2003a;Holmes 
et al., 2003b;Zhao et al., 2006;Kalueff et al., 2007a). However, opposite results exist in SERT-/- mice 
on a C57BL/6J. For example, male SERT-/- mice were only more anxious when they were exposed 
to predator odor exposure and not on basal levels in the EPM and light/dark box (Adamec et al., 
2006).  The SERT-/- rats on a Wistar background showed a general increase in anxiety-like behavior, 
as evident in the open field, the elevated plus maze, the home cage emergence test, and the 
novelty suppressed feeding. Humans are genetically heterogenous, and in that respect the 
outbred Wistar background of SERT-/- rats could be an advantage as opposed to inbred mouse 
strains. However, we did not test the effect of SERT-/- in other rat strains, and as in mice, rat strain 
background may affect the phenotype.
SERT-/- rats displayed alterations for all depression-like behaviors tested in this study. First SERT-/- 
rats consumed less sucrose in the two-bottle paradigm compared to SERT+/+ rats, being indicative 
for  anhedonia-like . And second, SERT-/- rats showed increased immobility in the forced swim test 
compared to SERT+/+ rats. Taken together, these results indicate a higher ‘depression’-like state in 
SERT-/- rats. 
In some SERT-/- mice, depression-like behavior was also present.  For example mice with a 129S6 
background (male and female) showed an increased immobility in the forced swim test (Holmes A, 
2002;Lira et al., 2003), but SERT-/- mice generated on a C57/6J genetic background only a showed 
an increased immobility when they were repeatedly exposed to the forced swim test (Wellman 
et al., 2007). In the tail suspension, a test used to measure depressive-like behavior in mice, the 
immobility of SERT-/- mice on a Swiss albino CD-1 strain (Alexandre et al., 2006) and of SERT-/- mice 
on a C57BL/6J background (Zhao et al., 2006) was increased. The sucrose consumption test was 
only performed in male SERT-/- mice with a C57BL/6 background. These mice were not different 
from the SERT+/+ mice in this test (Kalueff et al., 2006), suggesting that genetic ablation of the 
SERT with this specific genetic background does not induce anhedonia, in line with the unaltered 
forced swim test performance found in these mice (Holmes A, 2002). However, it does not rule out 
that SERT-/- mice with other background do not show this behaviour. Thus, SERT ablation leads 
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to either predominantly anxiety-like behavior in mice (on a C57BL/6 background) or depression-
like behavior (on a 129S6 background). In rats on a Wistar background, SERT ablation induces 
both anxiety and depression-like behaviour, although it remains to be established whether this 
is a species or a strain dependent phenomenon. The similarities found between SERT-/- rats and 
mice indicate that gene function is conserved among species and underlines the value that 
SERT-/- animals represent an interesting model for the anxiety/depression co-morbidity state in 
humans.
Despite, the higher level of activity of females in the open field, elevated plus maze and home 
cage emergence task, no differences were found in vulnerability to the deletion of SERT between 
male and female rats. In fact, if anything, male rats showed a slightly increased vulnerability for 
the deletion, since the latency to initiate food consumption in the novelty suppressed feeding 
test was increased in male SERT-/- rats, while in females there is no difference in latency between 
SERT-/- and SERT+/+ rats. Thus, in spite of basal 5-HT differences between males and females found 
before (Watts and Stanley, 1984;Carlsson and Carlsson, 1988;Haleem et al., 1990;Dominguez et 
al., 2003) our data show that lifelong absence of SERT in rats,  leads to a sex-independent  increase 
of anxiety- or depression-like behavior. This is in line with data from human studies showing 
an increased risk for both male and female individuals with the short version of the SERT gene 
promoter polymorphism  to develop depression (Mann et al., 2000). No big differences were 
found between male and female SERT-/- mice in anxiety and depression-like behavior (Holmes A, 
2002;Lira et al., 2003;Holmes A, 2003a;Holmes et al., 2003b).
The increase in anxiety- and depression-like behavior is most likely due to alterations in 
serotonergic neurotransmission in SERT-/- rats. As previously shown for male rats (Homberg et al., 
2007a) we found that besides males, also female SERT-/- rats have increased 5-HT levels. Increased 
extracellular 5-HT is expected to cause excess activity at postsynaptic 5-HT receptors which, in 
turn, could underlie increased anxiety-like behaviors in SERT-/- rats (Iversen, 1984;Graeff et al., 
1996). Also in the SERT-/- mice a fourfold to sixfold increase in basal levels of forebrain extracellular 
5-HT has been found (Montanez et al., 2003;Mathews et al., 2004). We can therefore conclude that 
a lifelong absence of the serotonin transporter in SERT-/- rats causes alterations in the serotonergic 
neurotransmission, independent of the sex.
As a first attempt to explain the observed effects on anxiety and depression in our SERT-/- rats, we 
studied the number of serotonergic cells in the dorsal raphe nuclei (DRN) in SERT+/+ and SERT-/- 
rats. The DRN contains the largest number of serotonergic cell bodies and hence is a crucial 
structure within the 5-HT network related to anxiety and depression. It contains over 50% of all 
5-HT neurons projecting to the forebrain (Steinbusch H.W.M., 1984). We used different ages for 
male and female rats, however a comparison between the groups is possible since aging has no 
effect on the number of serotonergic cells in the dorsal raphe nucleus (van Luijtelaar et al., 1992). 
Somewhat surprisingly, we found no significant differences in the number of immunopositive 
5-HT neurons in the DRN between SERT-/- and SERT+/+ rats, indicating that the absence of SERT 
has no consequences for the number of serotonergic cells. Obviously, this does not imply that 
the sensitivity of the 5-HT neurons may not be altered. It would be useful to further assess 
this for example by electrical recording of neural firing properties. In addition, we have found 
reduced levels of 5-HT and 5-HIAA tissue levels in SERT-/- rats (Homberg et al., 2007a), presumably 
reflecting an adaptive reduction of intracellular concentrations.  In contrast to SERT-/- rats, SERT-/- 
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mice on a 129S6 background showed an approximately 50% reduction in serotonin neuron 
number in the DRN (Lira et al., 2003), indicating another clear difference between rats and mice. 
Since the SERT-/- mice on a 129S6 background, in contrast to the SERT-/- rats, did not display any 
anxiety like behavior in the elevated plus maze and open field, it is tempting to speculate that 
the adaptive mechanism at the level of the DRN may somehow protect the SERT-/- mice. However, 
further research is needed to substantiate this suggestion. Nonetheless, it is important to realize 
that in post-mortem studies of human individuals suffering from depression no reduction in 
the number of serotonergic neurons in the DRN was found (Rajkowska, 2000;Hendricksen et al., 
2004), suggesting that the SERT-/- rat represents a good animal model for affective disorders in 
human. 
It is paradoxical that SSRIs are effective in the treatment of depression in adults, while neonatal 
SSRI treatment (Ansorge et al., 2004) or genetic inactivation of the SERT (present study) induce 
depression-like symptoms. In addition, down-regulation of the SERT with in vivo RNAi method 
(knockdown gene expression) in adult BALB/c mice, results into a reduction in immobility in 
the forced swim test (Thakker et al., 2005). A possible explanation for this paradox is that either 
underactivity or overactivity of a neurotransmitter system causes anxiety- and mood disorders. 
This means that the relationship between 5-HT and 5-HT disorders operates according to an 
“inverted-U” function, since high 5-HT levels in SERT-/- rats and low 5-HT levels in human patients 
show similar symptoms (Calabrese and Baldwin, 2001). Chamberlain et al. (2006) used this theory 
to explain their results in a cognition experiment in which either underactivity or overactivity 
of the 5-HT system impaired cognition (Chamberlain et al., 2006). Alternatively, a more likely 
explanation is that the effects of low SERT gene function are present from conception on, also 
during critical periods of development. Several studies have shown that 5-HT is implicated 
during the development and organization of the central nervous system (Zhang, 2003). The 
ontogenic role of monoamines can have a huge impact on the appearance of normal emotional 
behavior (Meaney et al., 2000;Caspi et al., 2002). In SERT-/- mice, it is already known that postnatal 
absence of the SERT gene can lead to disorganization of certain cortical regions (Persico et al., 
2001;Salichon et al., 2001). Moreover, a greater spine density in the pyramidal neurons in the 
basolateral amygdala was found, and the length of apical dendritic branches of infralimbic 
cortex pyramidal neurons of SERT-/- mice was increased compared to SERT+/+ mice (Wellman et 
al., 2007). In SERT-/- rats it is likely that a similar disorganization, or perhaps more widespread 
neurodevelopment abnormalities, have taken place and it is important to further elucidate this 
in the near future. 
In conclusion, SERT-/- rats showed increased anxiety- and depression-like behavior in a variety of 
tests. To understand how genetic reduction in SERT contributes to the vulnerability to develop 
mood or anxiety disorders later in life, more research is needed. Moreover, it is relevant to know 
if disorganization of brain regions, important for these disorders, takes place during a critical 
period of development. The SERT-/- rat will be a valuable model for unravelling developmental 
origins of mood and anxiety disorders. Moreover, since SERT-/- rats do not respond to SSRIs like 
citalopram, this animal model can be used to develop novel therapies especially useful for the 
relatively large group of patients that are not responding to current SSRI treatment.
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Abstract
Acute tryptophan depletion (ATD) transiently lowers central serotonin levels and can induce 
depressive mood states and cognitive defects. Previous studies have shown that ATD impairs 
object recognition in rats. As individual differences exist in central serotonin neurotransmission, 
the impact of ATD may vary accordingly. In this experiment, we investigated the hypothesis 
that male serotonin transporter knockout (SERT-/-), rats marked by a  lower SERT function, are 
more vulnerable to the effects of ATD in an object recognition task than male wildtype (SERT+/+) 
and heterozygous (SERT+/-) rats. Twelve male SERT+/+, SERT+/- and SERT-/- rats were treated with 
standard dose and low-dose ATD using a gelatine-based protein-carbohydrate mixture lacking 
tryptophan. In the control treatment L-tryptophan was added to the mixture. Four hours after 
treatment the rats were subjected to the object recognition task. In addition, the effects of ATD 
on plasma amino acid concentrations were measured and concentrations of 5-HT and 5-HIAA 
concentrations were measured in the frontal cortex and hippocampus of these rats. Plasma 
TRP levels and central 5-HT and 5-HIAA levels were decreased in all genotypes after ATD, but 
effects were stronger in SERT-/- rats. The standard dose of ATD impaired object recognition in 
all genotypes. SERT-/- and SERT+/- rats were more vulnerable to low-dose of ATD in the object 
recognition task compared to SERT+/+ rats. These results indicate a greater sensitivity to ATD in 
SERT-/- and SERT+/- rats, which may be related to stronger central depletion effects in these rats.  
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Introduction
Memory is a multifaceted cognitive function relating to the acquisition and storage of information 
for shorter or longer periods of time, and the subsequent retrieval of this information. The role of 
the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) in learning and memory has been 
demonstrated in both humans and animals (Buhot 1997;Buhot et al. 2000;Meneses 1999;Riedel et 
al. 1999;Schmitt et al. 2000). Studies using the method of acute tryptophan depletion (ATD), which 
results in lower peripheral and central levels of tryptophan and 5-HT (Biggio et al. 1974;Fernstrom 
and Wurtman 1997;Gessa et al. 1974;Moja et al. 1989;Stancampiano et al. 1997), consistently 
report impaired memory in healthy volunteers (Park et al. 1994;Riedel et al. 1999;Sambeth et al. 
2007;Schmitt et al. 2000) and rats (Jans et al. 2007a;Lieben et al. 2004b;Rutten et al. 2007). More 
specifically, ATD studies have shown impairments of long-term memory performance (Riedel 
et al. 2002) and reduced ability to actively recall, as well as recognize, words from a previously 
presented word list (Riedel et al. 1999). Whereas consolidation of new information into long-term 
memory appeared to be compromised by a reduction of central 5-HT activity, short-term memory 
functions were intact. Several studies have subsequently confirmed that 5-HT is specifically 
involved in long-term memory functioning (for review see Sambeth et al. 2007;Schmitt et al. 
2006). Interestingly, ATD did not affect long-term memory retrieval or recognition when the 
depletion was induced after learning and consolidation of a word list (Schmitt et al. 2000). Thus, 
these results suggest that consolidation of new information into long-term memory requires 
normal 5-HT functioning.
The serotonin transporter (SERT) has an important role in the reuptake of 5-HT from the synapse, 
returning it to the presynaptic neuron where it can be degraded or retained for future release. 
In fact, the SERT has an essential role in serotonergic neurotransmission as it determines the 
magnitude and duration of the 5-HT signal in the synaptic cleft. We recently developed a SERT 
knockout (SERT-/-) rat using N-ethyl-N-nitrosurea (ENU) driven mutagenesis (Smits et al. 2004;Smits 
et al. 2006). This animal has a premature stopcodon (TGC>TGA) introduced at position 3924 
in the third exon encoding the second extracellular loop of the SERT protein. Consistent with 
the absence of SERT in these rats, northern blot analysis revealed that the mutation resulted 
in nonsense-mediated decay of the mutant SERT transcript, and showed reduced SERT mRNA 
transcript in the SERT heterozygous knockout (SERT+/-) rat (Homberg et al. 2007a). In addition, 
[3H]citalopram (SSRI) binding to brain slices of SERT-/- rats is completely absent, whereas in SERT+/- 
rats, citalopram binding was reduced by approximately 40%. Moreover, extracellular 5-HT levels 
in the hippocampus of SERT-/- are nine-fold elevated (Homberg et al. 2007a; Olivier et al. 2008b), 
whereas in SERT+/- rats extracellular 5-HT levels are similar to wildtype littermates (SERT+/+) (Olivier 
et al. unpublished data). However, intracellular 5-HT levels were reduced by approximately 75-50% 
in SERT-/- rats and by 45-55%  in SERT+/- rats in several brain areas (Homberg et al. 2007a).
In humans, a polymorphism in the 5-HT transporter gene-linked promoter region (5-HTTLPR) 
results in individual differences in SERT expression and function (Heils et al. 1996;Lesch et al. 1996). 
Several studies have shown that 5-HTTLPR genotype can influence behavioral responses to ATD 
(Marsh et al. 2006;Neumeister et al. 2006;Roiser et al. 2006;Walderhaug et al. 2007). As wildtype 
(SERT+/+), heterozygous (SERT+/-) and knockout (SERT-/-) rats exhibit large differences in central 
5-HT neurotransmission, the impact of ATD may vary accordingly in these rats. In this study, these 
different types of rat were subjected to two different doses of ATD –a standard dose and a low 
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dose- and tested for memory in the object recognition task. Animals with lower SERT function 
were hypothesized to be more vulnerable to the effects of ATD on object recognition memory, as 
they rely more heavily on 5-HT synthesis than animals in which the re-uptake mechanism is fully 
functional. The magnitude of the depletion was determined by measuring plasma amino acid 
concentrations of TRP and five other large neutral amino acids (LNAAs: valine, leucine, isoleucine, 
phenylalanine, tyrosine) that compete with TRP for transport across the blood brain barrier. The 
ratio of TRP and these other LNAAs (TRP/ΣLNAA ratio) is thought to be a more sensitive index of 
brain tryptophan availability than plasma TRP (Fernstrom 1981;Wurtman et al. 1980), because 
this ratio determines the amount of tryptophan that can enter the brain. Moreover, 5-HT and 
5-HIAA concentrations were measured in the frontal cortex and the hippocampus, brain regions 
involved in cognition and memory (Dalley et al. 2004;Heidbreder and Groenewegen 2003;Squire 
and Zola-Morgan 1991;Wurtman et al. 1980).
Experimental procedures
Animals
The serotonin transporter knockout rat (Slc6a41Hubr) has been generated, bred and reared in 
the Central Animal Laboratory of the Radboud University of Nijmegen. Experimental animals 
were derived from crossing SERT+/- rats that were outcrossed for 4 or 5 generations. Twelve male 
SERT+/+, SERT+/- and SERT-/- littermates (age: 3 to 5 moths old) were used in this experiment. After 
weaning at the age of 21 days, ear cuts were taken for genotyping. Genotyping was performed 
at the Hubrecht Institute (Utrecht, the Netherlands) and the procedure has been described 
elsewhere (Homberg,et al. 2007a). During the experiment, all animals were individually housed 
in standard Macrolon® type 3 cages (42 x 26 x 20 cm) in temperature-controlled rooms (21 ºC ± 1 
ºC) with standard 12/12-h day/night-cycle (lights on at 7.00 am) and food (Sniff, long cut pellet, 
Bio Services, Uden, The Netherlands) and water available ad libitum. 
Drugs and chemicals
The Gelatin hydrolysate (Solugel P®) was obtained from PB Gelatins (Tessenderlo, Belgium). 
Glucodry 210 was obtained from Tate & Lyle (Koog aan de Zaan, The Netherlands). Kaliumchloride 
(KCl) and calciumchloride-dihydrate (CaCl2.2H2O) were purchased from Merck (Darmstadt, 
Germany). L-Tryptophan was obtained from Sigma (Zwijndrecht, the Netherlands).
Treatment
During a period of two weeks preceding the experiment, the rats were handled and habituated 
to oral injections with normal tap water (up to 10 ml/kg). The experiment consisted of blood 
sample collection (right after the handling period), object recognition task, and brain sample 
collection (one week after object recognition task). On blood and brain sampling days, rats were 
treated with a protein-carbohydrate mixture containing L-TRP (TRP+ group, 0.30% TRP of the 
total protein) or lacking L-TRP (TRP- 100 g group). In all treatment conditions, rats received two 
oral injections of 10 ml/kg with a 90-minute interval.  Blood samples were taken at baseline (10 
minutes before the first injection) and 4 hours after the first injection. Brain samples were taken 
without treatment and 4 hours after the first treatment. The composition of the nutritional mixture 
is shown in Table 1. In the object recognition task rats were tested without treatment, with TRP+, 
with TRP- 100 g (standard dose ATD) and with TRP- 40 g (low-dose ATD) respectively with a two-
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day interval. The TRP- 40 g condition is a mixture containing 40 g instead of the standard 100 g 
of Solugel P protein per 100 ml. Because TRP was absent and amino acids were given in a lower 
concentration this resulted into milder tryptophan depletion. On each testing day, behavioral 
testing was conducted 4 hours after the first oral administration. Treatment always took place 
between 8.30 and 12.00 hours and the object recognition task was performed between 12.30 
and 17.00 hours. The rats were fasted from 14 hours prior to treatment until the testing period 
was completed. This was done to minimize the availability of TRP from food. At the end of each 
testing day, the animals had ad libitum access to food. 
Biochemistry
Plasma amino acid levels. For the determination of plasma amino acid levels, blood samples were 
taken at baseline (T0; i.e., 10 minuters before the first oral administration) and repeated 4 hours 
after the first administration (T4). Blood sampling was done via a tail-incision method (Fluttert et 
al. 2000). Promptly after collection of blood in a sodium heparin tube (Microvette® CB 300, Sarstedt, 
Germany), the samples were kept on ice. After centrifugation of the blood samples (at 4°C for 15 
minutes at 3000 g), plasma samples were stored at –70°C. Plasma amino acid concentrations 
were determined with a fully automated high-performance liquid chromatography (HPLC). The 
concentrations of the total plasma amino acids are expressed as μmol/L.
Brain 5-HT and 5-HIAA levels. Animals were decapitated and tissue samples (frontal cortex and 
hippocampus) were dissected from the brain, weighed and stored at -80°C until further use. 
Proefschrift.indb   63 09-10-2008   23:00:22
64
Chapter 4
The tissue samples were homogenized in 250 μl of an ice-cold solution containing 5 μM 
clorgyline, 5μg/ml glutathione and 0.6 μM Nω-methylserotonin (NMET, internal standard), using 
a potter tube. To 100 μl  homogenate, 25 μl  2 M HClO4 was added and mixed. Then 20 μl 2.5 M 
potassium acetate was added and again mixed. After 15 minutes in ice water, the homogenates 
were centrifuged during 15 minutes at 15000g (4°C). The supernatants were diluted 10 times 
with water before HPLC analysis. The concentration of 5-HT and 5-HIAA in the tissue extracts were 
measured by HPLC with ECD. The HPLC system consisted of a pump model P100, an autosampler 
model AS300 (both from Thermo Separation Products, Waltham, MA, USA), A ERC-3113 degasser 
(Erma CR. Inc. Tokyo, Japan), an ESA Coulochem II detector with 5011 analytical cell set at potential 
+450mV (ESA Inc. Bedford MA, USA), a BD 41 chart recorder (Kipp & zn, The Netherlands) and a 
column (150mm x 4.6mm i.d.) packed with Hypersil BDS C18, 5 μm particle size (Alltech Associates, 
USA). The mobile phase solution consisted of 50 mM citric acid, 50 mM phosphoric acid, 0.1 mM 
EDTA, 45 μl/L dibutylamine, 77 mg/L 1-octanesulfonic acid sodium salt, 10% methanol; the pH of 
the buffer was adjusted to 3.4 with NaOH. Separation was performed at room temperature using 
a flow rate of 0.7 ml/min. The concentration of each compound was calculated by comparison 
with both the internal and the external standards. The limit of detection (signal/noise ratio 3:1) 
was 0.3 nM. Concentrations are expressed as nmol/g. The 5-HIAA/5-HT turnover was calculated, 
which can be used as an index of 5-HT system activity.
Behavior
Object recognition task. The object recognition task was performed as described elsewhere 
(Ennaceur and Delacour 1988;Prickaerts et al. 2002). The apparatus consisted of a square arena 
(100 x 100 x 40 cm), with an open top, dark walls and a dark floor. Testing was carried out in 
dimmed white light. We used four different sets of objects that could not be displaced by the rat. 
Each object was available in triplicate. The different objects were: 1) a bowl with handle made of 
green china (maximal diameter 15 cm and a height of 9 cm), 2) a cubic box (12×12×7 cm) made 
of polyvinyl, with a pink topping, 3) a china trapezium cylinder (maximal diameter 12 cm and 
minimum diameter 10.5 cm) with a dish on top (diameter 12 cm), and 4) a brown tinned cylinder 
(diameter 9.5 cm and height 15 cm). 
One day preceding testing, the animals were adapted to the procedure, i.e. they were allowed 
to explore the apparatus (without any objects) for 3 minutes. In the following days, the rats were 
tested twice. A testing session comprised two 3-minute trials with a 1 hour interval between 
trials. Two objects were placed in a symmetrical position about 10 cm away from the black wall. 
A rat was always placed in the apparatus facing one corner, which was the same for all rats. 
During the first trial the apparatus contained two identical objects. After the first exploration 
period the rat was put back in its home cage. One hour later the rat was put back in the apparatus 
for the second trial, but now with dissimilar objects, a familiar one and a new one. The duration of 
exploring each object in both trials was recorded manually on a personal computer. Exploration 
was defined as directing the nose to the object at a distance of no more than 2 cm and/or touching 
the object with the nose. Sitting on the object was not considered as exploratory behavior. In 
order to avoid the presence of olfactory trails, the objects were thoroughly cleaned between 
trials with a 70% ethanol solution. Moreover, each object was available in triplicate so that none 
of the two objects from the first trial had to be used as the familiar object in the second trial. In 
addition, all combinations and locations of objects were used in a balanced manner to reduce 
potential biases due to preferences for particular locations or objects. 
The basic measures in the object recognition task were the times spent by rats exploring an 
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object during trial 1 and trial 2. The discrimination index d2 ((exploration new object during trial 
2 - exploration familiar object during trial 2)/total exploration time during trial 2) was calculated 
for each treatment condition (see Rutten et al. 2007). The d2 is a relative index of discrimination 
between new and familiar object, because it corrects for total exploration time in trial 2 (see Şık 
et al. 2003). Rats that explored less than 5 s in any of the trials or explored only one of the objects 
were removed from analysis to avoid possible erroneous conclusions (see Şık et al. 2003).
Statistical analysis
For all variables, treatment effects were analyzed using parametric statistics (ANOVA). Plasma 
amino acid concentrations were analyzed with repeated measures ANOVA, with factors 
genotype, treatment, and time. Brain 5-HT, 5-HIAA and 5-HIAA/5-HT turnover were analyzed with 
2-way ANOVA, with factors treatment and genotype. Where appropriate, posthoc testing with 
Bonferroni correction was used. In the object recognition task, effects of treatment and genotype 
on exploration times in each trial was analyzed using 2-way ANOVA. Where appropriate, posthoc 
testing with Bonferroni correction was used. We compared the d2 values of untreated testing 
and treatment conditions with d2 values of a virtual control group (see Şık et al, 2003). The virtual 
control group had a d2 of zero, meaning there was no object recognition. The number of animals 
and SEM were similar to those of our treatment groups. Comparison with this virtual control 
group is used to evaluate more reliably whether discrimination performance differs from zero in a 
certain treatment condition. The d2 values were compared with ANOVA and a one-sided Dunnett 
post-hoc test was used to test whether d2 in a treatment condition was higher than in the virtual 
control group, which would indicate that the rats are able to discriminate the objects. 
Results
Plasma amino acid concentrations
To determine the effects of the treatment conditions, plasma amino acid concentrations were 
measured and the TRP/ΣLNAA ratio was calculated for each measurement, treatment and 
genotype (Figure. 1). Plasma TRP levels and the plasma TRP/ΣLNAA ratio decreased over the four 
hours [Time: TRP: F(1,29) = 45.20, p<0.001; Ratio: F(1,29) = 31.43, p<0.001]. Plasma TRP levels and 
the TRP/ΣLNAA ratio were lower in the TRP- 100g group compared to the TRP+ group [Treatment: 
TRP: F(1,29) = 77.46, p<0.001; Ratio: F(1,29) = 84.91, p<0.001]. There was no Time x Genotype x 
Treatment interaction effect and no Genotype x Treatment interaction effect on TRP or on the 
ratio (F’s < 2.15, ns). A Time x Treatment interaction effect was found on TRP [F(1,29) = 206.17, 
p<0.001] and on the TRP/ΣLNAA ratio [F(1,29) = 181.17, p<0.001]. Further analysis showed that 
in the TRP+ condition there was a significant increase of TRP and the TRP/ΣLNAA ratio over the 
four hours [TRP: F(1,13) = 26.26, p<0.001; Ratio: F(1,13) = 23.01, p<0.001], whereas in the TRP- 
100g condition these were significantly decreased [TRP: (1,14) = 223.26, p<0.001; Ratio: F(1,14) = 
222.13, p<0.001]. There was no Time x Genotype effect and no effect of genotype on TRP levels 
and on the TRP/ΣLNAA ratio. Thus, TRP- 100g ATD resulted in strong depletion of plasma TRP and 
the TRP/ΣLNAA ratio, whereas TRP+ treatment caused an increase in TRP and the TRP/ΣLNAA 
ratio. These effects were similar in all genotypes. 
Brain 5-HT and 5-HIAA concentrations 
To determine the central effects of the treatment, concentrations of 5-HT and 5-HIAA were 
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determined in the frontal cortex and in the hippocampus and for both structures the turnover 
(5-HIAA/5-HT) was calculated (Table 2). 
5-HT In the frontal cortex, a treatment effect on 5-HT was found [F(2,66) = 41.46, p<0.001]. 
Posthoc testing revealed that 5-HT levels were lower in the TRP- 100 g condition than in the 
untreated condition and the TRP+ condition (Figure 2A). Furthermore, 5-HT concentrations in the 
TRP+ condition were higher than in the untreated rats. Moreover, a genotype effect on 5-HT in 
the frontal cortex [F(2,66) = 73.76, p<0.001] was found. Posthoc analysis showed that 5-HT levels 
in SERT-/- rats were lower than in SERT+/- and SERT+/+ rats. No Treatment x Genotype interaction 
effect on 5-HT was found in the frontal cortex. In the hippocampus similar effects were found to 
the prefrontal cortex. In this structure also a treatment effect on 5-HT [F(2,66) = 17.85, p<0.001] 
was found, with lower 5-HT levels in the TRP- 100g condition than in the untreated condition 
and in the TRP+ condition (Figure 2A). Similar to the frontal cortex, 5-HT concentrations in the 
hippocampus were higher in the TRP+ condition than in the untreated rats. Also, a genotype 
effect on 5-HT was found in the hippocampus [F(2,66) = 67.25, p<0.001] with lower 5-HT levels in 
SERT-/- rats compared with SERT+/- and SERT+/+ rats. No Treatment x Genotype interaction effects 
were found on 5-HT in the hippocampus.
In order to test our specific hypotheses, we also analyzed the effects of treatment on behavior 
in each experimental group separately. In the frontal cortex, 5-HT levels in the TRP- 100g group 
were significantly lower than in the TRP+ group in all genotypes [Treatment: SERT+/+: F(2,20) = 
9.80, p<0.001; SERT+/-: F(2,21) = 12.75, p<0.001; SERT-/-: F(2,21) = 27.88, p<0.001]. In SERT+/+ and 
SERT+/- rats, 5-HT levels were higher in the TRP+ group than in the untreated rats, which was not 
Figure 1
Effects of treatment with TRP+ or TRP- 100g on plasma TRP/ΣLNAA ratio of all groups at baseline (T0) and 4 
h after the first administration of the mixture (T4). Percentage difference in TRP/ΣLNAA ratio between the 
baseline and the TRP+ and TRP- 100g condition after 4 h is indicated in the graph.
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the case in SERT-/- rats. In SERT-/- rats 5-HT was lower in the TRP- 100g condition than in untreated 
rats, which was not the case in SERT+/+ and SERT+/- rats.  In the hippocampus, there was a treatment 
effect on 5-HT in SERT+/- [F(2,21) = 9.29, p<0.001] and in SERT-/- rats [F(2,21) = 20.88, p<0.001], but 
not in SERT+/+ rats. In SERT+/- rats, 5-HT levels in the TRP+ condition were higher than in untreated 
and TRP- 100g treated rats. In SERT-/- rats, 5-HT levels in the TRP- 100g condition were lower than 
in the TRP+ condition and in untreated rats. 
5-HIAA A treatment effect on 5-HIAA was found in the frontal cortex [F(2,66) = 23.98, p<0.001], 
see Figure. 2B. Posthoc testing showed that 5-HIAA concentrations in the TRP- 100g condition 
were lower than in the untreated rats and in the TRP+ condition. In the frontal cortex a genotype 
effect was found on 5-HIAA in the frontal cortex [F(2,66) = 34.03, p<0.001]. Posthoc analysis 
showed that 5-HIAA levels in SERT-/- were lower than in SERT+/- and SERT+/+ rats. No Treatment x 
Genotype interaction effects on 5-HIAA were found in the frontal cortex.  Similar to the frontal 
cortex, a treatment effect on 5-HIAA was also found in the hippocampus [F(2,66) = 34.35, 
p<0.001]. As shown in Figure 2B, 5-HIAA concentrations in the TRP- 100g condition were lower 
than in the untreated rats and the TRP+ condition. In the hippocampus 5-HIAA levels were higher 
in untreated rats than in TRP+ treated rats. Moreover, a genotype effect on 5-HIAA was found in 
the hippocampus [F(2,66) = 35.30, p<0.001] showing lower 5-HIAA levels in SERT-/- rats compared 
with SERT+/- and SERT+/+ rats. No Treatment x Genotype interaction effects on 5-HIAA levels were 
found in the hippocampus.
In all genotypes, there was a treatment effect on 5-HIAA in the frontal cortex [SERT+/+: F(2,20) = 
18.69, p<0.001; SERT+/-: F(2,21) = 4.29, p<0.05; SERT-/-: F(2,21) = 10.66, p<0.001]. Posthoc testing 
revealed that in SERT+/+ rats 5-HIAA was lower in the TRP- 100g group compared to the TRP+ group 
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(p<0.01) and the untreated group (p<0.001). In SERT+/- and SERT-/- rats, 5-HIAA levels were lower 
in TRP- 100 g compared to untreated rats (SERT+/-: p<0.05; SERT-/-: p<0.001). For the hippocampus 
also, there was a treatment effect in all genotypes in the hippocampus as well [SERT+/+: F(2,20) = 
28.19, p<0.001; SERT+/-: F(2,21) = 7.16, p<0.001; SERT-/-: F(2,21) = 11.91, p<0.001]. Posthoc testing 
showed lower 5-HIAA levels in SERT+/+ and SERT+/- rats in the TRP- 100g group compared with the 
TRP+ (SERT+/+: p<0.001; SERT+/-: p<0.05) and untreated group (SERT+/+: p<0.001; SERT+/-: p<0.01). 
In SERT-/- rats, 5-HIAA was higher in the untreated rats compared with TRP+ (p<0.05) and TRP- 
100g (p<0.001) treated rats.
5-HIAA/5-HT As seen in Figure 2C, there was a Treatment x Genotype interaction effect on the 
5-HIAA/5-HT turnover in the frontal cortex [F(4,62) = 9.628, p<0.001] caused by the high 5-HIAA/5-
HT turnover rate of SERT-/- rats. A treatment effect was found on the turnover in the frontal cortex 
[F(2,62) = 11.60, p<0.001]. Posthoc testing revealed that the turnover was lower in the TRP+ 
condition than in the untreated rats and in the TRP- 100g condition. Moreover, a genotype effect 
on 5-HIAA in the frontal cortex [F(2,62) = 13.64, p<0.001] was found. The turnover was higher in 
SERT-/- rats than in SERT+/- and SERT+/+ rats. Similarly to the frontal cortex, a Treatment x Genotype 
interaction effect on the 5-HIAA/5-HT turnover was also found in the hippocampus [F(4,62) = 
12.60, p<0.001]. This effect seems to be the result of the high 5-HIAA/5-HT turnover rate in SERT-/- 
rats. Moreover, a treatment effect on the turnover was found in the hippocampus [F(2,62) = 9.02, 
p<0.001]. Again with a lower turnover in the TRP+ condition compared with the untreated rats 
and the TRP- 100 g condition. Similar to the frontal cortex, a genotype effect on 5-HIAA/5-HT 
was found in the hippocampus [F(2,62) = 28.62, p<0.001], with a higher turnover in SERT-/- rats 
compared with SERT+/- and SERT+/+ rats.
In all genotypes, there was a treatment effect on 5-HIAA/5-HT turnover in the frontal cortex 
[SERT+/+: F(2,20) = 4.64, p<0.05; SERT+/-: F(2,21) = 3.78, p<0.05; SERT-/-: F(2,21) = 16.37, p<0.001]. 
Posthoc testing showed that in SERT+/+ rats the 5-HIAA/5-HT was lower in the TRP- 100 g group 
compared to the untreated group (p<0.05). In SERT+/- rats 5-HIAA/5-HT was lower in TRP+ rats 
than in untreated rats (p<0.05). In SERT-/- rats 5-HIAA/5-HT was higher in TRP- 100 g compared to 
untreated rats (p<0.001) and TRP+ rats (p<0.001). In all genotypes, there was a treatment effect 
in the hippocampus [SERT+/+: F(2,20) = 7.31, p<0.01; SERT+/-: F(2,21) = 4.10, p<0.05; SERT-/-: F(2,21) 
= 15.12, p<0.001]. Posthoc testing showed that in SERT+/+ rats 5-HIAA/5-HT was lower in the TRP- 
100g group compared to the untreated group (p<0.01). In SERT-/- rats, 5-HIAA/5-HT was higher in 
the TRP- 100g treated rats compared  to untreated rats (p<0.01) and TRP+ treated rats (p<0.001). 
In SERT+/- rats no differences in 5-HIAA/5-HT were found.
Object recognition task 
In order to test whether animals with lower SERT function are more vulnerable to the effects of 
ATD we tested SERT+/+ SERT+/- and SERT-/- rats on object recognition memory. Exploration times 
of untreated rats and rats treated with TRP+, TRP- 100 g and TRP- 40 g treated were compared 
(data not shown). There were no Genotype x Treatment interaction effects on exploration time in 
trial 1 or in trial 2. There was no effect of Genotype or Treatment on exploration time in trial 1. In 
trial 2, there was an effect of Genotype [F(2,136) = 3.27, p<0.05] and Treatment [F(3,136) = 3.98, 
p<0.01] on exploration time. Posthoc testing showed that in trial 2, exploration time was lower in 
the TRP- 100 g and TRP+ condition compared to the TRP- 40 g condition (p<0.05). As mentioned 
before, d2 values of the untreated rats and the rats treated with TRP+, TRP- 100 g and TRP- 40 
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g of the present study were compared with d2 values of a virtual control group with no object 
recognition (see Şık et al, 2003). The effects of Genotype and Treatment on discrimination index 
d2 in the object recognition task are shown in Figure 3. 
Figure 2
Effect of treatment with TRP+ or TRP- 100 g on basal brain 5-HT (A), 5-HIAA (B) and 5-HIAA/5-HT turnover (C) 
levels in the frontal cortex and hippocampus. Bars represent mean and standard error. Numbers above the 
bars represent percentage difference from the untreated condition. 
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There was no Genotype x Treatment interaction effect [F(8,138) = 1.28, ns] and no effect of 
Genotype on discrimination index d2 [F(2,138) = 2.31, ns]. A treatment effect was found on the 
discrimination index d2 [F(4,146) = 21.65, p<0.001], post-hoc analysis showed that the untreated 
d2 and the d2 in the TRP+ and TRP- 40 g condition differed from the virtual control group with 
no object recognition. Only in the TRP- conditions rats were unable to discriminate between the 
new and familiar object after a one-hour interval. To evaluate whether SERT-/- rats were more 
vulnerable to ATD treatment than SERT+/- or SERT+/+ rats, treatment effects were analyzed within 
each genotype group. There was a treatment effect on d2 in all genotypes [SERT+/+ F(4,50) = 17.61, 
p<0.001; SERT+/- F(4,43) = 6.00, p<0.01; SERT-/- F(4,45) = 4.92, p<0.01]. In the SERT+/+ untreated rats 
and rats treated with TRP+ and TRP- 40 g were different from the virtual controls, but TRP- 100 g 
was not. In the SERT+/- only untreated rats and TRP+ treated rats were different from the virtual 
controls, but rats treated with TRP- 100 g and TRP- 40 g were not. In the SERT-/- rats only the 
untreated rats were different from the virtual controls, whereas rats treated with TRP+, TRP- 100 
g and TRP- 40 g were not. 
Discussion
In the present study, the effects of standard dose (TRP- 100 g) and low dose (TRP- 40 g) ATD 
were examined in SERT+/+, SERT+/- and SERT-/- rats in the object recognition task. The biochemical 
data showed plasma TRP depletion of 65% in SERT+/+, 61% in SERT+/- and 55% in SERT-/- rats four 
hours after standard dose TRP-. This decrease in plasma TRP levels is in agreement with other 
ATD studies (Jans et al. 2007a;Lieben et al. 2004b). SERT-/- rats showed stronger depletion of 5-HT 
in the frontal cortex (63%) than SERT+/+ and SERT+/- (both 19%) rats. Similar results were found 
in the hippocampus, where SERT-/- rats also showed a stronger depletion (70%) compared to 
SERT+/- rats (18%) and SERT+/+ rats (13%). Rats treated with standard dose TRP- showed lower 
5-HT levels in both brain structures compared to TRP+ treated rats and untreated rats. These 
Figure 3
Treatment effects in SERT+/+, SERT+/-, and SERT-/- on discrimination index d2. Treatment effect * p<0.05 
difference from virtual control group with no object recognition. 
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effects were most pronounced in SERT-/- rats, as only these rats showed significantly lower 5-HT 
in the standard dose TRP- condition than in the untreated condition. In both the frontal cortex 
and hippocampus, standard dose ATD decreased 5-HIAA to a similar extent in all genotypes. 
In SERT+/+ and SERT+/- rats, 5-HIAA/5-HT turnover was a bit lower in rats treated with TRP+ and 
standard dose TRP- compared with the untreated condition, but in SERT-/- rats, this turnover ratio 
was much higher in the standard dose TRP- group than in the TRP+ group and the untreated 
group. In previous studies, SERT-/- animals exhibited an increased 5-HT turnover at basal levels 
in the cortex and caudate putamen, but not in the amygdala medial prefrontal cortex, and 
orbitofrontal cortex (Homberg et al. 2007a;Homberg et al. 2007b). In line with this, untreated 
SERT-/- animals in this study did not have increased 5-HIAA/5-HT turnover in the frontal cortex. 
Although the central effects of ATD were stronger in SERT-/- rats, plasma TRP and TRP/ΣLNAA 
levels decreased to a similar extent in all genotypes. Thus, different effects seen in SERT+/+, 
SERT+/- and SERT-/- rats after ATD were found only in the brain and not in the periphery. Previous 
ATD studies reported a similar dissociation between peripheral and central effects (Jans et al 
2007a; Jans et al. unpublished data). Although the reason for this difference is not known, it is 
interesting to note that 5-HT synthesis in brain and pheripheral tissues function differently. For 
example, tryptophan hydroxylase (TPH), the rate-limiting enzyme to form 5-hydroxytryptophan 
(5-HTP) from tryptophan, is controlled by a different isoform in the brain than in the periphery 
(for review, see Walther and Bader, 2003). This difference in 5-HT synthesis might play a role in the 
different effects seen after ATD in brain and periphery.
The standard ATD dose (TRP- 100 g) is known to impair object recognition in Wistar rats (Jans 
et al. 2007a;Lieben et al. 2004b) and was thus expected to impair object recognition in all 
genotypes. The re-uptake mechanism in SERT+/+ rats is fully functional, whereas this mechanism 
is partly functional in SERT+/- rats, and not functional in SERT-/- rats. Therefore, SERT+/- and SERT-/- 
rats rely more heavily on 5-HT synthesis than SERT+/+ rats. Consequently, it was hypothesized 
that differences in object recognition between the genotypes would occur only after the low 
dose ATD treatment. It was found that all genotypes showed impaired object recognition after 
standard dose ATD. The relatively mild depletion of the TRP- 40 g treatment impaired object 
recognition in SERT+/- and especially in SERT-/- rats but not in SERT+/+ rats, suggesting that SERT-/- 
and SERT+/- rats are more sensitive to the memory-impairing effects of low-dose ATD. In SERT+/+ 
rats, the d2 in the TRP- 40 g condition was lower than in the untreated condition, but still different 
from the virtual control group with impaired object recognition. The stronger effects of the TRP- 
40 g treatment in SERT-/- rats may be related to the stronger effects of TRP- treatment on central 
5-HT levels. The same dose of TRP- 100 g had a stronger effect on central 5-HT levels in SERT-/- rats 
compared to SERT+/- and SERT+/+ rats. Notably, SERT-/- rats showed impaired object recognition 
after TRP+ treatment as well, although their untreated d2 indicated normal object recognition 
when untreated. This may be related to stress associated with the ATD procedure, such as the 
repeated oral injections. Chronic stress is known to impair object memory  (Beck and Luine 1999), 
and there is some evidence to suggest that diminished SERT function is associated with increased 
stress responsivity in humans (for review see Canli and Lesch 2007) and mice (Wellman et al. 
2007). In this way, the injection stress may have resulted in mildly impaired object recognition 
memory in TRP+ treated SERT-/- rats.
ATD has been reported to impair cognitive performance in humans (Park et al. 1994;Riedel et al. 
1999;Riedel et al. 2002;Sambeth et al. 2007;Schmitt et al. 2000), and impaired object recognition 
Proefschrift.indb   71 09-10-2008   23:00:25
72
Chapter 4
has been found in Wistar rats (Lieben et al., 2004b;Jans et al., 2007a). The effects of low-dose ATD 
on memory in groups that differ in serotonergic functioning have not been studied extensively. 
Booij et al. (2005) found that ATD had a dose-dependent effect on selective attention (Stroop 
color-word interference) in remitted depressed patients, but no other cognitive effects of low-
dose ATD were observed. The magnitude of the reduction of plasma tryptophan concentrations 
following ATD depends on the amount and composition of the amino acid mixture (Young et al. 
1989). In human studies, it has been suggested that a threshold exists that needs to be exceeded 
before any behavioral effects occurs, since studies in which the plasma tryptophan reduction 
was lower than 70% generally do not find any symptomatic effects (Van Der Does 2001). A similar 
threshold may also exist in the rat, although the level of the threshold is likely to be lower, as rat 
studies in general show lower plasma TRP depletion than human studies. In the present study 
SERT-/-, and to a smaller extent SERT+/- rats, showed impairment in recognition memory after 
low-dose ATD. Thus, it may be possible that in SERT-/-, and to a smaller extent in SERT+/- rats, the 
threshold is lower than in SERT+/+ rats, and less depletion of TRP is required to cause impaired 
memory. 
The results of this study indicate higher serotonergic vulnerability in SERT-/- and to a lesser extent 
SERT+/- rats than in SERT+/+ rats, as low-dose ATD only affected memory in subjects that already have 
a disturbed 5-HT system. Serotonergic vulnerability means that minor changes in serotonergic 
functioning do not cause symptoms but make the system more vulnerable, so that additional 
challenges of the serotonergic system may result in the occurrence of psychiatric symptoms 
(Jans et al. 2007b). Thus, serotonergic vulnerability can be demonstrated by challenging the 
5-HT system, as is done with ATD; only vulnerable subjects will react to such manipulations with 
changes in behavior. Challenging the 5-HT system in vulnerable subjects can have stronger 
effects on the memory function of these subjects. ATD in SERT-/- rats may therefore be a good 
tool to investigate serotonergic vulnerability.
Some possible limitations of this study have to be mentioned. First, plasma amino acid 
concentrations and brain 5-HT and 5-HIAA levels after the low dose TRP- 40g treatment could 
not be determined in this study due to the limited number of rats that were available for this 
study. Previous standard-dose ATD studies have shown a robust reduction in plasma TRP (about 
70%) and central tissue 5-HT (about 40-45%) concentrations in male Wistar rats (Lieben et al. 
2004a). Lowering the concentration of Solugel protein in the TRP- mixture had dose-dependent 
effects on the plasma TRP/ΣLNAA ratio in previous research, and there was a positive correlation 
between the plasma TRP/ΣLNAA ratio and performance in the object recognition task (Lieben et 
al. unpublished data). We can therefore assume that the low-dose TRP- 40g treatment resulted in 
milder TRP and 5-HT depletion. Further research may elucidate the exact level of peripheral and 
central depletion that is required to impair object recognition memory in SERT+/+, SERT+/- and 
SERT-/- rats. Secondly, the TRP+ treatment resulted in increased levels of plasma TRP and brain 
5-HT, suggesting an active control. Essentially, this means that we compared TRP depletion and 
mild TRP suppletion in all rats. This may have affected behavior in the TRP+ condition. Although 
these treatment effects in the TRP+ condition occurred to a similar degree in all genotypes, it 
cannot be excluded that the mild TRP suppletion had different effects in SERT+/+, SERT+/-, and 
SERT-/- rats. A third concern could be that the same group of rats were repeatedly subjected 
to ATD treatment (for the measurement of plasma levels, for the ORT, and eventually for the 
measurement of brain levels), although the treatment condition varied between tests. Previous 
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ATD studies have shown that repeated treatment did not alter the effect of the treatment on the 
plasma TRP/ΣLNAA ratio (Jans et al. 2007a) and that plasma levels returned to baseline levels on 
the treatment day (Jans et al., unpublished data). We therefore assume that the treatment has 
had comparable biochemical effects throughout the study.
The aim of the present study was to investigate whether male SERT+/+, SERT+/-, and SERT-/- serotonin 
transporter rats differed in their response to ATD with respect to object memory. Without 
treatment, all rats showed normal object recognition memory. After a standard 100g dose of 
ATD, object recognition memory was impaired in all genotypes. However, in the low-dose ATD 
condition, SERT+/- and SERT-/- rats showed increased responsiveness to the treatment than SERT+/+ 
rats by showing impaired object recognition after this relatively mild ATD treatment. Therefore, 
ATD in SERT-/- rats might be a valuable animal model to investigate serotonergic vulnerability. 
It can be concluded that there is a SERT gene-dosage effect with respect to the behavioral 
response to TRP depletion in the object recognition task. Because ATD decreased 5-HT levels 
in brain structures that play a crucial role in memory, such as the hippocampus and the frontal 
cortex, the outcome of the present study underlines the relevance of the serotonergic system in 
memory.  
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Abstract
Disturbances in the serotonergic system are implicated in many CNS disorders. The serotonin 
transporter (SERT) regulates the serotonin homeostasis in the synapse. We recently developed a 
rat which lacks the serotonin transporter (SERT-/-). It is likely that adaptive changes take place at 
the level of pre- and postsynaptic 5-HT receptors. Because autonomic responses are often used 
to measure 5-HT1A receptor function, we analysed these responses by examining the effects of a 
5-HT1A receptor agonist and antagonist under in vivo conditions in the SERT-/- rat. Moreover, we 
studied the effect of a mild stressor on  the temperature (stress-induced hyperthermia: SIH) because 
of the known involvement of 5-HT1A receptors in this phenomenon. Results show that core body 
temperature did not differ between genotypes under basal, non-stressed conditions. Compared 
to SERT+/+ rats, SIH was reduced in SERT-/- rats. The 5-HT1A receptor agonist [R(+)-N-(2[4-(2,3-
dihydro-2-2-hydroxy-methyl-1,4-benzodioxin-5-yl)-1-piperazininyl]ethyl)-4-fluorobenzoamide 
HCL (flesinoxan) reduced SIH in both genotypes. The flesinoxan-induced hypothermia in SERT+/+ 
rats was blocked by the 5-HT1A receptor antagonist  [N-(2-[4-(2-methoxyphenyl)-1-piperazinyl]
ethyl)-N-(2-pyridinyl) cyclohexanecarboxamide 3HCL (WAY100635). Moreover, WAY100635 
induced hyperthermia in SERT-/-, but not in SERT+/+ rats. In SERT-/- rats, WAY100635 completely 
blocked the flesinoxan-induced reduction of SIH and induced hyperthermia. Interestingly, 
flesinoxan induced hypothermia was absent in SERT-/- rats. It is concluded that the SERT knockout 
rat allows us to reveal that 5-HT1A receptors modulating SIH belong to a population of receptors 
that differs from that  involved in hypothermia.
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Introduction
Several studies support the involvement of the central serotonergic system in feeding and sexual 
behaviour as well as in systems affected by psychiatric disorders including anxiety, aggression, 
impulsivity and mood disturbances (Delgado et al., 1990;Stain-Malmgren et al., 2001;Neumeister 
et al., 2002;Moreno et al., 2002;Holmes et al., 2003c). Serotonergic (5-hydroxytryptamine, 5-HT) 
neurotransmission is primarily regulated by the serotonin transporter (SERT), which after its 
release into the synaptic cleft, transports 5-HT back into the presynaptic neuron where it is 
degraded or retained for future release (Murphy et al., 1998). A polymorphism in the human 
SERT has been described which leads to changes in SERT functioning early in life, and remains 
functional in adolescence and adulthood (Caspi et al., 2003;Beitchman et al., 2006;Covault J. 
et al., 2007;Schmitz et al., 2007).  This SERT polymorphism has been linked to vulnerability for 
various personality characteristics and psychiatric disorders (Hahn and Blakely, 2002). Given 
the prominent role of the SERT in the regulation of 5-HT neurotransmission, it is likely that this 
polymorphism will lead to adaptations in the serotonergic system, although such changes have 
not yet been studied.
Selective serotonin re-uptake inhibitors (SSRIs) are widely used in the treatment of mood disorders, 
obsessive-compulsive disorder, eating disorders, and substance abuse (Murphy, 1990)(Graham 
et al., 1989). Chronic administration of SSRIs produces adaptive changes in the serotonergic 
system (Briley and Moret, 1993;Blier and De Montigny, 1998)(Blier and de, 1998;Briley and Moret, 
1993). (Blier et al., 1997)However, such chronic treatments are still relatively short-lasting and 
provide only limited insight into the consequences of life-long adaptations in serotonergic 
functioning such as occurring in individuals with the above-mentioned SERT polymorphisms. 
Therefore, the goal of the present study was to investigate to what extent life-long disturbed 
5-HT neurotransmission in SERT gene knockout (SERT-/-) rats may result in adaptive changes 
in the serotonergic system. We especially focused on the 5-HT1A receptor pathways, because 
adaptive changes in these pathways, notably at the level of their receptors, are known to occur 
after chronic manipulations with the serotonergic system: e.g. chronic administration of SSRIs 
desensitizes 5-HT1A receptors in rats (Le Poul et al., 1995;Li et al., 1996;Li et al., 1997;Davidson and 
Stamford, 1998) and humans (Sargent et al., 1997;Berlin et al., 1998)(Sargent et al., 1997;Berlin 
et al., 1998). Although SERT-/- mice are available (Bengel et al., 1998), physiological responses 
to 5-HT1A receptor ligands strongly differ between mice and rats (see discussion) indicating that 
these responses are mediated by different 5-HT1A receptor populations in these species. SERT-/- 
rats were generated by ENU (N-ethyl-N-nitrosourea)-driven target-selected mutagenesis (Smits 
et al., 2004;Smits et al., 2006). Northern blot analyses have revealed that the premature stop 
codon results in a nonsense-mediated decay of the mutant SERT transcript. Compared to SERT+/+ 
littermates, SERT-/- rats have nine-fold higher extracellular 5-HT levels in brain structures such as 
the hippocampus (Homberg et al., 2007a). Both d-fenfluramine-induced hypothermia and [3H]
citalopram binding to brain slices are completely absent in SERT-/- rats (Homberg et al., 2007a). 
In this recently developed rat model, we examined the functional status of the 5-HT1A receptor 
pathways under in vivo conditions. 
Autonomic responses to selective 5-HT1A receptor agonists are frequently used to measure 
5-HT1A receptor function (Hjorth, 1985;Millan et al., 1993;De Vry, 1995;Cryan et al., 1999;Ootsuka 
and Blessing, 2003;Nalivaiko et al., 2005;Ootsuka and Blessing, 2006). 5-HT1A receptor agonists 
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cause hypothermia in both animals (Hjorth, 1985;Millan et al., 1993;De Vry, 1995;Cryan et al., 
1999;Bouwknecht et al., 2000) and humans (Pitchot et al., 2002;Pitchot et al., 2004). Several studies 
have suggested that the hypothermic responses to 5-HT1A receptor agonists in rats and humans 
are mediated by postsynaptic 5-HT1A receptors (Bill et al., 1991;Millan et al., 1993;Blier et al., 2002), 
although others have suggested that these effects are mediated by presynaptic receptors in rats 
(Goodwin et al., 1987;Higgins et al., 1988;Hillegaart, 1991) and mice (Goodwin et al., 1985b;Bill et 
al., 1991;Martin et al., 1992). 
We analyzed the effects of both the 5-HT1A receptor agonist flesinoxan, a potent and selective 
5-HT1A full agonist (Olivier et al., 1991), and the 5-HT1A receptor antagonist WAY100635 as well 
as the receptor specificity of these effects on core body temperature (Tc), heart rate and stress-
induced hypothermia (SIH) to investigate the role of 5-HT1A receptors in the modulation of these 
autonomic responses. When an organism is confronted with a stressor it responds with a short-
lasting increase of body temperature, the so-called SIH (Friedman and Thayer, 1998;Olivier et 
al., 1998;Nijsen et al., 1998a;Nijsen et al., 1998b;Bouwknecht et al., 2000). 5-HT1A receptors are, 
amongst others, involved in both the modulation of SIH (for review see Adriaan Bouwknecht 
et al., 2007) and the modulation of TC, although it is unclear whether both phenomena are 
regulated by the same populations of 5-HT1A receptors. Given the nine-fold higher extracellular 
5-HT level in the hippocampus of the SERT-/- rats (Homberg et al., 2007a), we hypothesized that 
the responsiveness of 5-HT1A receptors is changed in these animals, due to fully occupation by 
5-HT, or by downregulation of these receptors. 
The aim of the present study was therefore to investigate to what extent the thermoregulatory 
effects of 5-HT1A receptor agonists and antagonists are altered in the SERT-/- rat, and whether these 
alterations are (dis)similar for SIH and TC. To study this, we first measured the circadian rhythms 
in TC and heart rate of SERT+/+ and SERT-/- animals under unchallenged conditions to detect 
any significant genotype differences in this respect. Additionally, we determined the reaction 
of these animals to a mild stressor in order to detect putative differences in basal responses of 
both genotypes in SIH and stress-induced tachycardia. Once these control experiments were 
performed, we initiated the study on the drug-induced challenges.
Experimental procedures
Subject
Serotonin transporter knockout rats (Slc6a41Hubr) were generated by ENU-induced mutagenesis 
(Smits et al., 2004;Smits et al., 2006). All subjects have been bred and reared in the Central Animal 
Laboratory of the University of Nijmegen. Experimental animals were derived from crossing 
heterozygous SERT knockout rats that were out crossed for 5 generations. In all experiments, 
male SERT+/+ and SERT-/- littermates were compared. After weaning at the age of 21 days, ear cuts 
were taken for genotyping. All animals were housed two or three per cage in standard Macrolon® 
type 3 cages (42 x 26 x 20 cm) in temperature-controlled rooms (21ºC) with standard 12/12-h day/
night-cycle (lights on at 7.00 am) and food and water available ad libitum. Two groups of animals 
were used. The first group (9 months old) was used for (a) measuring the circadian rhythms, two 
weeks after surgery (see below), (b) measuring the responses to different doses of flesinoxan, 
given in an at random order from 4 weeks after surgery till 9 weeks after surgery (the saline 
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injection was used for measuring the hyperthermia induced by a mild stressor) and (c) measuring 
the responses to different doses of WAY100635, 11 weeks after surgery; the various doses were 
given in an at random order. The second group (4 months old) was used for (a) measuring the 
hyperthermia induced by a mild to intermediate stressor, one week after surgery (see below), (b) 
measuring the receptor-specificity of the drug-induced effects by giving WAY100635 immediately 
followed by flesinoxan, two weeks after surgery, and (c) measuring the response to the highest 
doses of flesinoxan (3 weeks after surgery) and WAY100635 (4 weeks after surgery) tested in the 
first group in order to study the possible occurrence of drug-induced changes in the sensitivity 
of the receptors. All experiments were carried out in accordance with institutional, national and 
international guidelines for animal care and the Dutch law concerning animal welfare. 
Surgery
The telemetry ECG transmitter was chronically implanted following a surgical procedure that 
was described before (Sgoifo et al., 1996). Briefly rats were deeply anesthetized with a mixture of 
N2O/O2 (1:2) and isoflurane (2.5%; Rhodia Organique Fine limited, Bristol, United Kingdom). ECG 
transmitters (Data Sciences InternationalTM, type TA11CTA-F40, St. Paul, MN, USA) were implanted 
in the abdominal cavity with one electrode subcutaneously placed on the muscle of the lower 
right limb of the animal, and the other electrode on the muscle bundle of the left shoulder. After 
surgery, animals were isolated and allowed to recover for 14 days; rats were checked daily during 
that period.
Radio-telemetry system
The radiotelemetry system consisted of an implantable transmitter (model TA11CTA-F40) with 
two flexible leads, a telemetric receiver (model RPC-1 and RLA1020), a Data Exchange Matrix 
collecting input from the receivers and an in-line analog ECG adaptor, all purchased from Data 
Sciences InternationalTM (St. Paul, MN, USA). The matrix was connected to an IBM Compaq 
486/66 computer. Signals from the transmitters were passed on via a radio signal to the receiver, 
localized under the animal cage, transforming it into a digital signal. Digital information from 
the telemetry receivers was collected by the data matrix and provided to the computer. Raw 
data were collected and analyzed by the software package Dataquest A.R.T. version 3.11 (Data 
Sciences InternationalTM, St. Paul, MN, USA).
Experimental protocol radiotelemetric studies
Data of all animals were sampled every 5 minutes, collecting body temperature (ºC) and heart 
rate (HR, beats per minute). 
Circadian Rhythm, baseline – Two weeks after recovery from surgery, TC and heart rate (HR) were 
recorded continuously during seven days. On days 1, 3 and 5 the experimenter performed a 
5-min inspection for animal health, water and food supplies. 
Stressful stimuli– To investigate basal differences in stress response between SERT-/- and SERT+/+ 
rats, the autonomic response (HR and TC) to two different stressors was measured.  A saline 
injection was used as a mild stressor (Baumgartner et al., 1998) in the first group of animals: 
this stressor is known to cause an increase in temperature and HR (Baumgartner et al., 1998). In 
the second group of animals a mild to intermediate stressor, namely exposure to a novel cage 
(standard Macrolon® type 3 cages (42 x 26 x 20 cm) with clean sawdust in it) was used.  These two 
types of stressor were assessed, because it is known that the response to a stressor varies across 
stressors with different intensity (van Bogaert et al., 2006a;Adriaan Bouwknecht et al., 2007). 
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The difference between basal temperature or HR (average of one hour before the injection) and 
the maximal temperature or HR increase after a saline injection is referred to as SIH and stress-
induced tachycardia, respectively.
Injection with drugs –Sampling data of the SERT-/- and SERT+/+ rats started at 9:00 AM the day 
prior to the administration of an intraperitoneal injection to obtain undisturbed baseline values. 
All doses of flesinoxan (0, 0.3, 1, 3 and 10 mg/kg) and WAY100635 (0, 0.1 and 1 mg/kg) were 
randomly administered at one-week intervals to each rat (within-animal design). The doses of 
WAY100635 (1 mg/kg) and flesinoxan (10 mg/kg) to assess the receptor-specificity of the drug-
induced effects were chosen on the basis of the outcome of the dose response curve made of the 
individual drugs. All injections were given at 11.00 AM. In case of the antagonism experiment, 
WAY100365 was IP injected to the left side, and immediately thereafter flesinoxan IP to the right 
side of the belly. The effects were measured till five hours after the injection.
Drugs
Flesinoxan HCL [R(+)-N-(2[4-(2,3-dihydro-2-2-hydroxy-methyl-1,4-benzodioxin-5-yl)-1-piperazininyl]
ethyl)-4-fluorobenzoamide was kindly provided by the department of Psychopharmacology, Utrecht 
University, Utrecht, the Netherlands. WAY100635 3HCL [N-(2-[4-(2-methoxyphenyl)-1-piperazinyl]
ethyl)-N-(2-pyridinyl) cyclohexanecarboxamide was derived from SIGMA, Lyon, France. All drugs 
were dissolved in saline (0.9% NaCl), and intraperitoneally injected in a volume of 1 ml/kg.
Data analysis
Circadian Rhythm, baseline – Data (TC and HR) were sampled every five minutes on undisturbed 
days (2, 4, 6 and 7). The data were averaged per hour and, subsequently, averaged across the four 
days, proving thereby a mean ± SEM for each hour of the day.  Differences in baseline conditions 
between genotypes were analyzed using two-way ANOVA, with genotype and time as repeated 
measures. Where appropriate, an independent sample T-test was used for post-hoc analyses.
Stressful stimuli – Data collected during the period starting one hour before the exposure to 
the stressor and ending five hours after exposure to the stressor were analyzed.  Genotype 
differences in TC and HR were analyzed by means of a two-way ANOVA for repeated measures 
with the factors genotype and time (repeated). Where appropriate, data were further analyzed 
by means of a post-hoc independent sample T-test on genotype.
Injection with drugs – The effects of the drugs  on SIH and TC were analyzed using a three-way 
ANOVA for repeated measures with the factors genotype, dose and time (repeated). In case of 
statistical significance a two-way ANOVA for repeated measures with the factors dose and time 
(repeated) was performed. Where appropriate, data were further analyzed by means of a LSD 
post-hoc test for doses, and independent sample T-test for time.
The level of significance was set at p < 0.05. All statistical analyses were performed using the 
Statistical Package for Social Sciences for Windows version 12.0.1 (SPSS, Chicago, IL, USA).
Results
Body temperature and heart rate are presented to illustrate putative differences between 
SERT+/+ and SERT-/- rats in circadian rhythms and stress-induced hyperthermia/tachycardia. 
Pharmacological data are presented only for body temperature, because HR and Tc showed 
largely similar results.
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Circadian Rhythm.
Figures. 1A and 1B show a clear day-night pattern in SERT+/+ and SERT-/- rats, with a higher TC and 
HR during the night, the active period of rats. No significant differences between TC (Figure. 1A) 
and HR (Figure. 1B) of SERT+/+ and SERT-/- rats were found. 
Stress-induced Hyperthermia (SIH) and Tachycardia (SIT).
The stress response to a single saline injection was significantly lower in SERT-/- rats compared 
to SERT+/+ rats (Figure. 2A). An overall genotype x time effect was found for temperature (Figure. 
2A; 2-way ANOVA: F(72,1152)=1.668; p<0.001). Post hoc analyses revealed a significant difference 
(SERT+/+ > SERT-/- rats) from 30 till 55 min, at 95 min, and from 105 till 125 min after injection. 
Stress-induced tachycardia was also lower in SERT-/- compared to SERT+/+ rats (Figure. 2B). An 
overall genotype x time effect was found for the heart rate (2-way ANOVA: F(72,1224)=1.448; p<0.01); 
post hoc analyses revealed significant differences (SERT+/+ > SERT-/- rats) after 20 till 30 min, at 50 
min and at 70 min after saline injection (Figure 2B). Interestingly, exposing the rats to a novel 
cage did not result in any difference between both genotypes (data not shown).
5-HT1A receptor agonist flesinoxan.
In SERT+/+ rats flesinoxan dose-dependently decreased SIH and elicited a dose-dependent 
hypothermic effect at the same time (Figure 3A). However, in SERT-/- rats flesinoxan produced a 
dose-dependent decrease in SIH that was slightly smaller than that seen in SERT+/+ rats, but had 
no hypothermic effect (Figure 3B). A highly significant genotype x dose x time interaction (3-way 
Figure 1
(A) Baseline temperature Circadian 
rhythm of TC over 12 h light/ 12 
h dark cycle (lights on from 7:00 
am to 7:00 pm). Data are based on 
mean values of 4 days in SERT+/+ and 
SERT-/- rats. Data present mean group 
values over 24 hours. Circadian 
rhythm is found in both genotypes. 
No differences are found between 
genotypes. (B) Baseline heart rate 
Circadian rhythm of HR over 12 h 
light/ 12 h dark cycle (lights on from 
7:00 am to 7:00 pm). Data are based 
on mean values of 4 days in SERT+/+ 
and SERT-/- rats. Data present mean 
group values of 24 hours. Circadian 
rhythm is found in both genotypes. 
No differences are found between 
genotypes.
Proefschrift.indb   81 09-10-2008   23:00:26
82
Chapter 5
ANOVA: F(288,6048) =9.918; p<0.001) was found. A subsequent 2-way ANOVA revealed a significant 
dose x time interaction in SERT+/+ rats (F(288,2952) =19.422; p<0.001), as well as in SERT-/- rats (F(288,3096) 
=2.074; p<0.001). 3 mg/kg flesinoxan significantly decreased the temperature in SERT+/+ rats 
compared to the saline injection from 15 min till 180 min after injection (p<0.05). 10 mg/kg 
flesinoxan also decreased the temperature in SERT+/+ rats compared to saline (p<0.05) from 20 
min post-injection until the end of the measurement (5 hours after injection). Furthermore, 3 
mg/kg flesinoxan decreased the temperature in SERT+/+ rats compared to 0.3 mg/kg flesinoxan 
(p<0.05), 10 mg/kg flesinoxan decreased the temperature compared to 0.3 mg/kg flesinoxan 
(p<0.05), compared to 1 mg/kg flesinoxan (p<0.05) and compared to 3 mg/kg flesinoxan 
(p<0.05). In SERT-/- rats only 10 mg/kg flesinoxan significantly decreased the SIH compared to 
saline (p<0.05) from 25 min till 145 min after injection. 
5-HT1A receptor antagonist WAY100635.
WAY100635 had no effect on the SIH response in SERT+/+ rats (Figure. 4A), but it dose-dependently 
increased the body temperature in the SERT-/- rats (Figure. 4B). A highly significant genotype x 
dose x time interaction (3-way ANOVA: F(144,3384) =3.958; p<0.001) was found. A subsequent 2-way 
ANOVA revealed a significant dose x time effect for SERT-/- rats (F(144,1728) =10.764; p<0.001), while 
no dose-dependent effects in SERT+/+ rats were found. The temperature in SERT-/- rats after 1 mg/
kg WAY100635 was significantly higher (p<0.05) compared to saline injected SERT-/- rats (25 min 
after injection till the end of the experiment). Temperature was also significantly higher in 1 
mg/kg WAY100635 injected SERT-/- rats, compared to 0.1 mg/kg WAY100635 injected SERT-/- rats 
(p<0.05). This difference was found at 35, 40, 65 and 85 min after injection till the end of the 
experiment. 
Figure 2
(A) Stress induced hyperthermia, 
mean ± SEM temperature after 
saline injection. SERT+/+ rats 
have significantly higher SIH 
(F(172,1152)=1.668 p<0.001) compared 
to SERT-/- rats from 30 till 55, at 
95 and from 105 till 125 minutes 
after injection. (B) Stress induced 
tachycardia; mean ± SEM heart 
rate after saline injection. SERT+/+ 
rats have significantly higher SIT 
(F(172,1224)=1.448 p<0.01) compared to 
SERT-/- rats from 20 till 30 minutes, at 
50 minutes and at 70 minutes after 
saline injection.
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5-HT1A Receptor-specificity of the response to flesinoxan.
As observed earlier (Figure. 3A) the stress response to a saline injection differed between SERT+/+ 
and SERT-/- rats (Figure. 5A); an overall genotype x time effect was found (F(60,1020)=1.995; p<0.001). 
The SIH seen after the saline injection in SERT-/- was significantly lower than that seen in SERT+/+ 
rats from 10 till 25 min after injection, at 45 till 140 min, at 150 min after injections and from 220 
till 260 min (independent T-test) after injections compared to SERT+/+ rats.  As shown in Figure. 5A, 
the effect of WAY100635 in flesinoxan-treated SERT-/- rats fully differed from that seen in identically 
treated SERT+/+ rats. Indeed, a highly significant genotype x treatment x time interaction (3-way 
ANOVA: F(60,1980)=9.320; p<0.001) was found. No significant treatment x time interaction in SERT+/+ 
rats (F(60,900) =1.306; p=0.064) was found: the hypothermic effect of flesinoxan in the SERT+/+ rats 
was completely blocked by WAY100635 (Figure 5A); In contrast, the treated SERT-/- rats showed 
an increase in temperature (2-way ANOVA: F(60,1080) =13.101; p<0.001). This hyperthermic effect 
was found from 45 min till 240 min after injection, compared to the saline injections (Figure 5A). 
Also a significant genotype x time interaction (2-way ANOVA: F(60,900)= 9.063; p<0.001) was found. 
SERT-/- rats showed a higher hyperthermia compared to SERT+/+ rats from 35 min after injection 
till the end of the experiment. 
Figure 3.
(A) Dose response curve of body 
temperature after flesinoxan in 
SERT+/+ rats. Effects of flesinoxan on 
mean ± SEM SIH and Tc in SERT+/+ 
rats. Temperature was significantly 
different between doses (F(288,2952) 
=19.422 p<0.001). Difference were 
found between saline and 3 mg/kg 
flesinoxan (p<0.001 from 15 minutes 
till 180 minutes after injection), 
between saline and 10 mg/kg 
flesinoxan (p<0.001 from 20 minutes 
post-injection until the end of the 
measurement), between 0.3 mg/kg 
and 3 mg/kg flesinoxan (p<0.004), 
between 0.3 mg/kg and 10 mg/kg 
flesinoxan (p<0.001), between 1 mg/
kg and 10 mg/kg flesinoxan (p<0.001) 
and between 3 mg/kg and 10 mg/
kg flesinoxan (p<0.001). (B) Dose 
response curve of body temperature 
after flesinoxan in SERT-/- rats. Effects of 
flesinoxan on mean ± SEM SIH in SERT-/- 
rats. Temperature was significantly 
different between doses (F(288,3096) 
=2.074 p<0.001). A difference was 
found between saline and 10 mg/kg 
flesinoxan (p<0.046) from 25 minutes 
till 145 minutes after injection.
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Drug-induced priming effects.
To study whether drug-induced changes in the sensitivity might have occurred during the 
study, the experiments on the highest doses of flesinoxan and WAY100635 were replicated 
at the end of the study in group 2. After 10 mg/kg flesinoxan again a genotype x treatment x 
time interaction was found (3-way ANOVA: F(60,1800)=16.850; p<0.001) showing that this dose of 
flesinoxan had a much stronger effect in SERT+/+ than in SERT-/- rats. In SERT+/+ rats a treatment 
x time effect was found (2-way ANOVA: F(60,900)=44.416; p<0.001) from 15 minutes after injection 
till the end of measurement (Figure 5B). In SERT-/- rats a treatment x time effect was found 
(2-way ANOVA: F(60,900)=14.813; p<0.001) from 20 minutes till 140 minutes after injection. Also 
a genotype x time was found (2-way ANOVA: F(60,960)=1.626; p<0.001) after flesinoxan. SERT+/+ 
rats were significant different from SERT-/- rats from 15 minutes till 225 minutes after injection 
of flesinoxan. These results  are equal to the results found in the first group of animals which 
were treated ad randomlywith different doses of flesinoxan, indicating that no priming effects 
were found after administration of flesinoxan. After treatment of 1 mg/kg WAY100635 we also 
found a genotype x treatment x time interaction (3-way ANOVA: F(60,1800)=13.353; p<0.001). 
In SERT+/+ rats no treatment x time effect was found (Figure 5C; 2-way ANOVA: F(60,900)=0.596; 
p<0,994), but in SERT-/- rats we again found a treatment x time effect  (2-way ANOVA: 
F(60,900)=29.269; p<0,001) from 55 minutes after injection till the end of the measurement. 
Also here a genotype x time effect was found (2-way ANOVA: F(60,840)=15.534; p<0,001). SERT+/+ 
rats significantly differed from SERT-/- rats from the injection till 10 minutes after injection 
and from 25 minutes after injection till the end of measurement (Figure 5C). The response to 
Figure 4.
(A) Dose response curve of 
temperature after WAY100635 in 
SERT+/+ rats. Effect of WAY100635 
on mean ± SEM SIH  in SERT+/+ rats. 
No differences were found between 
doses.
(B) Dose response curve of 
temperature after WAY100635 in 
SERT-/- rats. Effect of WAY100635 
on mean ± SEM SIH in SERT-/- rats. 
Significant differences were found 
between doses (F(144,1728) =10.764 
p<0.001); temperature after 1 mg/
kg WAY100635 was significant 
higher (p<0.001) compared to saline 
injected SERT-/- rats (25 minutes 
after injection till the end of the 
experiment). Differences were also 
found between 1 mg/kg and 0.1 mg/
kg WAY100635 (p<0.019; found at 35, 
40, 65 and 85 minutes after injection 
till the end of the experiment). 
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WAY100635 are found to be the same as found in the first group of animals, again indicating that 
priming, or other alterations, did not occur in these animals after treatment of different doses of 
WAY100635.
Figure 5
(A) Temperature after saline and 
after administration WAY100635 
followed by flesinoxan. Effect of 
the combination WAY100635 and 
flesinoxan on mean ± SEM Tc in SERT+/+ 
and SERT-/- rats. A difference was 
found between SERT+/+ and SERT-/- 
after the combination of WAY100635 
and flesinoxan (F(60,1980)=9.320 
p<0.001). In SERT+/+ rats no 
differences were found between 
the combination of WAY100635 and 
flesinoxan compared to the control. 
A significant difference was found in 
SERT-/- rats (F(60,1080) =13.101 p<0.001). 
The combination of WAY100635 
and flesinoxan gave a hypothermic 
effect, this effect was found from 
45 minutes till 240 minutes after 
injection, compared to the double 
saline injections. (B) Temperature 
after 10 mg/kg flesinoxan. Effect 
of 10 mg/kg flesinoxan on mean 
± SEM SIH and Tc in SERT+/+ and 
SERT-/- rats. A difference was found 
between SERT+/+ and SERT-/- after 
flesinoxan (F(60,840)=17.213; p<0.001) 
from 15 minutes till 225 minutes 
after the injection of flesinoxan. 
(C) Temperature after 1 mg/
kg WAY100635. Effect of 1 mg/
kg WAY100635 on mean ± SEM 
SIH in SERT+/+ and SERT-/- rats. A 
difference was found between 
SERT+/+ and SERT-/- after WAY100635 
(F(60,840)=15.534; p<0.001) from 
the injection till 10 minutes after 
injection and from 25 minutes after 
the injection till the end of the 
measurement.
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Discussion 
The 5-HT-transporter is the primary modulator of the tone of the serotonergic system in the CNS. 
Here we show that rats constitutionally lacking the SERT have altered 5-HT1A receptor reactivity. 
More importantly, however, the data show that this alteration in 5-HT1A receptor functioning is 
not a global phenomenon, but limited to some specific subpopulations of 5-HT1A receptors. This 
became clear by comparing autonomic responses like body temperature (TC) and heart rate (HR) 
under basal conditions, the effects seen in animals challenged by stressors, and the effects seen 
in animals treated with 5-HT1A receptor ligands. These phenomena are discussed below. In the 
experiments drugs were administered randomly over the whole experimental period. The effects 
of the drugs and controls found in the beginning of the study were similar to those found in the 
end, and we therefore conclude that the effect of the drugs remained stable during this study, 
indicating that priming or other alterations did not occur in our animals over the course of the 
experiments.
Circadian Rhythms.
Both SERT+/+ and SERT-/- rats displayed a clear circadian rhythm. During the dark period both 
TC and HR were higher in SERT+/+ and SERT-/- rats compared to the day; in line with the fact that 
nocturnal animals have their active period during the night (Benstaali et al., 2001). Apparently, 
a deletion of the SERT did not lead to disturbances in day-night rhythms in the autonomic 
parameters under an undisturbed 12-hour light/dark cycle. The suprachiasmatic nucleus (SCN) of 
the hypothalamus orchestrates circadian rhythms (Reppert and Weaver, 2002). Input to the SCN 
is, amongst others, provided by serotonergic projections originating in midbrain raphe nuclei, 
and disruption of 5-HT afferents to the SCN alters circadian behaviour in rodents (Banky et al., 
1988). Either constitutional absence of serotonergic transporters does not lead to disturbances 
in these serotonergic projections to the SCN or, alternatively, compensatory mechanisms may 
have taken place in SERT-/- rats. Because SERT-/-, 5-HT1A, 5-HT1B and 5-HT7 receptor knockout mice 
neither show differences in circadian rhythms (Li et al., 1999;Bouwknecht et al., 2001;Hedlund et 
al., 2003;van Bogaert et al., 2006b), we conclude that there are no basal differences in the circadian 
rhythm between rats and mice with regard to the serotonergic involvement. Apparently, the 
serotonergic system does not play a primary regulatory role in the circadian rhythm of rodents, 
although it may exert modulatory influences under certain conditions such as changed light/
dark phases as shown for example in mice lacking 5-HT1B receptors (Sollars et al., 2002;Sollars et 
al., 2006).
Like in SERT-/- mice (Li et al., 1999), no differences in basal Tc were found between SERT+/+ and SERT-/- 
rats, suggesting that serotonin in mice and rats plays no major role in the modulation of Tc. Still, 
both 5-HT1B knockout mice have a relatively enhanced Tc compared to wild types (Bouwknecht 
et al., 2001) and 5-HT1A knockout mice in a 129/Sv strain have a relatively low Tc compared to 
wild types (van Bogaert et al., 2006b), revealing that the serotonergic system at least in mice is 
nevertheless involved in the regulation of Tc.  
Stress Induced Hyperthermia. 
Under normal conditions, exposure to a mild stressor elicits SIH in rodents which is modulated, 
amongst others, by 5-HT1A receptors (Lesch, 1991;Groenink et al., 1996;van der Heyden 
et al., 1997;Friedman and Thayer, 1998;Olivier et al., 1998;Nijsen et al., 1998a;Nijsen et al., 
1998b;Bouwknecht et al., 2000). Compared to SERT+/+ wild type rats, SERT-/- rats displayed an 
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attenuated SIH response to a saline injection being a mild stressor according to Baumgartner 
et al., 1998. Because extracellular 5-HT levels have been shown to be nine times higher in the 
hippocampus of SERT-/- rats compared to SERT+/+ rats (Homberg et al., 2007a), it is likely that a 
relative hyperstimulation of 5-HT1A receptors underlies the relatively small SIH in SERT-/- rats. 
However, our present data do not allow a conclusion about the exact location of these receptors: 
it remains open for investigation whether these 5-HT1A receptors are pre- or postsynaptically 
located, or in which brain areas they are concentrated.
Exposure to a novel cage, which is considered to be a mild to intermediate stressor  (van Bogaert 
et al., 2006a; Vinkers et al., 2008) did not result in any SIH difference between SERT+/+ and SERT-/- 
rats. Therefore, the difference in SIH between the two genotypes studied appears to be present 
only after subtle stressors. As a final remark, exposure to a mild stressor such as a saline injection 
does elicit identical effects on body temperature in SERT+/+ and SERT-/- mice (Li et al., 1999), 
underlining the earlier mentioned notion that mice do differ from rats.
Flesinoxan-induced reduction of SIH. 
Both SERT+/+ and SERT-/- rats showed a clear reduction in SIH after administration of the full 
5-HT1A receptor agonist flesinoxan, although the reduction in SERT+/+ rats was stronger than that 
in SERT-/- rats. This stronger reduction may be caused (partially) by the additional hypothermic 
effects of flesinoxan in SERT+/+ rats that was not present in SERT-/- rats (see below), but does not 
rule out that 5-HT1A receptors involved in SIH are slightly desensitized in SERT-/- rats. To investigate 
whether the flesinoxan effect was 5-HT1A receptor specific, the highly selective 5-HT1A receptor 
antagonist, WAY100635, was tested. WAY100635 itself did not alter the core body temperature 
in SERT+/+ rats, but it dose-dependently increased the temperature in SERT-/- rats. It is unclear 
whether this hyperthermia (enhanced both in amplitude and duration) has to be ascribed to the 
enhancement of SIH per se, or involves an associated hyperthermia adding to the normal SIH. 
Nevertheless, WAY100635 completely antagonized the flesinoxan-induced reduction of SIH in 
SERT+/+ rats, providing compelling evidence that the effects of flesinoxan on SIH were mediated 
by 5-HT1A receptors. The increase of temperature seen in the antagonism experiment with SERT-/- 
rats can be ascribed to WAY100635 (blockade of 5-HT1A receptors), because WAY100635 alone 
caused a similar effect. More importantly, these results also show that the 5-HT1A receptors 
involved in the regulation of SIH were apparently not fully occupied, or desensitized,  in SERT-/- 
rats, because flesinoxan was still effective. This is highly remarkable in view of the earlier reported 
finding that the 5-HT levels in at least the hippocampus were greatly increased in SERT-/- rats 
compared to SERT+/+ rats. Apparently, such a 5-HT increase is limited to certain brain areas or 
other adaptational changes took place (see also below); future studies are required to investigate 
these possibilities.  
Flesinoxan-induced Hypothermia. 
The phenomenon that flesinoxan caused a dose-dependent hypothermia in the SERT+/+ rats, but 
not in SERT-/- rats, shows that changes occurred within the 5-HT1A receptor pathways involved 
in thermoregulation in SERT-/- rats. There are at least three processes that may give rise to these 
changes: first, the serotonergic tone is altered; second, the (sensitivity of the) receptor is altered; 
and, third, the postsynaptic machinery is changed. In view of the above mentioned notion that 
the 5-HT level is increased in at least some parts of the brain, the most likely explanation is 
that the involved receptors were fully occupied, preventing thereby flesinoxan to produce any 
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effect. Although the occurrence of desensitization and changes in the postsynaptic machinery 
are theoretically alternative explanations, this is unlikely in view of the fact that the antagonist 
WAY100635 was still fully effective (see above). 
Summarizing the above mentioned conclusions about the occupancy of the 5-HT1A receptors 
involved in either the SIH or the thermoregulation results in the evident notion that there 
are at least two distinct subpopulations of 5-HT1A receptors: one subpopulation of receptors 
involved in SIH which are at best partially occupied and one population of receptors involved in 
thermoregulation which are fully occupied. Future research is required to investigate whether 
these two subpopulations are differentially located at pre- and postsynaptic sites and/or located 
in different brain areas, each of them possibly marked by its specific 5-HT level in SERT-/- rats. An 
attractive explanation for differences in the occupancy of the 5-HT1A receptors might be that 
there is a site-specific difference in density of dopaminergic and noradrenergic terminals in the 
vicinity of the serotonergic terminals: these catecholaminergic terminals contain dopamine 
transporters (DAT) and noradrenergic transporters (NET) which can also transport serotonin into 
their terminals, removing thereby the surplus of serotonin in the serotonergic synapses of SERT-/- 
rats. Indeed, Homberg et al. (2007a) have shown that blockade of NET and DAT in SERT-/- rats 
blocks the [3H]5-HT uptake into hippocampal synaptosomes. In other words, it is suggested that 
the serotonergic tone may vary across brain regions that vary in number of catecholaminergic 
terminals in the vicinity of serotonergic terminals in SERT-/- rats.
Conclusion.
5-HT1A receptors of SERT-/- rats that are involved in flesinoxan-induced hypothermia, do not 
respond to 5-HT1A receptor agonists in contrast to the 5-HT1A receptors involved in SIH, which are 
completely active. Whether elimination of the SERT affects the sensitivity of other 5-HT receptors 
and systems in the brain remains to be investigated. The finding that  exposure to a mild, but 
not mild to intermediate, stressor results in a SIH in SERT-/- rats that is smaller than that seen 
SERT+/+ rats is suggested to be due to the relatively high serotonergic tone in the SERT-/- rats. 
The present study clearly indicates that rats with a lifelong 5-HT disturbance (SERT-/- rats) have 
regional specific changes in 5-HT1A receptor occupancy. It is highly interesting to see whether 
comparable changes occur in humans that suffer from lifelong 5-HT disturbances.
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Abstract
Given the modulatory role of 5-HT in emotional and cognitive processes, putatively adaptational 
changes in GABA-ergic, dopaminergic and noradrenergic systems in SERT-/- rats were investigated 
by assessing the stress-induced hyperthermia paradigm and measuring core body temperature. 
In response to the GABAA receptor agonist chlordiazepoxide, SERT-/- rats showed a small 
increased sensitivity with respect to the core body temperature, indicating a small change in 
sensitivity in the  GABA-ergic system. SERT-/- rats were slightly more sensitive to the NET blocker 
atomoxetine; the 1 mg/kg dose reduced core body temperature in SERT-/- rats, but not in SERT+/+ 
rats. The highest dose reduced core body temperature in both genotypes. Interestingly, there 
was a robust differential response to the DAT blocker GBR12909; while hyperthermic response 
was induced in SERT-/- rats, no response was found in SERT+/+ rats. Moreover, SERT-/- rats were more 
sensitive to blockade of both NET and DAT transporters with bupropion than SERT+/+ rats. The 
drug-induced changes in stress-induced hyperthermia did not differ between SERT+/+ and SERT-/- 
rats. We conclude that permanent changes in the serotonergic system lead to compensatory 
changes in the GABA-ergic, noradrenergic and dopaminergic system with regard to core body 
temperature regulation, but not stress-induced hyperthermia. 
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Introduction
Serotonin (5-hydroxytryptamine, 5-HT) plays an important modulatory role in a variety of 
processes such as emotion, motivation, cognition, feeding and sexual behaviour and a disturbance 
in the serotoninergic system can contribute to psychiatric disorders including affective disorders, 
violent aggression, impulsivity-related disorders, drug addiction, and eating disoders (Delgado 
et al., 1990;Stain-Malmgren et al., 2001;Neumeister et al., 2002;Moreno et al., 2002;Holmes et al., 
2003c;Murphy et al., 2004). Serotonin neurotransmission is primarily regulated by the serotonin 
transporter (SERT), which returns 5-HT from the synaptic cleft into the presynaptic neuron where 
it is degraded or retained for future release (Murphy et al., 1998). Selective serotonin re-uptake 
inhibitors (SSRIs) block the SERT and are widely used in the treatment of affective disorders, 
obsessive-compulsive and eating disorders as well alcoholism (Murphy, 1990; Graham et al., 1989). 
Chronic administration of SSRIs produces adaptive changes in the serotonergic system(Blier and 
de Montigny, 1998;Briley and Moret, 1993; Blier et al., 1997). To investigate to what extent life-long 
disturbed 5-HT neurotransmission may result in adaptive changes of GABA-ergic, dopaminergic 
and noradrenergic systems, we challenged the serotonin transporter knockout rat (SERT-/-) with 
drugs affecting these neurotransmitter systems and studied the resulting changes in body 
temperature. The choice for these systems is elaborated below.
SERT-/- rats were generated by ENU (N-ethyl-N-nitrosourea)-driven target-selected mutagenesis 
(Smits et al., 2004;Smits et al., 2006). Northern blot analyses revealed that the premature stop 
codon results in a nonsense-mediated decay of the mutant SERT transcript (Homberg et al., 
2007a). Compared to SERT+/+ littermates, SERT-/- rats have nine-fold higher extracellular 5-HT levels 
in brain structures such as the hippocampus (Homberg et al., 2007a;Olivier et al., 2008b). Both 
d-fenfluramine-induced hypothermia and [3H]citalopram binding to brain slices are completely 
absent in SERT-/- rats (Homberg et al., 2007a). 
Body temperature is not only affected by pharmacological agents,  but also increases  when an 
organism is confronted with a stressor. This relatively short-lasting increase in body temperature 
is generally referred to as stress-induced hyperthermia (Friedman and Thayer, 1998;Nijsen et al., 
1998a;Olivier et al., 1998;Bouwknecht et al., 2000) and is thought to be important for survival 
as preparation for fight-or-flight. Different psychological and physical stressors induce stress-
induced hyperthermia, for example taking an exam (Marazziti et al., 1992) or attending a sport 
contest (Renbourn, 1960). In animals, a mild disturbance (Bouwknecht et al., 2001), an injection 
(Olivier et al., 2003), a clean cage (Spooren et al., 2002;Groenink et al., 2003), predator smell (Rorick-
Kehn et al., 2005), or restraint stress (Terlouw et al., 1996) induces hyperthermia. The reproducible 
and robust stress-induced hyperthermia effects, combined with the relative ease of testing, 
makes the stress-induced hyperthermia paradigm very suitable for drug screening. Rats that 
lack the SERT display enhanced anxiety-like behaviour in an open field, an elevated plus maze, 
a novelty suppressed feeding test and an escape latency test (Olivier et al., 2008b). As a result of 
the changes in the serotonergic system of SERT-/- rats it is likely that adaptations have taken place 
outside the serotonergic system. GABA is known to have a negative influence on the firing of 
serotoninergic neurons (Gallager and Aghajanian, 1976;Ferraro et al., 1996), and GABAA receptors 
have been shown to mediate this inhibitory effect (Colmers and Williams, 1988;Pan et al., 1989). 
Moreover, the 5-HT system strongly interacts with the dopaminergic (DA) and the noradrenergic 
(NE) system (Korsgaard et al., 1985;Benloucif et al., 1993;Iyer and Bradberry, 1996;Salomon et al., 
2006;Guiard et al., 2008;Olivier et al., 2008b), raising the possibility that consititutive increased 
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extraneuronal 5-HT levels are compensated by adaptations in these catecholaminergic systems. 
The finding that application of the NE transporter (NET) blocker desimipramine, but not the DA 
transporter (DAT) blocker GBR12909 abolished residual [3H]5-HT uptake in the hippocampus of 
SERT-/- rats, suggests that 5-HT uptake is partially maintained by noradrenergic neurons in this region 
(Homberg et al., 2007a). In dopamine rich regions the DAT could be responsible for residual 5-HT 
uptake, as has been reported in the substantia nigra and VTA of SERT-/- mice (Pan et al., 2001;Zhou 
et al., 2002). Taken all these findings together, a life-long disturbed 5-HT neurotransmission may 
affect the sensitivity of the GABA-ergic, noradrenergic and/or the dopaminergic system. Brain 
catecholamines are involved in thermoregulation; however, no differences were found in the core 
body temperature of SERT-/- rats compared to SERT+/+ rats (Olivier et al., 2008a), indicating that 
adaptations have taken place with respect to the body temperature. We therefore investigated 
the pharmacological effects of the GABAA receptor agonist chlordiazepoxide, the NET blocker 
atomoxetine, the DAT blocker GBR12909, and the NET + DAT blocker bupropion in SERT+/+ and 
SERT-/- rats on body temperature to study putative sensitivity differences in these genotypes. 
Experimental procedures
Subjects
Serotonin transporter knockout rats (Slc6a41Hubr) were generated by ENU-induced mutagenesis 
(Smits et al., 2004;Smits et al., 2006). All subjects have been bred and reared in the Central Animal 
Laboratory of the Radboud University of Nijmegen, the Netherlands. Experimental animals were 
derived from crossing heterozygous SERT knockout rats that were out crossed for 5 generations. 
In all experiments, male SERT+/+ and SERT-/- littermates were compared. After weaning at the age of 
21 days, ear cuts were taken for genotyping at the Hubrecht Institute (Utrecht, the Netherlands). 
All animals were housed individually in standard Macrolon® type 3 cages (42 x 26 x 20 cm) in 
temperature-controlled rooms (21ºC ± 1) with 12/12-h day/night-cycle (lights on at 7.00 am) and 
food and water available ad libitum. Three groups of animals were used. The first group (4-5 months 
old; SERT+/+ n=8, SERT-/- n=8) was used for measuring the response to different doses of the GABA A 
receptor agonist chlordiazepoxide, the second group (4-6 months old; SERT+/+ n=8, SERT-/- n=9) 
was used for measuring different doses of the NET blocker atomoxetine, and the third group (6-8 
months old: SERT+/+ n=7, SERT-/- n=9) for the effects of  the DAT blocker GBR12909 and the DAT + 
NET blocker bupropion. Only in this latter group the two drugs were given in a random order in the 
same group of animals. All experiments were carried out in accordance with institutional, national 
and international guidelines for animal care and the Dutch law concerning animal welfare. 
Surgery 
The telemetry ECG transmitter was chronically implanted following a surgical procedure that was 
described before (Sgoifo et al., 1996;Olivier et al., 2008a). Briefly, rats were deeply anesthetized 
with a mixture of N2O/O2 (1:2) and isoflurane (2.5%; Rhodia Organique Fine limited, Bristol, 
United Kingdom). ECG transmitters (Data Sciences InternationalTM, type TA11CTA-F40, St. Paul, 
MN, USA) were implanted in the abdominal cavity with one electrode subcutaneously placed on 
the muscle of the lower right limb of the animal, and the other electrode on the muscle bundle 
of the left shoulder. After surgery, animals were isolated and allowed to recover for 14 days; rats 
were checked daily during that period.
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Radio-telemetry system
The radiotelemetry system consisted of an implantable transmitter (model TA11CTA-F40) with 
two flexible leads, a telemetric receiver (model RPC-1 and RLA1020), a Data Exchange Matrix 
collecting input from the receivers and an in-line analog ECG adaptor, all purchased from Data 
Sciences InternationalTM (St. Paul, MN, USA). The matrix was connected to an IBM Compaq 
486/66 computer. Signals from the transmitters were passed on via a radio signal to the receiver, 
localized under the animal cage, transforming it into a digital signal. Digital information from 
the telemetry receivers was collected by the datamatrix and provided to the computer. Raw 
data were collected and analyzed by the software package Dataquest A.R.T. version 3.11 (Data 
Sciences InternationalTM, St. Paul, MN, USA).
Experimental protocol radiotelemetric studies
Data of all animals were sampled every 5 minutes, collecting body temperature (ºC). 
Pharmacological effects of chlordiazepoxide, atomoxetine, GBR12909 and bupropion were 
measured on core body temperature and stress-induced hyperthermia in SERT-/- and SERT+/+ 
rats. Sampling data of the rats started at 18:00 hours the day prior to the administration of 
an intraperitoneal injection (vehicle, or the drug) to obtain undisturbed baseline values. The 
injection was used as a stressor (Olivier et al., 2003). All doses of chlordiazepoxide (0.0, 2.5, 5.0 
and 10.0 mg/kg), atomoxetine (0.0, 1.0 and 3.0 mg/kg), GBR12909 (0.0, 5.0 and 10.0 mg/kg), and 
bupropion (0.0, 7.5, 15.0 and 30.0 mg/kg) were randomly administered at one-week intervals to 
each rat (within-animal design). All injections were given at 11.00 AM. 
Drugs
Atomoxetine-HCL (Strattera 40 mg, Koster Pharmacy Lelystad, The Netherlands) and 
chlordiazepoxide-HCL (Pharbita, Zaandam, the Netherlands) were kindly provided by the 
department of Psychopharmacology (Utrecht University, Utrecht, the Netherlands). GBR12909 
dihydrochloride (vanoxerine= 1-(2-[bis(4-fluorophenyl)-[methoxy]ethyl)-4-(3-phenylpropyl) 
piperazine dihydrochloride) was derived from SIGMA-ALDRICH, (Steinheim, Germany). 
Bupropion-HCL (Zyban) was derived from GlaxoSmithKline (8037). Atomoxetine and bupropion 
were suspended in 0.5%/5% gelatin-mannitol (Pharmacy Utrecht University), GBR12909 was 
dissolved in 1% methylcellulose, further dilutions were dissolved in saline (0.9% NaCl), and 
chlordiazepoxide was dissolved in saline (0.9% NaCl). All drugs were intraperitoneally injected 
in a volume of 1 ml/kg.
Data analysis
The pharmacological effect of the drugs on the core body temperature was measured in 
5-minute intervals from 1 hour before the injection till 4 hours after the injection. For the 
stress-induced hyperthermia, data from one hour before the injection were averaged to one 
measurement (baseline). This baseline was subtracted from the temperature measured 30 
minutes (peak response) after the injection (T1). Thus, stress-induced hyperthermia = T1- baseline. 
The pharmacological effects on stress-induced hyperthermia were analyzed using a two-way 
ANOVA with genotype and dose as independent variables. Where appropriate, data were further 
analyzed by means of a LSD post-hoc test for doses. The area under the curve was calculated 
for three time periods: 1) from 65 minutes after injection till 120 minutes after the injection, 2) 
from 125 minutes after the injection till 180 minutes after the injection and 3) from 185 minutes 
after the injection till 240 minutes  after the injection. The first hour includes the stress-induced 
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hyperthermia; therefore, the area under the 
curve was not calculated for this hour. The 
pharmacological effects on the area under the 
curve were analyzed using a two-way ANOVA 
with genotype and dose as independent 
variables. Where appropriate, data were further 
analyzed by means of a LSD post-hoc test 
for doses. The level of significance was set at 
p<0.05. All statistical analyses were performed 
using the Statistical Package for Social Sciences 
for Windows version 16.0 (SPSS, Chicago, IL, 
USA). 
Results
GABAA receptor agonist chlordiazepoxide 
(CDP). 
Overall, CDP decreased the body temperature 
of both SERT+/+ (figure 1A) and SERT-/- rats 
(figure 1B). 
Stress-induced hyperthermia. Figure 1C shows no 
differences between genotypes (F(1,55) =0.215; 
p=0.644) in the stress-induced hyperthermia. 
However, a dose-effect of CDP was found (F(3,55) 
=6.396; p=0.001). Rats treated with 10.0 mg/
kg CDP showed a significantly smaller stress-
induced hyperthermia than rats treated with 
the vehicle (p<0.001). Moreover, 10.0 mg/kg 
CDP reduced the stress-induced hyperthermia 
more than that elicited by 5.0 mg/kg (p<0.05) 
or 2.5 mg/kg (p < 0.005) CDP. 
Core body temperature. A genotype difference 
was found in the  periods from 65 minutes till 
120 minutes after the injection (F(1,54)=13.13; 
p<0.001), from 125 minutes till 180 minutes 
after injection (F(1,54)=24.18; p<0.001) and from 
185 minutes till 240 minutes after injection 
(F(1,54)=28.33; p<0.001). Actually, the effects of 
CDP lasted longer in SERT-/- rats than in SERT+/+ 
rats (figure 1D + E). Indeed, when the data were 
split into genotypes, there was among others 
a significant treatment effect in the period 
of 185 till 240 minutes in SERT-/- rats (F(3,27) 
Figure 1
Effect of GABAA ligand chlordiazepoxide on body 
temperature in SERT+/+ (A) and SERT-/- (B) rats. 
Temperature is plotted in 5-min periods starting 
60 min before injection of chlordiazepoxide. Effect 
of GABAA ligand chlordiazepoxide on the stress-
induced hyperthermia (C: * significant different 
from saline group) and on the area under the 
curve in SERT+/+ (D) and SERT-/- rats (E). * significant 
difference (p<0.05). 
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= 3.44; p < 0.05), but not the SERT+/+ rats. The 
LSD posthoc test showed that the temperature 
of SERT-/- rats treated with 5.0 and 10.0 mg/
kg CDP still significantly differed from that 
measured in control SERT-/- rats treated with 
0.0 mg/kg CDP in the period of 180 till 240 min 
after the injection (figure 1D; p> 0.05), whereas 
the temperature of SERT+/+ rats treated with 
CDP (2.5 till 10.0 mg/kg) did not anymore differ 
from that measured in control SERT+/+ rats 
treated with 0.0 mg/kg CDP during that time-
interval (figure 1E; p<0.05). In the time period 
from 65 till 120 minutes the temperature of 
SERT+/+ rats treated with CDP was lower from 
that measured in control SERT+/+ rats treated 
with 0.0 mg/kg CDP during that time-interval 
(F(3,27)=7.58; p<0.001). Doses from 2.5 mg/
kg till 10.0 mg/kg CDP significantly lowered 
the temperature (p>0.05) of rats treated with 
CDP. Moreover, the temperature of SERT+/+ rats 
treated with 10.0 mg/kg CDP was significant 
lower compared to SERT+/+ rats treated with 2.5 
mg/kg CDP and 5 mg/kg CDP (p<0.05). In the 
time period 125 minutes till 180 minutes after 
the injection another effect of CDP was found 
(F(3,27)=3.29; p<0.05), temperature of SERT+/+ rats 
which were treated with 10.0 mg/kg CDP  was 
significant lower compared to SERT+/+ rats which 
were treated with 0.0 mg/kg CDP (p<0.05). 
In SERT-/- rats (figure 1E) similar effects were 
found compared to SERT+/+ rats in the time 
period from 65 till 120 minutes (F(3,27)=4.40; 
p<0.01) and from 125 till 180 minutes 
(F(3,27)=5.22; p<0.01). In both time periods the 
temperature of SERT-/- rats which were treated 
with 5.0 mg/kg CDP and 10.0 mg/kg CDP were 
lower compared to SERT-/- rats treated with 0.0 
mg/kg CDP (p<0.05). 
NET blocker atomoxetine. 
As shown in Figure 2, atomoxetine reduced the 
body temperature in both SERT+/+ (figure 2A) 
and SERT-/- (figure 2B) rats.
Stress-induced hyperthermia. No genotype 
differences were found in the stress-induced 
Figure 2
Effect of NET blocker atomoxetine on body 
temperature in SERT+/+ (A) and SERT-/- (B) rats. 
Temperature is plotted in 5-min periods starting 
60 min before injection of atomoxetine. Effect of 
NET blocker atomoxetine on the stress-induced 
hyperthermia (C: * significant different from saline 
group) and on the area under the curve in SERT+/+ 
(D) and SERT-/- rats (E).  * significant difference 
(p<0.05).
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hyperthermia after treatment with atomoxetine 
(F(1,46)=0.603; n.s.). As seen in Fig 2C, atomoxetine 
dose-dependently reduced the stress-induced 
hyperthermia (F(2,46)=30.063; p=0.001) in both 
genotypes. Atomoxetine (1.0 mg/kg and 3.0 
mg/kg (p<0.05)) significantly lowered the 
stress-induced hyperthermia when compared 
with rats treated with 0.0 mg/kg atomoxetine. 
Moreover, 3.0 mg/kg atomoxetine decreased 
the stress-induced hyperthermia significantly 
more than 1.0 mg/kg atomoxetine did. 
Core body temperature. A genotype difference was 
found in  the time period from 65 minutes till 120 
minutes after the injection (F(1,45)=6.22; p<0.05) and 
from 185 minutes till 240 minutes after injection 
(F(1,45)=4.47; p<0.05). Figure 2 clearly shows that 
the effect of a lower dose atomoxetine on core 
body temperature was more effective in SERT-/- 
rats than in SERT+/+ rats. When the data were split 
into genotypes, there was a significant treatment 
effect in the time period from 65 minutes till 120 
minutes after the injection in both the SERT-/- rats 
(F(2,24)=5.38; p<0.01) and SERT+/+ rats (F(2,21)=6.56; 
p<0.01). More importantly, the LSD posthoc test 
showed that a dose of 1.0 mg/kg atomoxetine 
already produced a significant decrease of the 
temperature in SERT-/- rats (figure 2E; p< 0.05), 
whereas a dose of 3.0 mg/kg atomoxetine was 
required to lower the temperature in SERT+/+ rats 
(figure 2D; p< 0.05).  
DAT blocker GBR12909
In figure 3 the effects of GBR12909 are shown. 
GBR12909 increased the body temperature, 
but only in SERT-/- rats. When the stress-induced 
hyperthermia effect waned around 60 minutes 
after the injection of GBR12909 in SERT+/+ rats, 
the core body temperature remained high or, 
even increased in SERT-/- rats treated with this 
compound. 
Stress-induced hyperthermia. No genotype 
(F(1,35)=0.04; n.s.) or dose effect (F(2,35)=2.42; n.s.) 
on the stress-induced hyperthermia was found 
after treatment with GBR12909 (figure 3C). 
Figure 3
Effect of DAT blocker GBR12909 on body 
temperature in SERT+/+ (A) and SERT-/- (B) rats. 
Temperature is plotted in 5-min periods starting 
60 min before injection of GBR12909. Effect of 
DAT blocker GBR12909 on the stress-induced 
hyperthermia (C: * significant different from saline 
group) and on the area under the curve in SERT+/+ 
(D) and SERT-/- rats (E). * significant difference 
(p<0.05).
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GBR12909 treated rats did not significantly 
differ at any time point from the vehicle treated 
rats; this held  for both genotypes.
Core body temperature. A genotype difference 
was found in the time period from 185 minutes 
till 240 minutes after the injection (F(1,35)=14.03; 
p<0.001). Figure 3 indeed shows that both 
doses of GBR12909 were still effective in SERT-/- 
rats, but not anymore in SERT+/+  rats during 
that period. 
Indeed, when the data were split into 
genotypes, only the  SERT-/- rats, but not the 
SERT+/+ rats,  displayed a significant treatment 
effect during the period of 65 till 120 min after 
the injection (F(2,17)=5.12; p<0.05), the period 
125 till 180 min after the injection (F(2,17)=15.38; 
p<0.001) and the period of 185 till 240 min 
after the injection (F(2,17)= 8.54; p<0.01; figures 
3D and E). The LSD posthoc tests showed that 
(a) during the period of 65 till 120 min after the 
injection the temperature of SERT-/- rats treated 
with 10.0 mg/kg GBR12909 was significantly 
different from SERT-/- rats treated with 0.0 mg/
kg GBR12909, (b) during the period of 125 till 
180 min after the injection the temperature of 
SERT-/- rats treated with 10.0 mg/kg GBR12909 
was significantly higher than that measured 
in SERT-/- rats treated with 5.0 mg/kg and 0.0 
mg/kg GBR12909 and that 5.0 mg/kg elicited 
a significantly higher temperature than that 
measured in SERT-/- rats treated with 0.0 mg/
kg GBR12909, and that (c) during the period 
of 185 till 240 min after the injection the 
temperature of SERT-/- rats treated with 10.0 
mg/kg GBR12909 was significantly higher 
than that measured in SERT-/- rats treated with 
5.0 mg/kg or 1.0 mg/kg GBR12909. 
DAT + NET blocker bupropion
Figure 4 shows the effects of bupropion in 
SERT+/+ (Figure 4A) and SERT-/- (Figure 4B) rats. 
In SERT-/-, but not SERT+/+, rats there was a small 
hyperthermia found after the stress-induced 
hyperthermia effects waned at the highest 
dose of bupropion. 
Figure 4
Effect of DAT + NET blocker bupropion on body 
temperature in SERT+/+ (A) and SERT-/- (B) rats. 
Temperature is plotted in 5-min periods starting 
60 min before injection of bupropion. Effect 
of DAT + NET blocker bupropion on the stress-
induced hyperthermia (C: * significant different 
from saline group; $ significant different from the 
15.0 mg/kg bupropion) and on the area under the 
curve in SERT+/+ (D) and SERT-/- rats  (E). * significant 
difference (p<0.05).
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Stress-induced hyperthermia. No genotype effect was found after treatment with bupropion in 
the stress-induced hyperthermia paradigm (Figure 4C). Bupropion dose-dependently reduced 
the stress-induced hyperthermia in both genotypes (F(3,56) = 9.598; p<0.001). Both 15.0 mg/kg 
(p<0.006) and 30.0 mg/kg (p<0.001) bupropion significantly reduced stress-induced hyperthermia 
compared with vehicle treated rats. In addition, 30.0 mg/kg bupropion reduced stress-induced 
hyperthermia stronger than 15.0 mg/kg (p<0.022) and 7.5 mg/kg (p<0.001) bupropion. No 
genotype x dose interaction was found. 
Core body temperature. A genotype difference was found in the time period from 65 minutes 
till 120 minutes after the injection (F(1,56)=8.34; p<0.01), from 125 minutes till 180 minutes after 
injection (F(1,56)=19.05; p<0.001) and from 185 minutes till 240 minutes after injection (F(1,56)=28.44; 
p<0.001). Figure 4 shows that a hyperthermia  was only found in SERT-/- rats after treatment with 
bupropion. When the data were split into genotypes, different effects were found. In SERT+/+ rats 
no differences were found in the core body temperature. Interestingly, in SERT-/- rats a difference 
was found in the time period from 185 minutes till 240 minutes after the injection (F(3,33)= 
4.81; p<0.01). A hyperthermia was found after treatment with 30.0 mg/kg bupropion (p<0.01) 
compared to SERT-/- rats treated with 0.0 mg/kg bupropion, but also compared to SERT-/- rats 
treated with 7.5 mg/kg bupropion (p<0.01) and compared to SERT-/- rats treated with 15.0 mg/
kg bupropion (p<0.01).
Discussion 
The SERT regulates the serotonergic neurotransmission and is therefore the primary modulator 
for 5-HT in the CNS.  In the present study we pharmacologically manipulated GABA-ergic, 
dopaminergic and noradrenergic systems and measured the drug-induced changes in the core 
body temperature and stress-induced hyperthermia in rats lacking constitutionally the SERT. The 
serotonergic system shows drastic changes upon  genetic manipulation of the SERT, both in rats 
and mice (see for an extensive discussion on SERT-/- mice and rats: Murphy and Lesch, 2008 & 
Olivier et al., in press). Previous results in rats have shown strongly increased extracellular 5-HT 
(Homberg et al., 2007a) and changed 5-HT1A receptor functioning (Homberg et al., 2008;Olivier 
et al., 2008a). Besides adaptive changes in the 5-HT system it is likely that adaptations in 
other neurotransmitters systems are also present (see Introduction). Our experiments using 
radiotelemetric measurements of body temperature showed that CDP decreased the body 
temperature in both SERT+/+ and SERT-/- rats; however, the effects seemed to last longer in SERT-/- 
rats than in SERT+/+ rats. Our results also showed that SERT-/- rats were slightly more sensitive 
to blockade of the NET than SERT+/+ rats, since both doses reduced the body temperature, 
compared to only the highest dose in SERT+/+ rats. Moreover, blocking the DAT showed a stronger 
hyperthermic response in SERT-/- rats compared to SERT+/+ rats. Combined blockade of both NET 
and DAT resulted in a stronger effect in the SERT-/- rats compared to the SERT+/+ rats. 
 
GABAA receptors play an important role in autonomic stress and anxiety responses, and GABAA 
receptor agonists dose-dependently reduce stress-induced hyperthermia across species (Olivier 
et al., 2002;Adriaan Bouwknecht et al., 2007). This effect was also found in SERT+/+ and SERT-/- rats; 
CDP dose-dependently and similarly reduced the stress-induced hyperthermia in both genotypes. 
Further, CDP dose-dependently reduced the body temperature in both genotypes; however, the 
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effect lasted longer in SERT-/- rats, suggesting an  adaptation in this system. Chlordiazepoxide, 
a non-subunit selective GABAA receptor agonist reduces stress-induced hyperthermia in mice 
and rats probably via activation of α2 and/or α3 subunits (van Bogaert et al., 2006b), whereas (at 
higher doses) core body temperature is decreased via activation of α1 subunits (van Bogaert et 
al., 2006b). It can be concluded that the absence of SERT does not lead to substantial changes 
in these GABAA subunits. Still, other GABAergic receptors than the GABAA receptor remains 
to be investigated. In SERT-/- mice for example, GABAB receptors, but not GABAA receptors, are 
functionally desensitized in the DRN (Mannoury la et al., 2004). This might also be the case in 
other parts of the brain, including parts involved with core bodytemperature.
5-HT strongly interacts with other neurotransmitter systems, in particular the DA and the NE 
system (Korsgaard et al., 1985;Benloucif et al., 1993;Iyer and Bradberry, 1996;Salomon et al., 
2006). SSRIs are known to inhibit the spontaneous firing rate of noradrenergic neurons in the 
locus coeruleus (Szabo et al., 2000;Seager et al., 2004;Dremencov et al., 2007), and decrease the 
firing rate of dopaminergic neurons  in the ventral tegmental area (Prisco and Esposito, 1995;Di 
et al., 1998). Although the SERT-/- rat is no longer able to take up 5-HT into the presynaptic neuron 
through the SERT, alternative routes by which 5-HT is taken up in the SERT-/- rat seem to exist. 
Hippocampal synaptosomes of SERT-/- rats take up 5-HT, which can be blocked by NET + DAT 
blockade, but not by DAT blockade alone suggesting that NETs take over the role of SERTs 
(Homberg et al., 2007a). 
Brain catecholamines are involved in thermoregulation, but NET inhibitors have not been 
tested before in the stress-induced hyperthermia paradigm. When the NET was blocked with 
atomoxetine, SERT-/- rats appeared slightly more sensitive compared to SERT+/+ rats. The highest 
dose (3.0 mg/kg) significantly lowered the body temperature in both SERT+/+  and SERT-/- rats, but 
in SERT-/- rats the effect was also apparent with 1.0 mg/kg atomoxetine. This indicates some mild 
adaptation of the NE system where SERT-/- rats seem to have a little more activated NET system 
compared to SERT+/+ rats. Upregulation of the NET seems a logical explanation for more 5-HT 
uptake, however the NET concentration is similar to SERT+/+ rats (Homberg et al., 2007a). It has 
been reported that in rats intrahypothalamic injection of NE decreases body temperature in rats 
(Cox and Lee, 1980). In addition, i.p. injection of 0.5 mg/kg NE lowered body temperature in rats 
for three hours, whereas in mice an i.p. injection of 1.0 mg/kg lowered body temperature for 30 
minutes (Clark and Lipton, 1986). Thus NE lowers the stress-induced hyperthermia and the core 
body temperature , with a milder effect in SERT+/+ rats compared to SERT-/- rats.
In the present study, DA influenced the body temperature in the SERT-/- rats, but not in SERT+/+ 
rats where GBR12909 had no consistent effects, neither on stress-induced hyperthermia nor on 
body temperature. The GBR12909-induced blockade of the DAT increased the body temperature 
in SERT-/- rats. It has been reported that intrahypothalamic injection of DA decreases body 
temperature in rats (Cox and Lee, 1980). Moreover, ethanol, that interacts amongst others with 
the DA system, produces no differences in hypothermia between SERT+/+ and SERT-/- mice (Boyce-
Rustay et al., 2006;Fox et al., 2007). The hyperthermic effects found in SERT-/- rats suggest that 
the SERT-/- rats are more sensitive to blockade of the DAT compared to SERT+/+ rats, and that the 
effects are opposite to the hypothermic effects seen in mice after ethanol, and to the hypothermic 
effects of intrahypothalamic injected DA in rats, indicating a shifted sensitivity to DA in SERT-/- rats 
Because the DAT concentrations are similar in SERT+/+ and SERT-/- rats (Homberg et al., 2007a), 
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these results suggest a higher activation of the DAT in SERT-/- rats. A possibility is that in the SERT-/- 
rats the DATs take up DA and 5-HT, and with blockade of the DAT levels of DA and 5-HT increase, 
causing a hyperthermia in these rats.
Bupropion is a weak monoamine reuptake inhibitor that shows selectivity for NET and DAT 
but has no effect on SERT (Hyttel, 1982;Richelson and Pfenning, 1984;Ascher et al., 1995). 
Administration of bupropion caused differential effects on body temperature of SERT+/+ and 
SERT-/- rats. As mentioned above SERT-/- rats appeared more vulnerable for blockade of DAT 
compared to SERT+/+ rats. After treatment with bupropion, some hyperthermia was also seen in 
SERT-/- rats at the highest dose used. These findings support the involvement of the DAT in the 
5-HT uptake in SERT-/- rats. Only when the DAT is blocked (in the SERT-/- rats) this effect is found. 
The non-selective inhibitor bupropion has been tested before on body temperature in rats. 
Hasegawa et al. (2005) have shown that body temperature is increased after administration of 
bupropion and that, using in vivo microdialysis, the increase of NE was higher compared to DA in 
the hypothalamus (preoptic area and anterior hypothalamus) after administration of bupropion 
(Hasegawa et al., 2005). It is likely that 5-HT uptake in the SERT-/- rat is taken over by different 
transporters in different brain areas, depending presumably on the relative density of the re-
uptake mechanisms. The 5-HT uptake of SERT-/- rats in the brain area involved with temperature 
regulation (probably hypothalamus) might be regulated by the DAT, while in the hippocampus, 
a brain area not important for core body temperature regulation, the 5-HT uptake may be mainly 
regulated by the NET (Homberg et al., 2007a). Reasoning along this line, the increase in body 
temperature after GBR12909 and bupropion could then be explained by blockade of the DAT in 
the brain area involved in the regulation of body temperature, thereby blocking the 5-HT uptake 
via the DAT and, subsequently, increasing the extracellular 5-HT in this brain area. However, 
it is well known that an increase of extracellular 5-HT normally leads to hypothermia. Drugs 
like the 5-HT releaser d-fenfluramine (Cryan et al., 2000) and the SSRI citalopram (Oerther and 
Ahlenius, 2001) are known to reduce core body temperature in rats, although d-fenfluramine 
induced hypothermia is reduced in SERT-/- (Homberg et al., 2007a). One possible explanation for 
this apparent discrepancy may lie in the fact that the extracellular 5-HT in SERT-/- rats is in the 
vicinity of the DAT and not the SERT and hence may induce an anomalous effect. Alternatively, 
the possibility exists that compensatory changes may also have occurred in the uptake of DA as 
well. Previous in vitro studies in the SERT-/- rats, however, have suggested that the consequences 
of the absence of SERT are limited to the serotonergic system and do not result in compensations 
of non-serotonergic neurons (Homberg et al., 2007a) 
For the GABA system, uptake and depolarization-induced release in superfused brain slices in 
SERT-/- rats is not different from SERT+/+ rats. Here we showed that the GABAA system, at least 
the response to GABAA receptor agonist in the stress-induced hyperthermia paradigm, was not 
affected in SERT-/- rats. However, the core body temperature was slightly changed. Blockade of the 
DAT, NET, or both, increases levels of DA, NE, or both respectively. Increasing the neurotransmitter 
levels will have an impact mainly on the postsynaptic neurons. In SERT-/- rats the NET and DAT 
concentrations are not significantly changed (Homberg et al., 2007a). Furthermore, [3H]NE and 
[3H]DA uptake and their depolarization-induced release in superfused brain slices are not different 
between SERT+/+ and SERT-/- rats  (Homberg et al., 2007a). Moreover, DA and NE tissue levels are 
similar in both genotypes (Homberg et al., 2007a). Therefore, we can conclude that basal NE and 
DA levels are similar in these rats, at least in vitro. However, the sensitivity of the DA and NE 
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system in vivo is changed, as shown by the change in sensitivity of the transporter blockers in the 
regulation of body temperature. It is possible that regional difference exist in the brain for the 
sensitivity of the DA and NE system. In conclusion, the SERT-/- rat shows adaptive changes in the 
catecholaminergic system. These changes might be shared with humans carrying the short allele 
of the serotonin transporter promoter length polymorphism, making the SERT-/- rat a good in vivo 
model to investigate targets for treatment in human psychiatric disorders.
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Introduction
Currently, ENU mutagenesis is the only approach to generate genetic knockouts in the rat 
(Zan et al., 2003;Smits et al., 2004;Smits et al., 2006). Using this method, we developed a rat 
with a premature stopcodon in the SERT gene (TGC > TGA transversion at position 3924 in the 
third exon). Since this technique will most likely lead to additional, unwanted mutations, rats 
carrying the SERT gene premature stopcodon were first outcrossed on commercially available 
wildtype rats (Harlan, The Netherlands) background for at least five generations before the first 
experiments began. This procedure led to a homozygous SERT knockout rat line and at the same 
time the risk for potential additional mutations was reduced. Unwanted mutations may seem 
to be a disadvantage of this rat knockout approach, but thus far target-selected mutagenesis 
is the only method available to generate knockout rats. Because the phenotypes of the SERT 
knockout rat described in this thesis are stable across generations and laboratories, and several 
phenotypes are concurrent with literature findings and SERT knockout mouse phenotypes, it is 
assumed that any phenotype in the knockout rat is most likely attributable to the absence of the 
SERT and not other induced mutations. 
The aim of the present thesis was to phenotypically characterize the SERT knockout rat by 
studying a variety of behavioral paradigms and measuring pharmacological and physiological 
parameters.  In this chapter, the results obtained in the various studies underlying this thesis are 
briefly summarized and discussed.
Confirmation of the SERT knockout rat at the molecular level
The nature of non-transgenic ENU-induced gene knockouts is fundamentally different from the 
homologous recombination method commonly used to generate mouse knockouts. In the latter 
models, genomic fragments encoding important protein domains or the complete protein are 
replaced by a selection cassette, whereas the SERT knockout rat presented here results from a 
single point mutation that introduces a premature stopcodon. It is theoretically possible that, due 
to an alternatively spliced transcript, the normal SERT protein is nonetheless produced; however, 
Northern blot analysis (chapter 2) and sequencing of RT-PCR products (unpublished observations) 
revealed that the SERT transcript is almost completely absent in SERT-/- rats. This is most likely 
due to a process called ‘nonsense mediated decay’ (Baker and Parker, 2004), a mechanism by 
which nonsense transcripts are degraded.  The expression level of the SERT transcript in SERT+/- 
rats is intermediate to that of SERT-/- and SERT+/+ rats. Autoradiography, using the tritium labeled 
form of the highly selective serotonin reuptake inhibitor (SSRI) citalopram, revealed that SERT 
binding was completely absent in SERT-/- rats (chapter 2). In SERT+/- rats, SERT binding was 
reduced by approximately 40% as compared to SERT+/+ littermates (chapter 2).  At the functional 
level, d-fenfluramine-induced hypothermia, which can be blocked by citalopram (unpublished 
observations), was completely absent in SERT-/- rats, and reduced in SERT+/- rats relative to SERT+/+ 
littermates (chapter 2). Finally, the in vitro maximum rate (Vmax) of [3H]5-HT uptake in synaptosomes 
prepared from the hippocampus was reduced by 13.4 % in  SERT+/- rats, and by 72.2 % in SERT-/- rats 
(chapter 2). These data strongly argue in favor of the hypothesis that the premature stopcodon in 
the SERT gene resulted in a full knockout of the SERT. Furthermore, the SERT+/- rat studies showed 
that there was a gene-dose effect for most molecular and neurochemical findings.
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General appearance of the SERT knockout rat
Despite the important role of 5-HT in the development of the nervous system (Lauder, 1990), 
SERT-/- and SERT+/- knockout rats appear normal, and score similarly to SERT+/+ littermates on 
measures of health and neurological functions. This has been shown by using an adapted 
SHIRPA protocol. The SHIRPA protocol has been developed to characterize the phenotype of 
transgenic and knockout mice (Roger et al., 1997). Several components of this protocol have 
been adapted to evaluate our rat subjects, including behaviors in the viewing Jar (body position, 
spontaneous activity, respiration rate, and tremor), behavior in an open arena (transfer arousal, 
locomotor activity, palpebral closure, piloerection, startle response, gait, pelvic elevation, tail 
elevation, touch escape, and positional passivity), behaviors recorded on or above the arena 
(trunk curl, limb grasping, visual placing, grip strength, body tone, pinna reflex, corneal reflex, toe 
pinch, and wire movement) and, finally, physiological conditions and behaviors were recorded 
during supine restraint (skin color, heart rate, limb tone, abdominal tone, lacrimation, salivation, 
prevoked biting, righting reflex, contact righting reflex, negative geotaxis, fear, irritability, 
aggression, vocalization and body temperature). Experimenters performing the SHIRPA protocol 
were blind to the genotype of the animals. No differences were found in the general appearance 
of male SERT+/+ and SERT-/- rats (unpublished observations); however, the body weight of female 
SERT-/-  rats was reduced by 10% from the age of 3 weeks compared to female SERT+/+ rats,  while 
the weight of male SERT-/-  rats was not different from SERT+/+ rats (chapter 2).
To generate experimental animals, SERT+/- x SERT+/- crossings are maintained, with litter sizes 
of 10 on average and a Mendelian distribution of +/+, -/- and +/- alleles. After 8-10 generations of 
outcrossings, it is ideal  to choose for SERT-/- x SERT-/- and SERT+/+ x SERT+/+ crossings to maintain the 
line and producing proper control animals, although the reproductivity  may be slightly reduced 
in SERT-/- x SERT-/- crossings (unpublished observations); however, one should realize that the 
genetic background of SERT-/- rats and control SERT+/+ rats may differ in a more systematic way 
than when using littermates as controls, which may confound measurements. 
Serotonin homeostasis
Throughout development, neuroplastic events are likely to have taken place which compensate 
for the lifelong reduced 5-HT uptake in SERT+/- and SERT-/- rats. An overview of the possible 
adaptations, and consequences of the absence of SERT, that have been studied in the SERT-/- rats 
are listed in table 1. The most obvious consequence of the absence of the SERT is that extra-
neuronal 5-HT levels were strongly increased in both male and female SERT-/- rats, as measured 
by microdialysis with the dialysis probe located in the hippocampus (chapter 2 and 3), a strongly 
serotonergic innervated region of interest for many types of behavior.  
Compensatory adaptations are likely to have taken place to enable the organism to ‘cope’ with this 
extreme condition. Presynaptically, the serotonergic system would be expected to be ‘silenced’, 
as the serotonergic tone is already high. However, tryptophan hydroxylase (5-HT synthesis) and 
monoamine oxidase (MAO-A; 5-HT degradation) enzymatic activity were not different between 
genotypes across several brain regions, including the raphe nuclei. These findings were supported 
by the absence of genotype differences in tryptophan hydroxylase immunoreactivity in the dorsal 
raphe nuclei (chapter 2). While the 5-HT synthesis and degradation machinery seem to function 
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normally, 5-HT tissue levels were reduced by approximately 55-75% and 5-hydroxyindoleacetic 
acid (5-HIAA) levels by approximately 45-50% in various brain regions (chapter 2; Homberg et 
al., 2007b). We assume that 5-HT tissue levels predominantly reflect intracellular 5-HT content, 
suggesting that intracellular 5-HT levels were decreased in neurons of SERT-/- rats, while 
extracellular 5-HT levels were increased. If less 5-HT is available for release and 5-HT release will 
have little effect on neurotransmission processes because of the high endogenous 5-HT tone, 
it is expected that 5-HT release would be attenuated. That is exactly what has been found for 
electrically-evoked Ca2+-dependent 5-HT release in superfused brain slices (chapter 2). Together, 
the findings of substantially reduced 5-HT uptake and release as well as reduced 5-HT tissue 
levels indicate that 5-HT recycling might be attenuated in SERT-/- rats, which further implies that 
the serotonergic system has lost its dynamics and flexibility. Thus, it is tempting to suggest that 
5-HT homeostasis may be changed in such a way that the animal is able to function normally 
under basal conditions, but when exposed to challenges or stimuli, this system may not be able 
to adapt appropriately, resulting in aberrant behavioral responses.
Interestingly, 5-HT levels in CSF were significantly reduced and 5-HT turnover (as reflected by the 
5-HIAA/5-HT ratio) in CSF was increased in SERT-/- knockout rats (Homberg et al., 2007b). Because 
selected subsets of serotonergic dorsal raphe neurons project to the ependymal wall of the 
ventricular system in the rat (Simpson et al., 1998), CSF 5-HIAA and 5-HT levels may particularly 
reflect 5-HT homeostasis processes in the raphe nuclei. Otherwise, the CSF may collect the freely 
diffusible 5-HIAA from diverse brain regions. Overall, the CSF measurements suggest that 5-HT 
turnover is increased in SERT-/- rats, which is in line with the increased serotonergic tone in this 
mutant rat model (chapter 2 and 3). 
Despite a 40% reduction in SERT binding (chapter 2), there were no differences in 5-HT tissue levels 
and 5-HT release in SERT+/- rats, probably because 5-HT uptake was only slightly reduced (chapter 2) 
and extraneuronal 5-HT levels are only slightly increased (unpublished observations) in these animals 
compared to SERT+/+ rats. Hence, there may be at least a redundancy of 40-50% in SERT availability. 
5-HT uptake in hippocampal synaptosomes was strongly decreased in SERT-/- rats, but not 
completely absent, which suggests that there are alternative routes by which 5-HT can be taken 
up. The monoamine transporters are neuron-specific, but not neurotransmitter-specific, and have 
low affinity and reuptake capacity for monoamines that do not match the monoamine transporter. 
Under extreme conditions, e.g. high levels of monoamines, the high affinity ‘monoamine-own’ 
uptake process will be overruled by the abundancy of other monoamines, resulting in the uptake 
of ‘false’ neurotransmitters (Vizi et al., 2004). The hippocampus is noradrenaline enriched. In this 
region, combined dopamine (DAT) and noradrenaline (NET) transporter blockade, but not DAT 
blockade alone, prevented the reuptake of residual 5-HT in SERT-/- rats (chapter 2), suggesting 
that the NET is responsible for residual 5-HT uptake in the hippocampus of SERT-/- rats. In 
dopamine-rich regions, e.g. the striatum, it is expected that residual 5-HT uptake will take place 
via the DAT, as has been reported in SERT-/- mice (Zhou et al., 2002). Due to false 5-HT uptake, DAT 
or NET blockade in SERT-/- models will not only result in increases in extracellular DA or NE levels, 
but also 5-HT levels (Shen et al., 2004).
The 5-HT system interacts with several other (neurotransmitter) systems and, secondary to 
the changes in 5-HT homeostasis in the knockout rat, these systems may adapt as well. The 
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presynaptic function of dopaminergic and noradrenergic neurons has been studied by measuring 
the electrically-evoked Ca2+-dependent dopamine (DA) and noradrenaline (NE) release. Despite 
the high endogenous 5-HT tonus, no change was observed in DA and NE release (chapter 2). 
The absence of presynaptic adaptations in dopaminergic and noradrenergic neuron function 
was further supported by the lack of genotype differences in DAT and NET binding and tissue 
levels of DA, NE, and their metabolites HVA and DOPAC (chapter 2). The exception was NE levels 
in the amygdala, which were decreased in SERT-/- rats, along with HVA levels. Also, the reactivity 
of cholinergic, glutamatergic and GABAergic neurons was not changed in SERT-/- rats (chapter 
2). Together, these in vitro data suggest that compensatory adaptations in response to the 
constitutive absence of the SERT are predominantly found in the serotonergic system; however, 
these data do not exclude changes in the responsiveness of the dopaminergic or noradrenergic 
system which can only be found in vivo. This observation makes the SERT-/- rat very valuable 
to study the role of the serotonergic system in any system of interest, although it should be 
kept in mind that, due to the lifelong increased 5-HT tonus, the SERT-/- condition is not directly 
comparable to the consequences of acute rises in 5-HT. 
Pharmacological responses
5-HT1A receptor agonists and antagonists
SERT-/- rats exhibit nine-fold increases in extra-neuronal 5-HT levels (chapter 2 and 3) that could 
potentially affect the functioning or responsivity of 5-HT receptors, as has been reported after 
chronic SSRI treatment (Blier et al., 1990;Briley and Moret, 1993). To address this issue, the effect 
of flesinoxan (5-HT1A receptor agonist) on body temperature and stress-induced hyperthermia 
(SIH) have been measured, processes that are well known to be modulated by 5-HT1A receptor 
ligands (Hjorth, 1985;Lesch, 1991;Millan et al., 1993;De, 1995;Friedman and Thayer, 1998;Olivier 
et al., 1998;Nijsen et al., 1998a;Nijsen et al., 1998b;Cryan et al., 1999;Bouwknecht et al., 2000). 
Flesinoxan-induced (10 mg/kg) hypothermia was completely absent in SERT-/- rats (chapter 
5). While flesinoxan dose-dependently (0.3-10 mg/kg) inhibited SIH and additionally induced 
hypothermia in SERT+/+ rats, a three-fold higher dose was needed to inhibit SIH in SERT-/- rats, 
and no additional hypothermia was observed (chapter 5). This higher dose needed to reduce 
SIH may be due to the absence of an additional effect of hypothermia as found in SERT+/+ rats. 
Moreover, WAY100635 alone strongly enhanced SIH in SERT-/- rats, but not in SERT+/+ rats (chapter 
5). These findings clearly indicate that the responsivity to 5-HT1A receptor ligands is changed 
in SERT-/- rats. The lower responsivity to 5-HT1A receptor agonists may be explained either by 
constitutive occupation of 5-HT1A receptors due to the high endogenous 5-HT tonus, or by 
desensitization of the receptors as a compensatory adaptive response to the high endogenous 
5-HT tonus, or both. The remarkable response to WAY100635 in SERT-/- rats is most likely explained 
by the high endogenous 5-HT tonus, such that WAY100635 is competing with endogenous 5-HT 
occupation of 5-HT1A receptors. In rats (e.g. Goodwin et al., 1987;Bill et al., 1991;Millan et al., 1993) 
and humans (Blier et al., 2002) 5-HT1A receptor-mediated hypothermia is thought to be mediated 
by postsynaptic 5-HT1A receptors, while in mice the somatodendritic 5-HT1A receptors seem to 
be involved (Goodwin et al., 1985a;Martin et al., 1992). However, some studies also suggest that 
5-HT1A receptor mediated hypothermia in rat is mediated by somatodendritic 5-HT1A receptors 
(Higgins et al., 1988;Hillegaart, 1991). Flesinoxan-mediated hypothermic responses may be 
exerted via postsynaptic 5-HT1A receptors. Hence, the response profile of SERT-/- rats may suggest 
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that postsynaptic 5-HT1A receptors are fully occupied in SERT-/- rats and/or (slightly) desensitized. 
Regarding the SIH, it is not clear whether this short-lasting thermogenic effect is mediated by 
somatodendritic or postsynaptic 5-HT1A receptors, or both. The finding that flesinoxan reduced 
the SIH in SERT-/- rats suggests that 5-HT1A receptors involved in SIH are still sensitive to 5-HT1A 
agonists and hence must represent a different population of 5-HT1A receptors than those 
involved in hypothermia.  While the 5-HT1A receptor-mediated autonomic responses have not 
provided sufficient data from which a firm conclusion can be drawn regarding enhanced 5-HT1A 
receptor occupation or receptor desensitization, autoradiography studies reveal slight, but 
significant decreases in 5-HT1A receptor density in the raphe nuclei and several terminal regions 
(unpublished observations). Hence, reduced expression of the 5-HT1A receptor may partially 
explain the reduced responsivity to 5-HT1A receptor agonists in SERT-/- rats.
Manipulation of the 5-HT system with acute tryptophan depletion
In humans, a polymorphism in the SERT gene-linked promoter region (5-HTTLPR) exists which 
causes individual differences in SERT expression and function (Lesch et al., 1996;Heils et al., 1996). 
Behavioral responses to acute tryptophan depletion (ATD) are influenced by this 5-HTTLPR 
genotype (Neumeister et al., 2006;Marsh et al., 2006;Roiser et al., 2006;Walderhaug et al., 2007). 
In line with this, the impact of ATD may vary in SERT+/+, SERT+/- and SERT-/- rats as they exhibit large 
differences in central 5-HT neurotransmission. Biochemically, the standard dose TRP- depletion 
caused a decrease of 65% in plasma TRP in SERT+/+, 61% in SERT+/- and 55% in SERT-/- rats (chapter 
4). Interestingly, SERT-/- rats showed stronger depletion of 5-HT in the frontal cortex (63%) than 
SERT+/+ and SERT+/- (both 19%) rats (chapter 4). Similar results were found in the hippocampus, 
where SERT-/- rats showed a depletion of 70%, whereas SERT+/- rats showed a 18% depletion and 
SERT+/+ rats a 13% depletion (chapter 4). The standard dose ATD decreased the 5-HIAA in frontal 
cortex and hippocampus to a similar extent in all genotypes (chapter 4). The 5-HIAA/5-HT ratio 
(reflecting turnover) in SERT+/+ and SERT+/- rats was somewhat lower in rats treated with TRP+ and 
standard dose TRP- compared with the untreated condition; however, in SERT-/- rats, the turnover 
in the standard dose TRP- group was much higher than in the TRP+ and the untreated group 
(chapter 4). The different effects seen in SERT+/+, SERT+/- and SERT-/- rats after ATD were found 
only in the brain and not in the periphery.  Although the reason for this difference is not known, 
it is interesting to note that 5-HT synthesis in brain and peripheral tissues functions differently. 
For example, tryptophan hydroxylase (TPH), which forms 5-hydroxytryptophan (5-HTP) from 
tryptophan, is controlled by different isoform in the brain and periphery (for review, see Walther 
and Bader, 2003). This difference in 5-HT synthesis might play a role in the different effects seen 
after ATD in brain and periphery. Another possibility could be that there is more compensatory 
5-HT in the intestine compared to the brain. It is known that compensatory systems exist in the 
intestine of SERT-/- rat (Linder et al., 2008) and SERT-/- mouse (Chen et al., 2001). 
In the object recognition test, two different doses of depletion were tested, the standard dose 
(TRP- 100g) and a mild depletion (TRP-40g). The standard ATD dose impairs object recognition 
in Wistar rats (Lieben et al., 2004b;Jans et al., 2007a) and was thus expected to impair object 
recognition in SERT+/+, SERT+/- and SERT-/- rats. As expected, all genotypes showed impaired 
object recognition after treatment with the standard TRP depletion (chapter 4). Interestingly, 
mild TRP depletion impaired object recognition in SERT+/- and especially in SERT-/- rats but not 
in SERT+/+ rats, indicating that SERT-/- and SERT+/- rats are more sensitive to mild ATD (chapter 
4). These data suggests that SERT-/- and to a lesser extent SERT+/- rats show higher serotonergic 
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vulnerability than SERT+/+ rats, as low-dose ATD only affected memory in subjects that already 
have a disturbed 5-HT system. ATD in SERT-/- rats may therefore be a good tool to investigate 
serotonergic vulnerability in humans.
Pharmacological responses to GABAergic, noradrenergicand dopaminergic systems
Adaptive changes in the serotonergic system occur after chronic administration of SSRIs (Blier and 
de Montigny, 1998;Briley and Moret, 1993). Besides the serotonergic system (Blier et al., 1997), 
adaptations also occur at the level of other neurotransmitters systems (Smith et al., 2000;Kugaya 
et al., 2003). In SERT-/- rats, small adaptations were found in body temperature after treatment 
with chlordiazepoxide, a GABAA receptor agonist (chapter 6). The effects of chlordiazepoxide 
lasted longer in SERT-/- rats than in SERT+/+ rats. After treatment with atomoxetine, a NET blocker, 
a slightly increased response was found in the SERT-/- rat (chapter 6). This result was very modest, 
the low dose of atomoxetine reduced core body temperature in SERT-/- rats, but not in SERT+/+ 
rats. The highest dose reduced core body temperature in both genotypes. These results indicate 
that NE receptors in SERT-/- rats are slightly more sensitive than in SERT+/+ rats. Treatment with the 
DAT blocker GBR12909 resulted in a hyperthermia in SERT-/- rats, which was not found in SERT+/+ 
rats (chapter 6). This might suggest a higher sensitivity of SERT-/- rats to blockade of the DAT 
in regions involved in body temperature. Interestingly, this hyperthermia was also found after 
treatment of the dual DAT and NET blocker bupropion (chapter 6). The drug-induced changes in 
stress-induced hyperthermia did not differ between SERT+/+ and SERT-/- rats. Together, these results 
show that permanent changes in the 5-HT system leads to an adaptation in responsivity of the 
GABAergic, the noradrenergic and the dopaminergic system, with regard to body temperature, 
but not stress-induced hyperthermia.  
Behavioral studies
Anxiety-like and depression-like behaviors of SERT-/- rats
In humans the 5-HTTLPR short variant, which results in reduced transcriptional efficiency of the 
SERT gene, is strongly associated with anxiety-related, harm-avoidance, negative personality 
traits, and exhibit more depressive symptoms, diagnosable depression, and suicidality in relation 
to stressful events compared with individuals with the long version (Lesch et al., 1996;Mann et 
al., 2000;Caspi et al., 2003;Anguelova et al., 2003;Sen et al., 2004;Kendler et al., 2005;Schmitz et 
al., 2007;Dick et al., 2007;Canli and Lesch, 2007). SERT-/- rats were therefore predicted to exhibit 
increased anxiety-like and depression-like behaviors. For anxiety-like behavior, both male and 
female SERT-/- rats spent significantly less time in the central part of the open field and less time 
on the open arms of the elevated plus maze as compared to their SERT+/+ littermates (chapter 
3). SERT-/- rats have also been subjected to the novelty suppressed feeding assay. In this test, only 
male SERT-/- rats showed a longer latency to start eating compared to SERT+/+ controls (chapter 
3).  The home cage emergence test has been used as a last assay to assess anxiety-related 
behaviors in the SERT-/- rats. In this test, both male and female SERT-/- rats showed a higher escape 
latency than SERT+/+ littermates (chapter 3). Taken together, these results indicate that anxiety-
like behaviors are intensified in SERT-/- rats. For depression-like behavior, SERT-/- rats displayed 
an increased immobility time in the forced swim test compared to SERT+/+ rats. Moreover, SERT-/- 
rats consumed less sucrose in the two-bottle paradigm compared with SERT+/+ rats. These results 
suggest a higher depression-like state in SERT-/- rats.
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Male versus female
In humans, women experience depression about twice as often as men (Gorman 2006). Possible 
explanations for this phenomenon are directly or indirectly linked to 5-HT neurotransmission. For 
example, in vivo measurements of 5-HT synthesis in the brain by positron emission tomography 
showed that whole brain rates of 5-HT synthesis is lower in women than in men (Nishizawa et al 
1997). Moreover, women have lower SERT binding in the prefrontal cortex than men (Mann et al., 
2000). Finally, depressed women show a decrease of SERT availability, while almost no decrease 
has been reported in men. In the SERT-/- rat, only anxiety- and depression-related behaviors were 
analyzed in male and female rats to find out if females were more sensitive to the loss of the SERT 
compared to males (chapter 3). Despite a higher general activity of females, no sex differences 
in anxiety- and depression-related behaviors have been found. Statistical analysis revealed no 
genotype x gender interactions (chapter 3). If anything, male rats show a slightly increased 
expression of anxiety-related behaviors, since the latency to initiate food consumption in the 
novelty suppressed feeding test was increased in male, but not female, SERT-/- rats compared to 
SERT+/+ rats. Thus, regardless of the basal 5-HT differences between males and females (Watts 
and Stanley, 1984;Carlsson and Carlsson, 1988;Haleem et al., 1990;Dominguez et al., 2003) these 
data show that lifelong absence of SERT in rats leads to a sex independent increase of anxiety- 
or depression-like behaviour. Apparently, the behavioural consequences of genetic inactivation 
of the SERT are so robust that any difference between male and female knockout rats might 
be completely masked. These results are in line with a human study, which reported that both 
male and female individuals with the short version of the SERT gene are more prone to develop 
depression (than those with the longer version) (Mann et al., 2000).
Synthesis
Adaptive processes
The SERT-/- rat is one of the various genetic and pharmacological models available to study the 
role of 5-HT, and in particular of the SERT, in any process in which 5-HT is potentially involved. 
A major concern of knockout models is that the absence of a gene affects early development 
and that compensatory processes could have taken place. As such, phenotypes of a knockout 
model may not be exclusively attributable to the gene that has been knocked-out, but also to 
secondary adaptations in interacting systems. Studying the function of the SERT itself may be best 
accomplished by using selective serotonin reuptake inhibitors, e.g. citalopram. SERT-/- models 
including their adaptive mechanisms are, however, of major relevance when studying stable 
(genetic) individual differences in central serotonergic activity as an endophenotype underlying 
personality, such as harm avoidance (Gerra et al., 2000) and social impulsivity (Fairbanks et al., 
2001), and those associated with the serotonin transporter promoter polymorphism (Dragan and 
Oniszczenko, 2006). Insight into these processes is of importance because they may increase our 
understanding of interactions between systems, and adaptive capabilities of the central nervous 
system. Further, due to such adaptive processes the impact of pharmacological compounds may 
change. Hence, individual differences in genetic, and consequently neurochemical make-up 
may determine the efficacy of pharmacotherapies. When considering the SERT-/- rat as potential 
model for inherited increased 5-HT levels, the pharmacological profile of these animals may have 
predictive value for pharmacological effects in humans exhibiting inherited increased central 
serotonergic activity.
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Rat versus Mouse
Until now, rat genetic tools are clearly lagging behind those that are available for mice. 
Homologous recombination in embryonic stem (ES) cells, which is used to generate knockout 
mice (for review see Capecchi, 1989), fails in rats. As an alternative, target-selected ENU driven 
mutagenesis has been used to generate knockout rats (Zan et al., 2003;Smits et al., 2004;Smits et 
al., 2006).  ENU induces random point mutations, and the currently available mutation-detection 
techniques are insufficient to screen the entire genome for mutations, raising the possibility that 
additional mutations in the SERT-/- rats could have gone undetected.  Using the homologous 
recombination technique in ES cells, the first SERT-/- mouse was generated 10 years ago (Bengel 
et al., 1998), which has been characterized extensively afterwards. To confirm that a premature 
stopcodon in the SERT gene results into a SERT-/- rat, and to establish whether rats and mice 
similarly adapt to the absence of the SERT, many experiments done in the SERT-/- mouse have 
been replicated in the SERT-/- rat. Interestingly, several phenotypes in SERT-/- mice and rats are 
comparable. For instance, both SERT-/- mice (Fabre et al., 2000;Holmes A, 2002a;Holmes et al., 
2002b;Lira et al., 2003;Montanez et al., 2003;Holmes et al., 2003b;Holmes et al., 2003c;Mathews 
et al., 2004;Shen et al., 2004;Kim et al., 2005;Zhao et al., 2006;Carroll et al., 2007;Fox et al., 
2007;Kalueff et al., 2007a;Kalueff et al., 2007b) and rats (Homberg et al., 2007b; chapter 2 and 
3) display strongly enhanced extra-neuronal 5-HT levels, no change in in vitro MAO-A and TPH 
activity, reduced 5-HT and 5-HIAA tissue levels, unchanged NET density, no changes in DA, NE, 
DOPAC and HVA tissue levels in the PFC, nucleus accumbens and caudate putamen, reduced 
responsivity to 5-HT1A ligands and reduced 5-HT1A receptor binding, thigmotaxis, increased 
anxiety and depression-related symptoms. These similarities in neurochemistry and behaviours 
indicate that phenotypes of SERT-/- rats are valid in the sense that the phenotypes in SERT-/- rats 
generally meet our expectations and are consistent with the literature. Moreover, they indicate 
that the influence of unknown additional mutations, if present, is minimal. Furthermore, these 
similarities between SERT-/- rat and mice models strengthen the assumption that gene function 
is conserved among species and thereby highlight the value of genetic animal models to 
understand gene function in humans.
 Interestingly, differences between SERT-/- mice and rats were also found. For example, in contrast 
to SERT-/- rats (chapter 2), there is no compensatory 5-HT uptake in hippocampal synaptosomes 
of SERT-/- mice (Bengel et al., 1998), oral free-choice sucrose intake is decreased in SERT-/- rats 
(chapter 3), but not in SERT-/- mice (Kalueff et al., 2006), and no changes in 5-HT1B receptor binding 
are found in SERT-/- rats (unpublished observations), while regional changes in 5-HT1B receptor 
binding have been found in SERT-/- mice (Fabre et al., 2000). Finally, there are no differences in the 
number of immunopositive 5-HT neurons in the dorsal raphe nuclei between SERT-/- and SERT+/+ 
rats (chapter 3), while a 50% reduction of serotonergic cell number has been found in the SERT-/- 
mouse (Lira et al., 2003). It should be noted that techniques or experimental conditions used in 
mice and rat studies differ, which hamper direct rat-mouse comparisons. In addition, the SERT-/- 
mouse has been generated in two different inbred lines, which differ among themselves (Holmes 
et al., 2003b;Adamec et al., 2006;Altamura et al., 2007), thereby further complicating comparisons 
with the SERT-/- rat that has been generated on a outbred Wistar background. Whether and how 
SERT-/- rat phenotypes are affected by genetic background is currently investigated. Together, 
studying similarities and differences between SERT-/- rats and mice are highly informative for 
cross-species translation of results obtained in different rodent models and/or the extrapolation 
to the human situation. 
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SSRIs
Interestingly, chronic SSRI treatment results in a profound reduction in SERT expression and 
function (Benmansour et al., 1999), and increased extracellular 5-HT levels. Furthermore, 
SSRI-induced reduction in 5-HT1A receptor function has been reported (Dawson et al., 2002). 
Adaptations that have been observed in SERT-/- rats are strikingly similar. This may suggest that the 
SERT-/- rat can be considered as a model for studying the consequences of chronic SSRI treatment. 
However, SERT-/- rats paradoxically show anxiety- and depression-like phenotypes. Early postnatal 
SSRI treatment induces rather than ameliorates anxiety- and depression-like symptoms during 
adulthood, which are comparable to symptoms found in SERT-/- mice (Ansorge et al., 2004) and 
rats (chapter 3). It has been hypothesized that hyperserotonemia at early stages of development 
can cause loss of 5-HT terminals in the brain that persists throughout subsequent development 
(Whitaker-Azmitia, 2005). Hence, early SSRI treatment or the constitutive loss of the SERT is 
expected to have profound effects on brain development (Persico et al., 2001;Salichon et al., 
2001), which obviously differs from the impact of chronic SSRI on the mature brain (Taravosh-
Lahn et al., 2006). The finding that prenatal exposure to chronic fluoxetine increases anxiety-like 
behaviour in adult mice (Ansorge et al., 2004), supports this developmental hyperserotonemia 
hypothesis. Otherwise, chronic SSRI treatment decreases aggressive (Fuller, 1996) and sexual 
behavior (de Jong et al., 2005b) in rats, phenotypes that are also observed in SERT-/- rats 
(Homberg et al., 2007b; unpublished observations). Apparently, not all SERT-/--related behavioral 
phenotypes are opposite of those seen after chronic SSRI treatment during adulthood. Although 
highly speculative, it is possible that some effects of chronic SSRI treatment directly relate to 
SERT inhibition and increased extra-neuronal 5-HT levels, while others depend on associated 
compensatory adaptations or are the result of developmental changes induces by the constitutive 
absence of the SERT.  
Conclusion
Although the ENU-driven target selected mutagenesis approach to generate knockout rats could 
theoretically be associated with unknown mutations additional to the premature stopcodon in 
the SERT gene, the SERT-/- rat has proven to exhibit both expected and novel phenotypes that may 
contribute to the further understanding of SERT function and its role in diseases. Furthermore, the 
SERT-/- rat models several important endophenotypes, and can be used as such. While research 
on SERT-/- mice has already revealed several novel 5-HT-mediated phenotypes and processes, the 
SERT-/- rat allows complementary in-depth research through its greater accessibility of behavioral 
and neurochemical techniques. The SERT-/- rat has only recently been generated (Smits et al., 
2006), and based on the output the knockout rat has already provided, we expect that this 
mutant will become a very valuable research tool in neuroscience research and beyond.
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Abbreviations
Ach:  acetylcholine
AMY:  amygdale
ATD:  acute tryptophan depletion
BNST:  bed nucleus stria terminalis
CDP:  chlordiazepoxide
CNS:  central nerve system
CP:  caudate putamen
Cpm:  counts per minute
CSF:  cerebrospinal fluid
DA:  dopamine
DAT:  dopamine transporter
DOPAC:  dihydroxyphenylacetic acid
DMI:  desmethylimipramine
DRN:  dorsal raphe nucleus
ECG:  electrocardiogram
ENU:  N-ethyl-N-nitrosurea
GAPDH:  glyceraldehyde-3-phosphate dehydrogenase
Hipp  hippocampus
HPLC:  high-performance liquid chromatography
Htal:  hypothalamus
HVA:  homovanillic acid
LNAA:  large neutral amino acids
MAO:  monoamine oxidase
mRN:  medial raphe nucleus
NACC:  nucleus accumbens
NE:  noradrenaline
NET:  noradrenaline transporter
PBS:  phosphate-buffered saline
PFC:  prefrontal cortex
RN:  raphe nuclei
SERT:  serotonin transporter
SERT-/-:  homozygous serotonin transporter knockout rat
SERT+/-:  heterozygous serotonin transporter knockout rat
SERT+/+:  wildtype serotonin transporter knockout rats
Sc:  subcutaneously
SCX:  somatosensory cortex
SIH:  stress-induced hyperthermia
SN:  substantia nigra
SSRI:  selective serotonin reuptake inhibitor 
Tc:  core body temperature
Thal:  thalamus
TLLING:  targeting induced local lesions in genomes
TPH:  tryptophan hydroxylase
TRP:  tryptophan
VTA:   ventral tegmental area
5-HIAA:  5-hydroxyindoleacetic acid
5-HTP:  5-hydroxytryptophan
5-HTTLPR: polymorphism in the promotor region of the SERT gene
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Serotonine is een neurotransmitter die een belangrijke rol speelt in processen die in de hersenen 
plaats vinden. De serotonerge huishouding wordt primair gereguleerd door de serotonine 
transporter (SERT). Recent moleculair genetisch onderzoek heeft aangetoond dat afwijkingen in 
de SERT het risico op het ontstaan van neuropsychiatrische aandoeningen zoals angststoornissen, 
pathologische agressie en depressie sterk verhoogd. Vooralsnog is niet duidelijk wat de 
consequenties van deze genetische verandering in de SERT voor de serotonine huishouding 
heeft. Meestal worden deze aandoeningen behandeld met medicijnen die aangrijpen op de SERT. 
Alhoewel deze therapieën de serotonerge neurotransmissie moduleren, is de efficiëntie vaak 
niet optimaal en gaat een dergelijke behandeling vaak gepaard met ongewenste bijwerkingen. 
Een goed model voor deze neuropsychiatrische aandoeningen en meer specifiek de serotonerge 
aandoeningen zou perspectieven kunnen bieden voor de ontwikkeling van medicijnen tegen 
deze stoornissen. Het doel van dit proefschrift is daarom het karakteriseren van een diermodel 
dat onderzoek naar humane serotonerge aandoeningen mogelijk maakt
Serotonine transporter
De SERT is een transporteiwit dat de extracellulaire serotonine terug naar het presynaptische 
neuron transporteert. Hier wordt serotonine verder afgebroken of opgeslagen voor hergebruik. 
Veel medicijnen die worden voorgeschreven tegen neuropsychiatrische aandoeningen blokkeren 
de SERT. Hierdoor is heropname van serotonine niet meer mogelijk en wordt de extracellulaire 
concentratie van serotonine in de synaps verhoogt. Selectieve serotonineheropnameremmers 
(SSRI) zijn stoffen die de SERT blokkeren. Zij worden veel voorgeschreven in de behandeling van 
onder meer depressie. Er zijn verschillende polymorfismen bekend in het humane SERT-gen. De 
5-HTTLPR is een insertie of deletie van 44 baseparen in een repetitieve sequentie van de promotor 
van het SERT-gen. Bij een deletie van de baseparen spreekt men van de korte variant (S), bij 
een insertie van de lange variant (L). Bij de S-variant komt de SERT minder vaak tot expressie, 
waardoor de SERT minder goed functioneert. Mensen met de S-variant lijken gevoeliger voor 
het ontwikkelen van angststoornissen en depressieve symptomen dan mensen met de L-variant, 
vooral na blootstelling van stress. Hieruit blijkt dat de serotonine transporter een belangrijke rol 
speelt in het centrale zenuwstelsel.
Serotonine transporter knock-outrat 
De laboratoriumrat (Rattus norvegicus) is een van de meest gebruikte proefdieren voor het 
bestuderen van humane aandoeningen. Veel gedragsmatige testen, die model staan voor 
humane ziekten, zijn ontwikkeld en gevalideerd voor ratten. Ook genetische variaties in het 
genoom, zoals single nucleotide polymorphism, worden bestudeerd. Nu het complete genoom 
van de rat bekend is, is het interessant om genetische variaties, zoals een gen dat uitgeschakeld 
is (knock-out), in deze diersoort te bestuderen. Deze variaties kunnen een belangrijke rol spelen 
in het onderzoek naar associaties tussen genen en gedrag. 
In hoofdstuk 1 wordt beschreven hoe de serotonine transporter knock-outrat (SERT-/-) is gemaakt. 
Kort samengevat vindt dit plaats met behulp van de mutagene stof N-ethyl-N-nitrosourea (ENU). 
ENU is in staat zijn ethylgroep over te dragen aan de nucleobasen in nucleïnezuren; hierdoor 
ontstaan op willekeurige basis puntmutaties in het DNA van spermatogenale stamcellen. Bij een 
puntmutatie wordt één nucleotide uitgewisseld voor een andere. Als deze mutatie optreedt in 
een coderend gedeelte van een gen, kunnen er duidelijk zichtbare gevolgen zijn. In de SERT-/-
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-rat is door zo’n puntmutatie een premature stopcodon ontstaan, waardoor translatie van het 
DNA niet meer mogelijk is. Het gen is uitgeschakeld (knock-out) en zal niet worden afgelezen, 
waardoor er geen functioneel eiwit gevormd wordt. Zoals eerder genoemd speelt de SERT een 
belangrijke rol in het centrale zenuwstelsel. De SERT-/--rat is daarom een interessant model om 
dysfuncties in het serotonerge systeem mee te onderzoeken.
Als het SERT-gen niet meer functioneert, heeft dit gevolgen voor de rat. In hoofdstuk 2 wordt 
een primaire karakterisatie gegeven van de SERT-/--rat. Door de puntmutatie in de SERT blijkt dat 
het SERT-mRNA en het functionele eiwit niet langer aanwezig zijn. Daarnaast kan het tritium 
gelabeld citalopram (een SSRI) niet meer binden aan de SERT. Door de afwezigheid van het 
SERT- eiwit is het logisch dat de serotoninehomeostase wordt verstoord. De verstoring blijkt uit 
het verlaagde serotoninegehalte in verschillende hersengebieden, maar ook uit de verlaagde 
elektrisch opgewekte [3H]serotonineafgifte in meerdere hersengebieden.
 D-fenfluramine is een serotonine-releaser die werkzaam is middels de SERT. Na toediening 
van d-fenfluramine vindt een uitstoot plaats van serotonine, die een verlaging van de 
lichaamstemperatuur (hypothermie) veroorzaakt. Bij de SERT-/--rat is deze temperatuurverlaging 
niet meer aantoonbaar. Nu de SERT niet langer functioneel blijkt, is heropname van serotonine 
in het presynaptische neuron niet mogelijk. Daardoor is het extracellulaire serotoninegehalte 
tot ongeveer negen keer verhoogd. In vitro is de opname van serotonine in hippocampale 
synaptosomen met ongeveer 72% verlaagd; er treden echter geen veranderingen op in de 
activiteit van de tryptofaanhydroxylase, een enzym dat betrokken is bij de synthese van 
serotonine, en in de activiteit van de monoamine-oxidase, een enzym dat betrokken is bij de 
afbraak van serotonine. Buiten het serotonerge systeem zijn ook geen verschillen gevonden 
aangaande de noradrenalinetransporter (NET) en de dopaminetransporter (DAT) concentraties, de 
monoamineniveaus en de door depolarisatie geïnduceerde afgifte van dopamine, noradrenaline, 
glutamaat en GABA. Omdat de opname van serotonine verlaagd, maar niet compleet afwezig is, 
is het aannemelijk dat de dopamine- of noradrenalinetransporter een gedeelte van de serotonine 
opname voor zijn rekening neemt. In de hippocampus blijkt dat remming van de DAT niet leidt 
tot een verandering in serotonineopname. Wanneer de DAT en NET beide geremd worden, 
blijkt dat de serotonineopname afneemt. Dit duidt erop dat de NET verantwoordelijk is voor 
serotonineopname in de hippocampus. De hippocampus is rijk aan noradrenaline, waardoor het 
aannemelijk is dat de serotonine door de NET wordt opgenomen. Dit sluit echter niet uit dat in 
een gebied als het striatum, waar dopamine de overhand heeft, de serotonineopname door de 
DAT wordt gereguleerd, zoals eerder in SERT-/--muizen is aangetoond. 
Angst en depressie 
Angststoornissen en depressie hebben veel overeenkomsten, zoals een verminderde 
concentratie, vermoeidheid, verhoogde irritatie, slaapstoornissen, nervositeit en rusteloosheid. 
Het is algemeen bekend dat het verminderd functioneren van serotonine een rol speelt bij de 
ontwikkeling van depressies. Bij patiënten met een depressie is er bijvoorbeeld een verlaging 
van 5-HIAA (metaboliet van serotonine) gevonden in de cerebrale vloeistof, hetgeen duidt op 
een verlaagd serotoninemetabolisme. Daarnaast is een vermindering gevonden van bepaalde 
serotoninereceptoren, met name in het aantal 5-HT1A-receptoren. Deze receptoren herstellen zich 
niet meer na remissie van depressie. In beeldverwerkingsstudies van depressieve patiënten is 
aangetoond dat bij hen minder serotonineopname mogelijk is. Daarnaast is de beschikbaarheid 
van SERT aantoonbaar verminderd bij zowel depressieve patiënten als patiënten met een 
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angststoornis. Hieruit valt te concluderen dat veranderingen in het serotonerge systeem 
bijdragen aan symptomen van depressies en angststoornissen. Als het serotonerge systeem 
goed functioneert, is de kans op het ontwikkelen van deze verschijnselen kleiner.
In hoofdstuk 3 komt aan de orde of SERT-/--ratten gevoeliger zijn in angst- en depressiegerelateerde 
testen. Omdat vrouwen vaker depressies en angststoornissen ontwikkelen dan mannen, is in 
dit hoofdstuk ook gekeken naar geslachtsverschillen. Vergeleken met SERT+/+-ratten bleken 
zowel mannelijke als vrouwelijke SERT-/--ratten minder tijd door te brengen in het centrum 
van het open veld en op de open armen van een verhoogde plus-maze. Daarnaast duurde het 
langer voordat SERT-/ --ratten begonnen met eten in een nieuwe omgeving en uit hun thuiskooi 
ontsnapten. Samengevat lijkt het erop dat SERT-/--ratten meer angstgerelateerde gedragingen 
vertonen dan SERT+/+-ratten.  De zwemtest waarin geen ontsnapping mogelijk is, wordt gebruikt 
om antidepressiva te testen. Zodra een rat doorheeft dat het onmogelijk is om uit de zwemtest 
te komen, zal het dier blijven drijven en zo min mogelijk zwemmen (immobiel worden). Na 
toediening van antidepressiva blijven ratten langer proberen om te ontsnappen (ze blijven 
mobiel). SERT-/--ratten bleken eerder immobiel te worden dan SERT+/+-ratten, wanneer ze aan 
deze test werden blootgesteld.  Depressieve mensen beleven minder plezier aan dingen waarvan 
ze eerst wel genoten; een symptoom dat ook wel anhedonia wordt genoemd. In ratten is dit te 
meten door suikerwater naast gewoon water aan te bieden en te meten hoeveel suikerwater er 
wordt ingenomen. SERT-/--ratten bleken minder suikerwater te drinken dan SERT+/+-ratten. Samen 
met de verhoogde immobiliteit in de zwemtest duidt dit erop dat SERT-/--ratten ook gevoeliger 
zijn in depressiegerelateerde testen. 
Verschillen tussen mannelijke en vrouwelijke ratten zijn in dit model niet naar voren gekomen. 
Alleen in de voedseltest hadden SERT-/--mannelijke ratten een hogere latentietijd, terwijl er bij 
de vrouwelijke ratten geen verschil was tussen SERT+/+- en SERT-/--ratten. In de andere testen 
bleken SERT-/--mannelijke en vrouwelijke ratten hetzelfde te reageren. Tevens is gekeken naar 
de extracellulaire niveaus van serotonine. Deze bleek omstreeks negen maal verhoogd in 
SERT-/--ratten en niet onderling te verschillen tussen mannen en vrouwen. Daarnaast is een 
immunokleuring uitgevoerd om te onderzoeken of het aantal serotonerge neuronen verschilt 
tussen SERT+/+- en SERT-/--ratten. Dit bleek niet het geval te zijn. Bovendien waren er geen 
verschillen tussen mannelijke en vrouwelijke ratten. Deze bevindingen tonen aan dat SERT-/--
ratten angst- en depressiegerelateerd gedrag vertonen,  onafhankelijk van hun geslacht. Blijkbaar 
heeft de genetische inactivatie van de SERT een dermate grote impact op de neurotransmissie 
van serotonine dat mogelijke verschillen tussen mannen en vrouwen worden gemaskeerd.
Tryptofaandepletie
Serotonine wordt gemaakt uit tryptofaan, dat we binnenkrijgen via ons voedsel. Als tryptofaan 
zich in de bloedbaan bevindt, moet het de competitie aangaan met vijf andere grote aminozuren 
om actief door de bloed-hersenbarrière getransporteerd te worden. Hoe minder concurrerende 
eiwitten, hoe hoger het tryptofaangehalte in het brein. Eenmaal in het brein wordt tryptofaan 
omgezet in serotonine. De beschikbaarheid van vrij tryptofaan is dus de beperkende factor in de 
synthese van serotonine. Acute tryptofaandepletie is een manier om het serotonerge systeem 
uit te dagen. Door een verlaging van tryptofaan in het bloed zal het serotoninegehalte in de 
hersenen dalen. Toediening van een aminozuurmix zonder tryptofaan leidt tot een verlaging 
van tryptofaanniveaus in het plasma en tot een verlaging van serotonineniveaus in de hersenen. 
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Daarnaast is gebleken dat acute tryptofaandepletie leidt tot een verminderd geheugen; dit is 
gevonden bij zowel mensen als ratten.
In hoofdstuk 4 komt de bepaling van concentraties plasmatryptofaan, centrale serotonine 
en 5-HIAA van SERT-/--, SERT+/-- en SERT+/+-ratten na acute tryptofaandepletie aan bod. Bij alle 
drie de genotypen was het plasmatryptofaan, het serotoninegehalte in de hippocampus en 
frontale cortex en de 5-HIAA niveaus verlaagd, met de sterkste daling bij de SERT-/--ratten. Met 
een standaarddosering van tryptofaandepletie was de objectherkenning van de SERT+/+-, de 
SERT+/-- en de SERT-/--ratten  verslechterd. Bij een lagere dosering bleken de SERT+/-- en de SERT-/--
ratten gevoelig voor de depletie (geen objectherkenning), maar de SERT+/+-ratten niet (volledige 
objectherkenning). Deze resultaten laten zien dat SERT-/-- en SERT+/--ratten gevoeliger zijn voor 
acute tryptofaandepletie dan SERT+/+-ratten.
Farmacologische respons
Een verandering in het serotonerge systeem zou de gevoeligheid van serotonine receptoren 
kunnen beïnvloeden. Daarnaast zou een verandering in het serotonerge systeem ook een invloed 
kunnen hebben op de gevoeligheid van het GABAerge, het dopaminerge en het noradrenerge 
systeem, daar het interacteert met deze systemen.
Het is bekend dat na chronische toediening van SSRI’s de gevoeligheid van serotonerge 
receptoren verandert. De verhoogde extracellulaire serotonine van de SERT-/--rat zou vergelijkbare 
gevolgen kunnen hebben op het functioneren en de gevoeligheid van serotoninereceptoren. 
Daarom is in hoofdstuk 5 gekeken naar het effect van flesinoxan, een 5-HT1A receptor agonist, 
op de lichaamstemperatuur en stressgeïnduceerde hyperthermie (SIH). Beide processen kunnen 
worden gemoduleerd door 5-HT1A receptor(ant)agonisten. De hypothermie, die door flesinoxan 
geïnduceerd wordt, bleek afwezig in de SERT-/--rat. Interessant genoeg werd de SIH in SERT-/--
ratten wel verminderd door flesinoxan, ofschoon de dosering om dit te bewerkstelligen hoger 
lag bij SERT-/--ratten dan bij SERT+/+-ratten. Deze verhoging in dosering zou verklaard kunnen 
worden door het ontbreken van hypothermie bij SERT-/--ratten, terwijl bij SERT+/+-ratten de 
hypothermie bij een lagere dosering op gang was gebracht. Toediening van WAY100635, een 
5-HT1A receptor antagonist, resulteerde in een verhoogde SIH-respons bij SERT-/--, hetgeen bij 
SERT+/+-ratten niet zichtbaar was. Deze resultaten tonen aan dat de gevoeligheid van de 5-HT1A-
receptor veranderd is bij SERT-/--ratten. De verlaagde gevoeligheid van de 5-HT1A-receptor kan 
verklaard worden door de hoge endogene tonus, door desensitisatie van de 5-HT1A-receptor, 
of door beide. De opmerkelijke hyperthermie in SERT-/--ratten die ontstaat na toediening van 
WAY100635 is hoogstwaarschijnlijk te verklaren door de hoge endogene serotonineconcentratie, 
die de receptoren continu bezet. Doordat WAY100625 de serotonine van de receptor verdringt, is 
de compensatie duidelijk zichtbaar. Dat flesinoxan de hypothermie niet in gang kan zetten, maar 
wel een verlaging van de SIH kan geven, duidt erop dat deze processen, in ieder geval bij SERT-
/--ratten, gereguleerd worden door verschillende populaties van 5-HT1A-receptoren. Immers, de 
ene populatie (de receptoren betrokken bij SIH) is gevoelig voor een 5-HT1A receptoragonist, 
terwijl dit bij de andere populatie (de receptoren betrokken bij hypothermie) in het geheel niet 
het geval is.  
Serotonine interacteert met andere neurotransmittersystemen. Een verandering in het 
serotonerge systeem zou hun functioneren dus kunnen beïnvloeden. In hoofdstuk 6 is bij de 
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SERT-/--rat gekeken naar de effecten van toediening van een DAT-blokker, een NET-blokker en een 
GABAA-receptor-agonist op SIH en lichaamstemperatuur. 
GABAA-receptoren spelen een belangrijke rol in autonome stress en angst. Bij veel diersoorten 
kan de SIH gereduceerd worden door GABAA-receptor-agonisten. Chlordiazepoxide (CDP) is 
een GABAA-receptor-agonist en verlaagt de SIH in zowel de SERT+/+- als de SERT-/--ratten. De 
hypothermie, die ontstaat na CDP, is ook terug te vinden in beide genotypen, alleen duurt het 
effect bij SERT-/--ratten langer. Hieruit blijkt dat er een adaptatie heeft plaats gevonden in het 
GABAergic systeem. 
Naast het GABA systeem beïnvloedt serotonine ook het dopamine- en noradrenalinesysteem. 
Onderzoek heeft aangetoond dat door gebruik van SSRI’s de spontane vuursnelheid van 
noradrenerge neuronen in de locus coeruleus en dopaminerge neuronen in het ventrale 
tegmentaalgebied vermindert. Zoals in hoofdstuk 2 is beschreven, kan serotonine langs 
alternatieve routes worden opgenomen door de SERT-/--mutant. Het is de vraag wat het effect 
zal zijn van een blokkade van de NET, de DAT, of beide tegelijk. Na blokkade van de NET met 
atomoxetine is te zien dat SERT-/--ratten gevoeliger zijn voor deze blokkade. Bij een lagere 
dosering is al duidelijke hypothermie te zien bij de SERT-/--rat; bij de SERT+/+-rat zien we dit pas 
bij een hoge dosering. Hieruit blijkt dat een milde adaptatie heeft plaatsgevonden en dat de 
SERT-/--rat een iets actiever NET-systeem heeft dan de SERT+/+-rat. Na toediening van de DAT-
blokker GBR12909 was er bij de SERT+/+-rat geen effect op de lichaamstemperatuur, terwijl er een 
duidelijke hypothermie te zien was bij de SERT-/--rat. Hetzelfde resultaat werd bereikt na blokkade 
van zowel de NET en de DAT door toediening van bupropion. Opnieuw was een hypothermie 
zichtbaar bij de SERT-/--rat en niet bij de SERT+/+-rat, vermoedelijk als gevolg van de blokkade van 
de DAT. Ook hieruit blijkt dat een adaptatie in het dopaminerge systeem heeft plaatsgevonden. 
De onderzoeksresultaten maken duidelijk dat een verandering in het serotonerge systeem ook 
veranderingen teweeg brengt in het dopaminerge, het noradrenerge en het GABAerge systeem, 
zoals is gebleken bij de SERT-/--rat. 
Een goed diermodel voor humane serotonerge aandoeningen
In hoofdstuk 7 worden de bevindingen bediscussieerd en wordt antwoord gegeven op de 
vraag of de SERT-/--rat een goed diermodel is voor humane serotonerge aandoeningen. De SERT-
/--rat is een van de beschikbare genetische en farmacologische modellen waarmee de rol van 
serotonine, en in het bijzonder van de SERT, in bepaalde centrale processen bestudeerd kan 
worden. Het SERT-gen functioneert bij de SERT-/--rat vanaf de conceptie niet. Daarnaast hebben 
er verschillende compensaties in het dier plaatsgevonden. Het fenotype van een knock-outrat 
hoeft daarom niet per se een oorzaak te zijn van het missen van het gen, maar kan ook een gevolg 
zijn van secondaire adaptaties in het systeem. De functie van de SERT zou misschien het beste 
bestudeerd kunnen worden met een stof die de SERT zeer selectief blokkeert, zoals een SSRI. Dan 
nog blijft de SERT-/--rat met zijn adaptaties zeer belangrijk om stabiele (genetische) individuele 
verschillen in centrale serotonerge activiteit te onderzoeken. Het is belangrijk om deze processen 
te begrijpen, zodat duidelijker wordt hoe de interacties tussen bepaalde systemen plaatsvinden 
en hoe adaptaties in het centrale zenuwstelsel ontstaan. Daarnaast is het aannemelijk dat door 
bepaalde adaptaties in het lichaam de gevoeligheid voor bepaalde medicijnen verandert. 
Chronische behandeling met een SSRI resulteert in een verminderde expressie en functie van de 
SERT en verhoogde extracellulaire serotonineniveaus. Daarnaast is aangetoond dat de functie 
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van de 5-HT1A-receptor vermindert na gebruik van SSRIs. Deze adaptaties zijn vergelijkbaar 
met de bevindingen bij de SERT-/--rat. Er zijn echter belangrijke verschillen. De SERT-/--rat 
vertoont angst- en depressieachtig gedrag, terwijl SSRI’s vaak worden gebruikt om dit gedrag 
tegen te gaan. Het is bekend dat kinderen van vrouwen die tijdens hun zwangerschap SSRI’s 
hebben gebruikt op volwassen leeftijd gevoeliger zijn voor het ontwikkelen van angst- en 
depressiestoornissen. Een verklaring hiervoor zou kunnen zijn dat de verminderde SERT-functie 
vanaf de zwangerschap aanwezig is en daarom ook de verstoorde serotonineniveaus. Het is dus 
belangrijk dat de serotoninehuishouding normaal functioneert tijdens de foetale ontwikkeling, 
de kindertijd, maar ook in het volwassen leven. Er zijn gedragingen bekend na het gebruik van 
SSRI die overeenkomen met fenotypen in de SERT-/--rat. Chronisch gebruik van SSRI’s vermindert 
bijvoorbeeld agressiviteit en seksueel gedrag, wat ook gevonden werd bij SERT-/--ratten. Blijkbaar 
zijn niet alle SERT-/--gerelateerde gedragsfenotypes tegengesteld aan het gedrag na chronisch 
gebruik van SSRI’s. Het is mogelijk dat sommige effecten van chronische SSRI-behandeling 
direct relateren aan de inhibitie van de SERT, terwijl andere gedragingen wellicht relateren 
aan compensaties in het lichaam, of het resultaat zijn van veranderingen tijdens de foetale 
ontwikkeling door systematisch gemis van de SERT.
De ENU-geïnduceerde mutagenese levert in theorie, naast de premature stopcodon in het 
SERT-gen, ook onbekende mutaties op. Maar omdat de SERT-/--rat zowel verwachte als nieuwe 
fenotypes laat zien, wordt aangenomen dat deze mutaties zijn uitgekruist. De fenotypen van 
de SERT-/--rat kunnen gebruikt worden om de functie en met name de rol van de SERT in het 
ontwikkelen van bepaalde stoornissen te onderzoeken. Daarnaast is de SERT-/--rat een goed 
model voor verschillende fenotypen. De SERT-/--muis heeft vele nieuwe serotonine-gerelateerde 
fenotypen en processen aan het licht gebracht. De SERT-/--rat kan hieraan bijdragen, omdat het 
repertoire van gevalideerde, gedragsmatige testen en gevalideerde, neurochemische technieken 
voor ratten vele malen groter is dan voor muizen. Gezien de uitkomsten van onderzoek met 
de SERT-/--rat lijkt deze mutant een waardevol model in de neurowetenschappen. Toekomstig 
onderzoek met de SERT-/--rat zou een fundamentele bijdrage aan het onderzoek naar serotonerge 
stoornissen kunnen leveren.
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Dankwoord
Mijn promotietraject is een ontzettend leuke, onvergetelijke en leerzame periode geweest. 
Natuurlijk heb ik dat aan een hoop mensen te danken die ik op deze pagina’s in het bijzonder wil 
bedanken.
In de eerste plaats wil ik mijn co-promotor Bart Ellenbroek en promotor Lex Cools bedanken. 
Bart, jouw enthousiasme voor dit onderzoek werkt aanstekelijk. Het was soms moeilijk om keuzes 
te moeten maken, want alles was leuk! Gelukkig hebben onze besprekingen en discussies, zelfs 
na je vertrek bij PNF, een goede richting aan het onderzoek gegeven. Bedankt voor alles!
Lex, met name in het laatste jaar heb jij je over mij ontfermd. Na het vertrek van Bart en mijn 
overplaatsing naar een andere afdeling, heb jij me meteen het gevoel gegeven dat ik bij je terecht 
kon. Je maakte altijd (ondanks je overvolle agenda) tijd voor me vrij als ik ergens mee zat. Ook 
jouw data-interpretaties en hulp tijdens het schrijven heb ik erg gewaardeerd. Dank daarvoor!
Edwin Cuppen, jou wil ik bedanken voor de goede samenwerking en het vertrouwen in mijn 
onderzoek. Ik heb het erg leuk gevonden dat ik af en toe een snufje in de keuken van het Hubrecht 
Institute mocht nemen. Peter Deen, ondanks dat ik geen fysioloog ben, heb jij me in je groep 
opgenomen. Hierdoor kon ik mijn onderzoek toch nog afronden waar ik je erg dankbaar voor ben.
Verder wil ik al mijn collega’s van PNF (Martine, Liselotte, Michel, Luuk, Dick, Carly, Cathalijn 
en Elvira) bedanken voor alle gezelligheid, borrels, discussies en roddels. Het was af en toe 
één grote soap! Martine, je verhalen blijven me boeien. Niks is te gek bij jou: heerlijk om naar 
te luisteren! Liselotte, jij was een erg gezellige collega. We hebben een hoop gelachen. Vooral 
met het trainen voor de Nijmeegse 4-daagse! Michel, met name in het laatste jaar hebben we 
veel steun aan elkaar gehad, omdat we in hetzelfde schuitje zaten. Ik denk dat jij toch echt 
de laatste AIO van Lex bent! Luuk, jij ook bedankt voor al je gezelligheid en behulpzaamheid 
tijdens de experimenten. Dick, het was een stuk gezelliger op mijn kamer als jij er zat. Bedankt 
voor alle goede koffiegesprekken en natuurlijk ook voor de introductie in de statistiek, ik ben 
er een stuk wijzer van geworden. Ik ben benieuwd of we elkaar nog tegenkomen tijdens de 
zevenheuvelenloop en vooral, wie er dan sneller is! Carly, meteen vanaf het begin dacht ik al: 
prettig gestoord, maar wel gezellig! Ik zal jullie allemaal missen! 
Natuurlijk hebben er ook veel studenten op de afdeling rondgelopen, een paar wil ik in het 
bijzonder noemen: Margreet, Peter, Miel, Rik, Rembrandt, Frank, Linda, Francisca, Monique, 
Ruud (alias überchipper) en Rachel. Jullie zijn allemaal studenten op mijn project geweest en 
hebben dus min of meer bijgedragen aan dit proefschrift, bedankt voor jullie inspanningen. 
Ook van het Hubrecht Institute in Utrecht wil ik een aantal mensen bedanken. Judith, onze 
samenwerking was toch de meest essentiële. We hebben een hoop over en weer gemaild en veel 
samen gedaan. Het werk is er alleen maar beter van geworden, bedankt voor al je input. Joram, 
in het begin als student, maar later als AIO, was het prettig om samen te werken. Ook naast het 
werk hebben we een hoop gelachen tijdens de voetbalcompetitie FC PNF tegen FC Hubrecht. 
Gelukkig bleek PNF altijd de sterkste! Bart, ook jij bedankt voor de goede samenwerking in mijn 
eerste jaar.
Hoofdstuk 4 heb ik mede te danken aan collega’s uit Maastricht. Linda, je hebt me voor een paar 
maanden vergezeld in Nijmegen. Naast dat we daar samen heel wat mooie experimenten hebben 
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gedaan was het vooral ook heel erg leuk om met je samen te werken. Jammer dat we nu niet 
meer het werk de schuld kunnen geven van onze soms wel uren durende telefoongesprekken. 
Arjan, ook jou wil ik bedanken voor je input voor de tryptofaan experimenten.
Collega’s van neuroanatomie: Jan, Jos en Trynke, ik vond het altijd erg gezellig om de histologie 
bij jullie uit te voeren. Bedankt voor al jullie tips en expertise in de anatomie. Marieke en Thomas 
bedankt voor alle microdialyse experimenten die jullie in Groningen uitgevoerd hebben bij 
Brains online. Het is een onmisbaar gedeelte van hoofdstuk 2 en 3 geworden. Henk, Annet, 
Frans, Henny en Leo, bedankt voor de goede zorg over mijn ratten. Henk en Annet jullie wil ik 
in het bijzonder bedanken voor al jullie inzet. Met name als ik weer met mijn lijsten aan kwam 
zetten, waren jullie altijd bereid om te helpen. Het chippen was altijd erg gezellig om samen met 
jullie te doen. 
Pascal bedankt voor de lay-out en omslag van mijn proefschrift. Ik hoop dat je er niet gek van 
geworden bent! Wouter, bedankt voor de last minute check! Ben, fijn dat je mijn introductie en 
nederlandse samenvatting wilde checken, bedankt daarvoor.
Als je aan het einde van je proefschrift met vierkante ogen naar het computerscherm zit te staren, 
waardeer je iedereen die je (tijdelijk) achter het scherm vandaan heeft gehouden. Vrienden, 
voetbaldames, FC PNFers, tennispartners, shop until you drop vriendinnetjes, ik ga jullie 
allemaal bedanken op het feest!
Paranimfen horen bij promoveren. Vincent, jou ken ik al vanaf de eerste dag dat ik ging studeren. 
Toen was het al gezellig en dat is eigenlijk altijd zo gebleven. Bedankt voor je vriendschap en 
gezelligheid. Xandra, samen in één buik zitten schept toch een hele speciale band. En vanaf 
het moment dat papa en mama ons op onze zolderkamer uit elkaar haalden omdat we te 
veel kletsten in plaats van huiswerk maken wisten we het al: onafscheidelijk! Onze dagelijkse 
telefoongesprekken bewijzen dat maar weer! 
Pap en Mam bedankt voor jullie onvoorwaardelijke steun en liefde. Jullie hebben me de basis 
meegegeven en zonder dat had ik het nooit gekund! Mam, bedankt voor je luisterende oor, 
adviezen en steun. Ik ben erg blij dat ik mijn hart af en toe eens bij je kon luchten. Pap, ik weet 
nu zeker dat ik in elk geval de helft van jouw genen heb. Samenwerken met je eigen vader is 
toch wel heel speciaal, fantastisch dat we dat ook hebben laten zien in twee artikelen die in dit 
proefschrif t staan, bedankt voor al jouw steun daarbij! 
Broer, zussen & co; Selina, Anne-Gjalt, Susanne, Flynn, Xandra, Ben, Wies &  Ben, bij onze 
grote familie hoort gezelligheid, lachen en discussies. Heerlijk! Ik ben blij dat ik jullie (schoon)zus ben.
De van Eijkjes horen hier natuurlijk ook te staan. Joop en Lea, bedankt voor de vele interesse die 
jullie getoond hebben tijdens mijn promotieonderzoek. Ondanks dat ik ga promoveren mogen 
jullie mij altijd jullie Guppie blijven noemen. Ric, Bianca, Tarn, Jana, Ivar, Guido, Saskia, Jaap, 
Luza en Lonne jullie ook bedankt voor al jullie interesse. Hopelijk komt er nu weer meer tijd voor 
logeerpartijtjes!
Lieve Roel, ik ben blij dat jij er altijd voor me bent. Eigenlijk wil ik maar een ding tegen jou zeggen: 
ik vind je lief! 
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Jocelien Danielle Attalie Olivier was born on 4 April 1978 in Kampen, the Netherlands. In 1995 she 
passed her final exams at the Christelijke College Nassau Veluwe in Harderwijk and studied from 
1995 till 2000 higher laboratorial education at the Hogeschool van Utrecht. In order to receive 
her Bachelor degree in zoology, she investigated the effects of CREB activity in the nucleus 
accumbens on rat behavior and investigated the influence of the retinoid receptor RXRγ on 
adaptive changes in the nucleus accumbens caused by opiate addiction. This internship was 
performed under supervision of dr. Michel Barrot and Professor dr. Eric Nestler at Yale University, 
New Haven, U.S.A.. In 2000 Jocelien started her study in Medical Biology at the Vrije Universiteit 
in Amsterdam. During her Master degree she investigated the effects of apomorphine on sexual 
behavior of male rats and studied the brain areas activated in sexual behaviour. This internship 
was performed under supervision of dr. Jan Veening at the Radboud University Medical 
Centre Nijmegen. In 2002 she worked one year as a Research Associate at Utrecht University. 
Since 2003 Jocelien worked as a PhD-student on the research project “Reverse genetics by 
resequencing of mutagenized animals; Making a knock-out library of the rat” at the department 
of psychoneuropharmacology of the Radboud University Medical Centre in Nijmegen, under 
supervision of dr. Bart Ellenbroek and prof. dr. Alexander Cools. Most of the results obtained in 
this project were described and discussed in the present thesis.
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